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SUMMARY 
Radiotherapy is a medical technique which utilises ionising radiation in the 
treatment of malignant cells. The source of this ionising radiation is typically high 
energy photons or electron beams, which are potentially deadly to all cells at high 
dosage. For this reason, these beams which are also carcinogenic must be targeted in 
such a way as to only eradicate cancerous cells while preserving surrounding normal 
tissue.  
Developments in the field of nanotechnology have potentially provided an 
alternative to conventional radiotherapy techniques through the application of 
nanomaterials such as gold nanoparticles (AuNPs). High atomic (Z) number materials 
such as iodine and gadolinium have already been successfully used as dose enhancers 
when applied to tumours in preclinical trials. This has paved the way for the 
investigation of AuNPs as possibly preferable radiation dose enhancers, which is the 
subject of this thesis.  
The main aim of this work was to investigate the feasibility of the application 
of AuNPs for radiation dose enhancement for various radiotherapy techniques; 
specifically, this thesis focuses on superficial radiotherapy (SXRT), microbeam 
radiotherapy (MRT) and synchrotron based stereotactic radiosurgery (SSR). Studies 
were conducted using biological cell survival assay and phantom using polymer gel. 
The cell culture study demonstrated in this thesis is based on endothelial cells model 
which are the vital component in tumours biological system. In the complex structure 
of tumours involving microvasculature, it is important to take into account the 
radiation damage to the cells lining the vasculature. It might be unrealistic to assume 
that the AuNPs were uniformly distributed throughout the tumor and tissue.  
Therefore, endothelial cells lining the blood vessel might receive a significantly high 
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dose, which could lead to tumor death when the blood vessel is damaged. While the 
primary aim is to eradicate the tumours cells, it is very important to understand the 
response of normal cells to radiation especially in the presence of AuNPs which is 
part of the novel work in this thesis. 
The results of the study provide evidence that AuNPs are effective dose 
enhancers for superficial radiotherapy using kilovoltage x-ray beam and megavoltage 
electron beam. The AuNPs enhanced the cells killing up to 15 times for 1 mMol/L of 
AuNPs irradiated with 80 kVp x-ray beams. Maximum dose enhancement factor (DEF) 
of 3 times was measured for 6 MeV electron beams in the presence of 1mMol/L 
AuNPs. However, minimal dose enhancement was observed for megavoltage photon 
beams which measured DEF are around 1 time (100% enhancement). Radiobiological 
analysis of the dose enhancement by AuNPs using linear quadratic model found 
systematic changes of alpha (α) value which is increases with inclusion of AuNPs while 
there are very small changes for beta (β) value. DEF was also calculated from analysing 
the Mean Inactivation Dose ( D ) which showed good agreement with results obtained 
from a cell survival curve. 
MRT is an innovative radiotherapy technique that uses a beam of microscopic 
scale with very high dose of x-rays (several hundred Gy) from a synchrotron source. 
Synchrotron generated x-rays provide very high intensity beams compared to 
conventional x-rays. They have minimal beam divergence and are able to produce 
higher dose rate irradiation. These particular properties are used to create radiosurgical 
techniques that may eventually eliminate radioresistant cancers, such as brain tumours, 
which are surrounded by sensitive normal tissue. Unlike conventional radiosurgery 
treatment, which uses megavoltage photon beams, MRT uses synchrotron x-rays with 
spectral energies similar to those of kilovoltage machines which is the optimal energy to 
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be employed in combination with high Z materials. Studies focused on dose 
enhancement by AuNPs for MRT produced consistent results with studies on broad 
beam using superficial x-rays and electron beams. Less number of cells survived 
compared to the control and the irradiation area is completely eradicated when treated 
with MRT in the presence of AuNPs. These findings lead to the conclusion that the 
combination of MRT and AuNPs may permit much lower curative doses to be applied 
to the tumours without exceeding the normal tissue tolerance dose.  
An important aspect of MRT is the regeneration of normal tissue vasculature 
after exposure to high radiation dose. The tolerance of normal tissue to such high doses 
is due to the migration of endothelial cells, which replace the damaged irradiated 
endothelial cells. The presence of AuNPs may increase the number of the tumour cells 
killed by MRT; however, investigation of how the normal tissue repair mechanism is 
affected by the presence of AuNPs is needed and is therefore also included in this 
thesis. The cell migration into the depleted gap created by the microbeam was observed 
and it is found that AuNPs are involved in accelerating the cells migration. In another 
experiment, scratch assays were conducted to investigate the role of AuNPs in the 
acceleration phenomenon of the rate of cell migration into the gap. Similar results were 
obtained where cells with AuNPs fill the gap faster in comparison to the control cells. It 
is also observed that normal cells migrate faster compared to the tumours cells which 
indicates differential cell response between normal and tumour cells in the presence of 
AuNPs.   
An area of ongoing research on the use of AuNPs is that of the assessment of 
their toxicity in humans. While gold is a relatively inert and biocompatible material, in 
the form of nanoparticles its toxicity is dependent upon the possible surface coating and 
the functional groups attached to the particles. Assessment of AuNPs’ toxicity is 
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included as parts of this thesis. Results of the studies on the AuNPs cytotoxicity for 
different concentrations and sizes were found to be minimal. Viability tests and cell 
morphology studies show no significant effects of AuNPs to the cells (P < 0.05).  
The phantom study of polymer gel doped with AuNPs yields fascinating results 
in terms of the application of polymer gel dosimeter to measure the dosimetric effects of 
metallic nanoparticles. The use of methods other than biological study to measure the 
radiological effects of radiosensitiser and contrast agents is difficult using the current 
dosimeters available in medical radiation. In this work, normoxic type Polyacrylamide 
Gel (nPAG) dosimeters are employed for dose quantification for different sources of 
radiation. Comparison of dose deposited by the same beam in nPAGs with those 
impregnated with gold nanoparticles (AuNPs) is used as an indicator of the level of 
dose enhancement by radiations due to the existence of the AuNPs. In the presence of 
AuNPs, the dose enhancement ratio was 1.94 +/- 0.66 and 1.10 +/- 0.15, for 80 kV x-
rays and 6 MV electron beam, respectively. This study show that AuNPs effectively 
enhance the absorbed dose when irradiated with kilovoltage x-rays and electron beams. 
The results from the phantom study are in agreement with the biological study where 
the effects of enhancement were observed for both materials. This phantom study using 
polymer gels shows that these gels are suitable in assessing AuNPs as a tool to enhance 
dose delivery to tumours.  In conclusion, AuNPs can potentially be applied as a novel 
radiobiological dose enhancer for radiation therapy, synchrotron based microbeam and 
stereotactic radiotherapy as reported in this thesis.   
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THESIS OUTLINE 
 
This thesis is divided into 2 sections: 
Section A: Biological / Cell culture study 
Section B: Phantom study  
 
Chapter 1 is an introduction to basic radiation physics, radiobiology and AuNPs. The 
aims of the thesis are also explained. 
Chapter 2 contains a review of previous and current work on radiation dose 
enhancement using high Z material and AuNPs. Detailed description of the interaction 
of radiation with high atomic number materials and the theoretical background of the 
dose enhancement effects are also provided. The dose enhancement factor for different 
concentrations of AuNPs and beam energies is also calculated and presented in this 
chapter.  
Chapter 3 describes the general protocols for radiobiological study using cell culture. 
The protocols specify the correct preparation of AuNPs for biological study, cell culture 
protocol, cell irradiation methodology with different x-rays modalities and cell survival 
assay. In this chapter, a technique for measuring the cell survival curve using 
colorimetric assay, which requires less time and is less technically demanding than 
clonogenic assay, is developed. Protocol for measuring AuNPs cytotoxicity and 
localisation inside the cells are also described. 
Chapter 4 contains the results of the experiments which were conducted to measure the 
dose enhancement effects of AuNPs for different x-ray beam energies, AuNPs 
concentration and also electron beams. The Dose Enhancement Factor (DEF) is 
extrapolated from the cell survival curve and the kilovoltage energy range is identified 
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as the range at which the maximum DEF occurs. Radiobiological parameter such as 
alpha and beta values are analysed; the alpha value is found to increase as AuNPs 
concentration increases. Cytotoxicity studies showing the minor effects of AuNPs 
toxicity to the cells is also included in this chapter. 
Chapter 5 is dedicated to the investigation of dose enhancement for MRT. This chapter 
starts with an introduction to and review of MRT, followed by experimental methods 
and results. The dose enhancement effects are measured and more cells are found to be 
killed at the irradiation area containing AuNPs. Cells with AuNPs are found to migrate 
faster to the irradiated area compared to the cells without AuNPs. This finding was 
again supported by scratch assay studies that show accelerated cell migration in the 
presence of AuNPs. 
Chapter 6 reports the results of the phantom study on dose enhancement. In this chapter, 
study using polymer gels is explained, including the gels’ preparation methods, gels 
irradiation, gels scanning and image analysis. Some review and introduction to the 
polymer gels is also included. The study was conducted using normoxic polyacrylamide 
gels doped with AuNPs and irradiated with x-rays. Results correspond to the dose 
enhancement effects as found in the biological study.  
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1. INTRODUCTION AND AIMS  
 
This chapter contains an introduction and background to radiotherapy and 
basic radiation physics. It includes an examination of the production of x-rays by 
conventional clinical modalities and the production of synchrotron radiations. Some 
radiation interaction processes at an atomic level and the effects of these interactions 
on the biological materials (targets) such as cells are illustrated. Basic biological cell 
structures and their important parts are also described to facilitate a better 
understanding of the damage caused by radiation. Definitions of the radiobiological 
and physical parameters used to quantify the radiation damages are listed. An 
introduction to the properties of gold nanoparticles (AuNPs) as dose sensitisers is 
also provided in this chapter. This chapter concludes with a description of the 
objectives of this thesis.  
 
1.1 Introduction to radiotherapy 
 
Worldwide statistics show that 12.4 million new cancer cases were 
diagnosed and 7.6 million deaths were reported from the disease in 2008 (1). In 
Australia, over 100,000 new cases of cancer are diagnosed each year (2). 
Radiotherapy has become one of the primary tools to treat and prevent the spread of 
the abnormal cancerous cells; slightly more than 50% of all patients who developed 
cancer will require radiotherapy at some stage of their illness (3).  
Radiotherapy utilises ionising radiations and has been used for over 100 
years to treat a wide variety of cancer types (4). When radiotherapy was first 
introduced, x-rays in the kilovoltage energy range were prescribed to treat cancerous 
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tissues, but the low penetration of such radiations means that they have a limited 
effect on deep-seated tumours and delivered high dose (some times above the 
threshold) to the tissues in their path to the tumour or in other word, they have low 
skin sparing effect. Major developments have recently been made to address this 
shortcoming, and within the last decade electron linear accelerators machine 
(LINAC) have been introduced which can generate higher energy x-rays and 
electron beams in megavoltage range of energy for radiotherapy. These are now the 
most common sources of ionising radiations and have been replacing kilovoltage 
and orthovoltage x-rays for use in clinical centres to deliver most forms of 
radiotherapy. Improvement in dose distribution and skin sparing by such high 
energy x-rays increased and continues to improve the effectiveness of radiotherapy 
in treating cancer since an adequate dose can be delivered to tumours without 
producing acute reaction to the skin or the surrounding normal tissues. As well as 
producing x-rays, electron LINACs can also be used to generate high energy 
electron beams which are useful for treating superficial cancers. They have therefore 
also replaced most of the kilovoltage x-rays in this application. While LINACs 
generating megavoltage x-rays are the most common modality employed in modern 
radiotherapy centres, megavoltage gamma-rays from high radioactivity cobalt-60 
sources or radioactive seeds such as iridium-192, which is used in brachytherapy, 
serve as an alternative modality in radiotherapy to treat certain types of tumours 
while being less dependent on electrical energy. Particle radiotherapy such as proton 
and heavy ion beams are less common due to the high installation cost, but are also 
currently used in the treatment of cancer. Particle radiotherapy provides better dose 
concentration at the tumour and has a proven role in the management of orbital 
tumours such as base of skull sarcoma (1) .     
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Technological advances in radiotherapy equipment have not only expanded 
the range of beam energies that can be delivered to the patient but also provided 
better tumour targeting while minimizing radiation dose to the surrounding normal 
tissues. Modern LINACs are able to perform sophisticated techniques such as 
stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) that 
produce conformal dose to the tumours with high precision. Accurate delivery of the 
radiation dose to tumours can also be enhanced through the use of imaging 
equipment to better localise the tumours. Image-guided radiotherapy (IGRT) is 
currently available in many radiotherapy centres.  
The improvement of radiotherapy treatment in order to achieve maximum 
tumour control and reduce normal tissue complications not only depends on the 
advancement in technology and engineering, but also on an understanding of 
radiobiological science. Altering tumour cell radiosensitivity with the objective to 
deliver adequate radiation dose that can eradicate the tumours without exceeding 
normal tissue tolerance may improve the whole radiotherapy treatment regime. 
Radiosensitising agents or radiation dose enhancers may increase the effect of 
radiation to the tumour provided that the agents are able to be selectively targeted to 
cancer cells. Previously, the effectiveness of oxygen as an agent to increase the 
radiosensitivity of tumours has been evaluated and various investigations have been 
made to manipulate tissue oxygen content to maximise killing of the tumour cells. 
However, concurrent treatment using hypoxic cell sensitisers was not shown to 
enhance cancer treatment (5) . Chemotherapy drugs such as cisplatin have been 
investigated as a potential radiosensitiser, but lack of dose enhancement was 
observed and they have been shown to be unsuitable for future clinical application 
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(6). Enhancing tumour radiosensitivity by increasing the cross section of radiation 
interaction in the tissue using high atomic number (Z) materials has been explored 
over the last 20 years, typically using iodinated contrast agents (7). Enhancements 
of radiation effects by iodine were observed using many biological and phantom 
studies which proved the potential applicability of high Z materials as 
radiosensitisers. This exploration has continued employing various high Z atoms 
and recent improvements in nanotechnology have made it possible to efficiently 
deliver large numbers of such high Z atoms to target regions. Among the many 
types of high Z nanoparticles which have been tested, such as silver and platinum, 
gold as a noble element was found to be the most effective and biologically 
compatible.  
Metallic nanoparticles such as AuNPs appear to be promising as a 
radiosensitiser agent for radiotherapy. Recently, the emerging nanotechnology field 
has created unprecedented potential for improving the outcome in cancer treatment 
using nanomaterials. Nanoparticles are typically smaller than several hundred 
nanometers in size, in the size range of large biological molecules such as enzymes, 
receptors and antibodies (8). In this size range (approximately one hundred times 
smaller than human cells) nanoparticles can easily interact with biomolecules such 
as proteins and cellular structures. The nanometer size and high Z properties of 
AuNPs provide potential advantages in enhancing radiation dose to the tumour 
while preserving the surrounding normal tissue which is the ultimate goal in 
radiotherapy.   
The general aim of this thesis is to investigate the feasibility of using AuNPs 
in radiotherapy as a radiosensitising agent (dose enhancer), particularly in the 
energy range which provides optimal dose enhancement. Application of AuNPs as a 
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radiosensitiser will be assessed by quantifying the dose enhancement factor (DEF), 
which represents how many times the dose is enhanced, and through radiobiological 
analysis of the cell survival curve. Studies were also conducted using polymer gel 
phantoms to validate the results obtained from in-vitro studies. Effects of AuNPs on 
cells, such as localisation inside cells and cytotoxicity, will also be examined. This 
thesis also investigates the functionalities of AuNPs in radiotherapy’s special 
techniques such as microbeam radiotherapy (MRT) and synchrotron stereotactic 
radiosurgery (SSR) which are currently heading towards clinical trial (9-10). 
Finally, this thesis will examine effects of AuNPs on normal and cancerous cell 
migration and the cellular mechanisms involved. Details of the aims and objectives 
of the thesis will be covered at the end of this chapter. 
 
1.2 Basic radiation physics 
 
Radiation can be categorised as ionising and non-ionising radiation. 
Radiotherapy utilises mainly ionising radiations to treat cancer.  The term ionising 
radiation means that the radiation has sufficient energy to ionise an atom. Photons 
such as x-rays and gamma rays are commonly used in radiotherapy, as well as other 
‘particle type’ radiations such as alpha, beta, neutrons, protons and heavy ions. The 
ionising radiations are aimed at the target and result in damage to the tumour due to 
specific interactions of ionising radiation with biological material.   
Ionising radiation can be further classified into directly ionising radiation 
and indirectly ionising radiation. The electrons, protons and alpha particles are 
charged particles which can directly interact with matter and therefore be classified 
as directly ionising radiation. This type of ionising radiation lost energy in a large 
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number of small increment along the ionising track in the medium which is utilised 
in radiotherapy to produce damage to the cancerous tissues (11). The ionising 
process will occur if the incident particles have enough energy to eject an electron 
and when there is no sufficient energy, excitation process will occur when the 
electron is only move to higher energy levels. The ejected electron in some situation 
will have enough energy to produce secondary ionising radiation which is known as 
delta (δ) ray. On the other hand, uncharged particles such as neutron and photon are 
known as indirectly ionising radiation as its interaction with matter involves 
production of directly ionising particles from the matter. Interaction of photon with 
the atom of the material will produce secondary electrons that will latter produce 
track of ionisation in the matter. The energy deposited by this secondary electrons 
responsible for most of the damaged caused by incident radiation in target such as 
tumours.  In the following sections, a brief overview of the production of x-ray or 
photon from the interaction of electron (directly ionising radiation) with matter will 
be explained. Generation of synchrotron radiation from relativistic electron 
interaction with magnetic field is presented. Interaction of photon (indirectly 
ionising radiation) which is most commonly used in radiotherapy is also given. 
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1.2.1. Production of x-rays  
 
X-rays used for imaging or therapeutic purposes are produced by two 
different mechanisms that produce which yields into two types of x-rays; 
‘bremsstrahlung’ x-rays and characteristic x-rays. In conventional x-ray tubes or 
linear accelerator, an electron will be accelerated in vacuum and aimed at a high Z 
target such as tungsten. As a result, radiative “collision” interaction between a high 
speed electron and the field of an atomic nucleus will produce a type of x-ray called 
‘bremsstrahlung’ (braking radiation) (11). In this interaction, an electron passing 
near a nucleus will be deflected or decelerated because of the attractive force of the 
target nucleus and the electron will lose energy which will be irradiated as 
bremsstrahlung x-rays. The other type of radiation that is produced, when the 
electron hits the target, is called characteristic x-rays. In this interaction, the electron 
will interact with the atom in the target by ejecting an orbital electron and results 
into a transition in the orbital electron such as K, L and M. This transition from high 
energy level to lower energy level will result in emission of characteristic x-rays. 
The emission of bremsstrahlung radiation may have any energy up to the initial 
energy of the electron but the characteristic radiations are emitted at discrete 
energies (11). The mechanism of both interactions is illustrated in Figure 1 and 
Figure 2. 
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Figure 1: Illustration of the production of bremsstrahlung x-rays. 
 
Figure 2: Illustration of the production of characteristic x-rays. 
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1.2.2. Synchrotron Radiation (SR) 
 
Synchrotron radiations (SR) are electromagnetic radiations generated when 
electrons moving at almost the speed of light in a curved trajectory under the 
influence of a circular magnetic field emit electromagnetic waves ranging in 
wavelengths from very low such as x-rays and some of much longer such as the 
visible light range (12-13). It is consist of the entire electromagnetic spectrum from 
radiowaves, infrared light, visible light, ultraviolet light, x-rays and gamma rays. 
Natural synchrotron radiation occurs in outer space were observed to be emitted by 
the pulsar wind nebulae cause by the electron trapped in the strong magnetic field 
around the pulsar. Synchrotron radiation has special characterization such as 
brightness, high intensity, high directionality and variable polarisation, which is 
different from bremsstrahlung or characteristic x-rays.  The synchrotron radiation 
produce articfially by synchrotron is the brightest man made x-rays source.  
 
1.2.2.1. Production of SR 
 
In comparison to the x-rays produced by conventional x-ray tubes or linear 
accelerators, synchrotrons produce one billion times more brilliant and intense light.  
In the third generation synchrotron, production of synchrotron radiation starts with 
an electron gun emitting an electron into a linear accelerator. The electron beam is 
accelerated before being transmitted to a booster synchrotron, which again 
accelerates the electron in orbit or circular motion. From the synchrotron, the 
electrons are then injected to the storage ring in which they circulate at almost 
99.99% of the speed of light in vacuum for several hours. During the electron 
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circulation, the synchrotron radiation is emitted from all curved parts of this orbit 
with a continuous spectrum (from infrared up to hard x-rays) (14). Figure 3 shows a 
schematic illustration of a synchrotron and its main components. 
 
Figure 3 : Schematic illustration of a synchrotron and its main component (Image from 
Australian Synchrotron) 
 
The synchrotron radiation is emitted tangential to the electron beams orbit 
when the electron is being deflected at the bending magnet in a vertical beam of 
narrow dimensions centered at the plane of the electron beam orbit. Highly 
collimated synchrotron beams produced is an important characteristic of 
synchrotron radiation which will be discuss in section 1.2.2.2.  In order to maintain 
the characteristic small narrow beam, a quadrupole or focusing magnet is used to 
provide a restoring or a focusing force to the electrons which deviate to much from 
the orbital path (ideal orbit) (15)  Yet another magnet, a sextupole or steering 
magnet, is used to correct the chromatic aberrations caused by focusing errors 
because of energy spread of electron within a bunch (15). These magnets will 
determine the basic features of the synchrotron beam before the before the beam is 
enhanced in terms of flux, brightness, and spectral range by wiggler and undulator 
insertion magnets. Wiggler magnet is functioned to produce high intensity broad 
band radiation up to photon energy larger than those available with bending magnet 
(15). Special type wigglers or undulators operate at much reduce field strength 
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provoking a weak deflection of the beam and therefore yielding a source of very 
brilliant light.  
Each time synchrotron radiation is emitted, the circulating electron losses 
energy.  This energy loss must be returned or replenished to maintain the 
circulation. The electron energy is replenished in the form of electromagnetic 
radiofrequency pulses. These radiofrequency pulses are generated by a transmitter 
and conducted to the cavity by waveguide or coaxial cables (14, 16). Further details 
about the production of synchrotron radiation can be obtained from the work of 
Bordovitsyn (1999) (14), Winick (1980) (16) and Sokolov (1967) (12).  
 
1.2.2.2. Properties and application of SR 
 
Synchrotron radiations consist of a continuous spectrum from infrared to 
hard x-rays. Synchrotron radiation produced by the latest 3rd generation 
synchrotrons like SPring-8 in Japan can achieve one billion times more intense 
radiation than the x-rays produced by conventional clinical x-rays tubes. Relativistic 
electrons moving along a circle are a source of such intense electromagnetic 
radiations as a result of large centripetal acceleration (12, 14). The synchrotron 
radiation intensity (W) is determined by a charge (e) moving along a circle of radius 
(R) with velocity (v = βc) and is proportional to the fourth power of its total energy 
E (12). The intensity is calculated using the equation  ( 1 ): 
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W = Intensity 
 e = charge  
 β = angle of charge 
 R = Radius  
 E = Total energy of electron 
 mo = mass  
 c = speed of light in vacuum 
 
Synchrotron radiation can also be described using Brilliance. Brilliance is a 
parameter to compare the quality of radiation from different sources which takes 
into account photon energy, collimation, source size and spectral distribution into a 
single quantity (17-18).  The brilliance is calculated using equation ( 2 ) :  
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Figure 4 shows a comparison of the brilliance of various radiation sources 
and also the spectrum of light produced by a synchrotron.  
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Figure 4 : Brilliance of various radiation sources. Japan Synchrotron Radiation Research 
Institute, Copyright (2008). 
  
Another feature of synchrotron radiations is that they are highly directional, 
with a narrow vertical beam centred at the plane of the electron orbit which provides 
natural collimation. The beam can also be either linearly or circularly polarized or 
time structured (short pulses separated by longer intervals) (15). These special 
features of synchrotron radiations enable many experiments from various fields to 
be done. Generally, synchrotron radiations are used for scientific studies in wide 
areas of biology, physics, chemistry and others as well as industrial application. In 
medical sciences, synchrotron radiations are becoming more important especially 
for imaging such as angiography, mammography, computed tomography and x-rays 
diffraction (19-20). It was Larsson (1983) who first suggested the use of synchrotron 
radiation for radiotherapy (21). Synchrotron radiations from the 3rd generation 
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synchrotron are highly beneficial for currently active research on microbeam 
radiotherapy (MRT) and synchrotron stereotactic radiosurgery (SSR) which are both 
under clinical trial at European Synchrotron Radiation Facility (ESRF), Grenoble, 
France (10). Here it should be noted that the Australian synchrotron is currently 
constructing a special beam line for medical applications and studies. Next section 
will focus on the synchrotron employed in this work. 
 
 
1.2.2.3. SPring8, Japan - The world’s largest 3rd generation synchrotron   
 
In this thesis, all of the experiments regarding MRT and SSR were 
conducted in Spring-8, a Japanese synchrotron radiation facility located in Harima 
Science Park City, Hyogo Prefecture, Japan. SPring-8, which stands for “Super 
Photon Ring-8 GeV,” is currently the world’s largest 3rd generation synchrotron 
radiation facility. SPring-8 was first opened for use in 1997 and currently produces 
synchrotron radiations ranging from soft x-rays (300 eV) to hard x-rays (300 keV). 
It is open to industrial, academic and government users, domestic and international 
for research in various areas. Figure 5 shows geographical location of SPring-8 in 
Japan. Figure 6 and Figure 7 shows the aerial view of the SPring-8 and the beamline 
map of SPring-8. 
 
 22 
 
Figure 5: SPring8 location in Japan. Image obtained from Japan Synchrotron Radiation 
Research Institute.  
 
 
Figure 6: SPring8 aerial view. Image obtained from Japan Synchrotron Radiation Research 
Institute.  
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Figure 7: Beam line map of SPring8. Image obtained from Japan Synchrotron Radiation 
Research Institute.  
 
Field Trips to SPring8, Japan; 
For experimental work on MRT and SSR in this thesis, two field trips to Japan were 
done.  
1. July 2008 
2. February 2009  
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1.2.3 Interaction of photon with matter at the atomic level 
 
X-rays or photon beams are used for majority of the work in this thesis. In 
some experiments, electron beams were also employed. As explained in the section 
1.2, these two types of radiations; electromagnetic type radiation (indirectly 
ionising) and particle type radiations (directly ionising), interact differently with 
matter. The interaction of electrons has been explained briefly in previous section 
‘production of x-rays’. X-rays interaction involves energy transfer to the medium 
resulting in the ejection of an electron from the atom in the medium which in turn 
causes the ionisation and excitation of the atoms along their path (11). The 
probability of this interaction mechanism occurring is highly dependent on the x-
rays’ energy, as well as the atomic number and density of the target medium.  
Major processes that will occur when photon beams pass through a medium 
are photoelectric effects, Compton scattering and pair production. The primary 
photoelectric effect involves incident photons ejecting inner shell orbital electrons 
from atoms; kinetic energy is transferred to release the electron from the shell. The 
energy used to release the electron is equivalent to the binding energy of the 
electron. The ejected electron will leave a vacancy in the inner shell, which will be 
filled by an electron from an outer orbit. The transfer of an outer orbital electron to 
the inner shell will release characteristic x-rays or fluorescent photons of energy 
equal exactly to the ∆E. These characteristic x-rays sometimes are absorbed locally 
by an orbital electron that will be emitted as Auger electron, which is termed as a 
secondary photoelectric effect. Figure 8 shows schematic figure of photoelectric 
interaction.   
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Figure 8: Illustration of the photoelectric interaction 
 
The probability of either of these photoelectric effects occurring is highly 
dependent on the energy of the photon and atomic number of the absorbing 
materials. The relationship between the photon energy and atomic number can be 
approximated to be as proportional to (Z/E)3, where E is the incident photon energy 
and Z is the atomic number of the absorbing material. For high Z materials (such as 
gold) the interaction dominates at energies < 0.5 MeV while for tissues photoelectric 
effect is dominant at energies below 30 keV.  
The second process is the Compton interaction, in this process the photon 
interacts with the free electron of the atoms or loosely bound electron (the electrons 
at the very last orbits qualify to be considered either free or almost free). There are 
very low probability of the interaction with bound electron and almost negligible. 
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The electron will receive some of the energy from the incident photon and the rest 
of the energy will be emitted as a scattered photon. The Compton process is 
illustrated graphically in Figure 9. In this process, the incident energy must be large 
compared to the binding energy of the electron. Therefore, when the energy 
increases more than the binding energy of the K shell electron, the Compton 
interaction will dominate the photoelectric effects. The Compton interaction is 
independent of the atomic number Z of the absorbing medium since the process 
involves only free electrons at the very outer orbits. 
 
 
Figure 9: Diagram to explain the Compton interaction 
 
As the photon energy increases, the Compton interaction will subsequently 
decrease too. When the energy reaches more than 1.02 MeV, pair production 
interaction will start. The mechanism of pair production involves the interaction of 
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photons with the electromagnetic field of the atomic nucleus. The incident energy 
must be more than twice the rest mass of electron (0.511 MeV) in order for it to be 
absorbed to create an electron-positron pair. The illustration of the pair production 
processes is shown in Figure 10. 
 
 
 
Figure 10: Mechanism of the pair production process 
 
These 3 major interactions will lead to the emission of scattered photons (x-
rays), photoelectrons, Compton electrons, Auger electrons, fluorescence photons 
and positrons which produce much localised ionisation resulting in energy 
deposition locally or depart energy locally. Hence these low energy electrons are 
responsible for most of the damage caused to the biological materials. 
Radiation that undergo different processes when interacting with matter will 
be either absorbed or attenuated and hence will reduced the intensity of the incident 
radiation. The intensity (I) of radiation that goes through a material with thickness 
(x) can be described by equation ( 3 ): 
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 xeIxI µ−= 0)(  
 
( 3 ) 
 
I (x) = Intensity transmitted through absorber  
Io = Intensity incident on the absorber 
µ = Linear attenuation coeffiecient (cm-1) 
x = absorber thickness  
 
The transmitted intensity I (x) is resulted from photon that did not interact 
with the material. On the other hand, the fraction of photons absorbed or removed 
per unit thickness that have undergone the attenuation process is described using 
linear attenuation coefficient or µ. This coefficient depends on the energy of the 
photons, density and atomic composition of the material (11). If the density factor is 
removed, mass attenuation coefficient or µ/ρ is introduced that take into account the 
atomic composition of material only (11). 
Photons that undergo the absorption and attenuation process will have part or 
all its energy converted into kinetic energy of electrons. Therefore, fraction of 
photon energy that is attenuated or absorbed by the materials can be described using 
mass energy attenuation coefficient (µ/ρ) and mass energy absorption coefficient 
(µen/ρ). In radiotherapy, the amount of energy absorbed in tissue or radiation dose 
can be determined using these coefficients and hence biologic effects of radiation 
can be predicted. The influence of this dose on the biological target is briefly 
described in the next section 
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1.3 Introduction to radiobiology 
 
In radiotherapy, ionising radiations are targeted to tumours, which are a 
category of biological tissue and are therefore living organisms. The study of the 
action of ionising radiations on biological material is called ‘radiobiology’ (22). 
Biological materials, like other matter, absorb radiations when exposed to ionising 
radiations and undergo different interactions outlined in previous section (1.2.3). 
The interaction of ionising radiations with biological structure results in cell or 
tissue damage. If the damage is unrepairable, cell death will occur. In radiotherapy, 
tumour cell death is the main objective and it is very important to understand how 
this occurs as well as the pertinent aspects of the biology of cells in general.  
 
1.3.1 Cell biology  
 
Cells are the fundamental unit of life. All organisms are made of cells, which 
are arranged into more complex structures such as tissues and organs. Like other 
living things, cells demonstrate fundamental functional aspects, such as 
reproduction and responding to their environment. Every cell is different but they 
share some common characteristics and can therefore be classified broadly as either 
prokaryotic or eukaryotic. Prokaryote cells are simpler, smaller and independent; 
generally bacteria are an example of this kind of cell. Eukaryote cells usually exist 
in multicellular organisms such as animals and plants (23). 
 Animal cells are typically 5-20 µm in diameter.  Cells are enclosed by a 
plasma membrane that separates the inside of the cell from its environment.  The 
internal component of these cells are called organelles and include the nucleus, 
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mitochondria, ribosome, vesicles, Golgi apparatus, rough endoplasmic reticulum, 
smooth endoplasmic reticulum, cytoskeleton, lysosomes and centrosome. There are 
also structures outside the cell wall such as capsule, flagella and fimbriae (pili) 
which are not exist in animal cells and can be found in prokaryote cells. The 
endothelial cells used in this thesis, are shown in Figure 11 and Figure 12. The 
functions of the cell’s organelles, suborganelles and their structure are listed in 
Table 1. 
 
Cell nucleus
cytoplasm
 
Figure 11: Bovine aortic endothelial cells in culture with nucleus stained 
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Figure 12: Bovine aortic endothelial cells under high magnification. 
 
 
 
Table 1: Description of cell organelles, suborganelles and their functions.  
Organelle Structure and 
suborganelle 
Functions 
Nucleus  • Spherical  
• Separated from 
cytoplasm by nuclear 
envelope (membrane) 
• Contains nucleolus and 
chromatin  
• Controls the centre of the cells 
• Directs protein synthesis by 
producing messenger RNA 
(mRNA) according to instructions 
provided by the DNA  
• DNA replication and RNA 
synthesis (transcription). 
Cytoplasm  • Part of a cell that is 
enclosed within the cell 
membrane.  
• Contains organelles  
Site where most cellular activities 
occur, such as many metabolic 
pathways like glycolysis, and 
processes such as cell division. 
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Mitochondria • 1-10 µm long 
• Present in cytoplasm 
with various number 
depends on cells 
metabolic activity 
 
• Produces energy in the form of 
ATP from sugars, fats and other 
fuels with the help of oxygen. 
Ribosome  • Made of ribosomal 
RNA and protein 
• Consists of two 
subunits 
• Free ribosome floating 
in cytosol, bound 
ribosome attached to 
endoplasmic reticulum  
or nuclear envelope 
• Protein synthesis and assembling 
polypeptide chains 
 
Golgi 
apparatus 
• Flatten membrane sacs 
in many or hundred of 
stack 
• Modifying polypeptide chains into 
mature proteins; sorting and 
shipping macromolecules such as 
proteins and lipids for secretion or 
for use inside cell 
 
Rough 
endoplasmic 
reticulum  
• Organize as stacked, 
flattened sacs 
• Many ribosome on 
surface 
• Modifying newly form polypeptide 
chains 
• Membrane factory for the cells 
Smooth 
endoplasmic 
reticulum 
• Curve through 
cytoplasm like 
connecting pipes  
• No ribosome on  
surface 
Main site of lipid synthesis 
 
 
 
 
Cytoskeleton  • A network of fibers 
extending thoughout the 
cytoplasm 
• Mechanical support for the cells, 
maintains cell shape, protects and 
internal organization of the cell.  
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 • Moving the cell and its internal 
structures 
• Regulation of biochemical activities 
of the cells  
Vesicles  • Small membrane-
enclosed sac that can 
store or transport 
substances. 
• Transporting, storing or digest 
variety of substances such as 
cellular products and waste.  
Lysosomes  • Membranous sac of 
hydrolytic enzymes that 
use to digest 
macromolecules.  
• Intercellular digestion  
 
Cells undergo different cellular processes in order to maintain functions such 
as metabolism and growth. Cells harvest nutrients, organic molecules and 
metabolise this into energy by way of two major processes; catabolism (breakdown 
pathway) and anabolism (biosynthetic pathway) (23). In the catabolic process, a cell 
breaks down complex molecules with the help of enzymes to produce energy. 
Cellular respiration is one example of the catabolic pathway, in which oxygen is 
consumed as a reactant along with the organic fuel. In anabolic metabolism, cells 
consume energy to construct complex molecules. Protein synthesis from amino 
acids is one example of an anabolic pathway, also known as biosynthetic pathways. 
In order to generate energy, the breakdown of the complex sugar such as glucose 
takes place via a process called glycolysis within a biochemical cycle (Kreb’s citric 
acid cycle). When the glucose is absorbed inside the cells via diffusion process, 
glucose will be broken down to make adenosine triphosphate (ATP) which is a form 
of energy.  This energy will be used in all the cell’s functions such as protein 
synthesis, cell proliferation and cell movement.  
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Cellular functions are controlled by the nucleus, which is the largest 
organelle in a cell. The nucleus contains genetic material in the form of 
deoxyribonucleic acid (DNA) molecules. DNA is organised into discrete units 
called chromosomes which carry the genetic information. Each chromosome is 
made up of a material called chromatin, a complex of proteins, and DNA (23). 
Ionising radiation can cause breakage to this DNA strand resulting in cell death and 
mutation. It has been established that DNA and chromosome structure is the 
principal target in biological damage by ionising radiation (22).  
 
1.3.2 DNA damage by ionising radiation 
 
The interactions of ionising radiation with matter, which has been detailed in 
section 1.2, result in the production of secondary electrons and free radicals. The 
production of secondary electrons and the free radicals can be categorised as the 
result of direct action or indirect processes. Direct action usually involves high 
linear energy transfer (LET), such as neutrons and alpha particles. In this process, 
the ionising radiation directly interacts with the targets, causing atoms to become 
ionised and excited. An atom in an ionised and excited state can be considered as a 
free radical that will interact with other atoms and produce a chain of biological 
effects. Unlike this direct action, indirect action occurs when ionising radiation 
interacts with other atoms and molecules, such as water, and induces the production 
of free radicals. The free radicals will then travel to the targets and break the 
chemical bonds of proteins and DNAs. The disruption of the chemical bonds will 
create new bonding and cross linkage between these macromolecules that will affect 
cells’ vital function. For example, the DNA double strand structure can be broken 
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by either single strand breakage or double strand breakage. Single strand breakage is 
usually easily repaired using the template from the other unbroken strand and 
therefore may result in minor biological consequences only if the repair is incorrect. 
Double strand break, however, causes significant effects leading to severe biological 
damage. Double strand breaks are usually irreparable and can be wrongly matched 
even if they undergo repair. This complete disruption leads to cell death, 
carcinogenesis or mutation.  The single and double strand break is illustrated in 
Figure 13. At larger scale, ionising radiation may cause chromosome aberration or 
chromatid aberration. Chromosome is a complex of DNA molecules with 
ribonucleic acid (RNA) and protein to form a threadlike structure containing genetic 
information arranged in linear sequence. Two progeny strands of a duplicated 
chromosome joined at the centromere during mitosis or meiosis is called chromatid 
(22). Chromosome aberration or breakage is shown in Figure 14.      
 
 
Figure 13: Illustration of DNA breakage cause by free radical A) Single strand break B) Double 
strand break.   
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Figure 14: Illustration of chromosome aberration or breakage cause by free radical A) Two 
chromosome breaks as a result from two separate free radical B) Two chromosome breaks as a 
result from single free radical   
 
The damage by ionising radiation to biological matter is usually quantified 
by using cell survival curves. Cell survival curves represent the relationship between 
the radiation dose and the proportion of cells that survive irradiation as measured in 
vitro (22). The shape of the cell survival curves is dependent on factors such as the 
type of radiation and the cell line. In Figure 15, the sparsely ionising radiation, such 
as x-rays, exhibits cell survival curves that initially start with a linear slope, 
followed by a shoulder and then become straight again at high dose. For densely 
ionising radiation such as neutrons, the cell survival curve is a straight line from the 
beginning. The shape of cell survival curve is usually described using 
radiobiological model and one of the most common models used is the linear 
quadratic model. In the Figure 15, the cell survival curve is fitted to a linear 
quadratic model function and illustrated.  
 
 37 
 
Figure 15: Typical shape of cell survival curve for mammalian cells with the fraction of cells 
surviving as plotted on a logarithmic scale against dose on linear scale. The linear quadratic 
model is described by the linear component (αD), which is proportional to the dose and 
quadratic component (βD2), which is proportional to the square of dose. The α/β ratio is the 
value where the linear and quadratic components are equal.  
 
This model assumes that there are two parameters or constants which 
represent the severity of cell death by radiation, one that is proportional to the dose 
and one that is proportional to the square of the dose (22). This model can be 
described by equation ( 4 ):   
 2DDeS βα −−=
 
 
( 4 ) 
 
S is the fraction of cells surviving a dose D where α and β are constants. The 
linear portion of the cell survival curve represents α and the quadratic component 
represents β (22). The linear portion of the survival curve or α indicates the 
probability of an interaction between the two chromosome breaks which is 
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proportional to the dose. These two chromosome breakages at low dose (the linear 
portion of the curve or α) are the product of single electron from the absorption of 
radiation interaction (22). While at a higher dose, or the quadratic portion of the cell 
survival curve (β), the two chromosome breakage is the product of two separate 
electrons breaking both of the two chromosomes. The probability of this interaction 
is proportional to the square of the dose (22). Two chromosome break may cause the 
asymmetric exchange type aberration that results the cell’s loss of reproductive 
ability (22).  
The damage caused by ionising radiation to biological materials is highly 
dependent on number of radiation interaction and dose deposited. We have 
explained that the interaction of x-rays with high density and high Z materials will 
result into high numbers of free radicals which will cause significant damages to the 
DNA molecules in the cells hence leading to cell death. Therefore, if large numbers 
of such particles are introduced into cells in the target it will enhance radiation 
effects. One mechanism lately explored for delivering high Z atoms into biological 
targets is nanostructures which has been mainly utilised in this study. A brief 
introduction of such nanoparticles is given in the next section. 
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 1.4 Introduction to the gold nanoparticles (AuNPs) 
 
The production of nanometer size materials had a big impact on whole host 
of fields including medicine. This has attracted a large amount of interest in research 
into the possible applications of these materials which resulted in an exponential 
growth of publications and literature in nanomedicine areas (24). Nanometer size 
materials provide the prospect of more effective diagnosis and treatment of diseases, 
especially cancer. They are believed to have specific advantages over conventional 
drugs in the management of malignant diseases.  
Nanoparticles are defined as nanostructures consisting of a number of atoms 
or molecules in the 1-1000 nm diameter range in at least one dimension (25-26). 
The ASTM (American Society for Testing and Materials) defines nanoparticles as a 
sub-classification of ultrafine particles with lengths in two or three dimensions 
greater than 0.001 micrometer (1 nanometer) and smaller than about 0.1 micrometer 
(100 nanometers) and which may or may not exhibit a size-related intensive 
property (27). They are also defined as the point at which the properties of the 
particles differ from those of the bulk materials. Nanoparticles can be produced 
from different types of materials: semiconductor nanoparticles, such as quantum 
dot, metallic nanoparticles, such as gold nanoparticles (AuNPs) and carbon 
nanotubes. Comparison of nanoparticles with other biological material is shown 
Figure 16. 
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Figure 16: Nanoscale comparison of nanoparticles size (using AuNPs) with other biological 
materials. 
 
Bulk materials in micrometer size and larger are very well studied and their 
properties are well known. Nanometer size materials neither behave like bulk 
material nor like molecules. Different from bulk materials, nanoscale materials and 
their properties depend on the particles’ size, interparticle distance, the nature of the 
coating or shell around them and shape of the nanoparticles (28). The particles’ size 
determines the behaviour of the particles; hence, the properties of the nanoparticles 
are controllable or tuneable. The nanoparticles can be ‘naked’ or coated with shell 
made of either organic or inorganic material. They also can be produced in different 
shapes of nanoparticles such as rods, spheres, cubes, disks, wires, tubes, branches, 
triangular prisms and tetrahedral nanoparticles (24).  
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In this thesis, gold nanoparticles (AuNPs) are used. Historically, gold 
particles have been used ever since 5th or 4th century B.C by ancient Egyptian and 
Chinese. Colloidal gold were used for making ruby glass and for colouring ceramics 
which gave different colours for the glass and ceramic. It was also known to have 
healing properties for various diseases such as heart problems, dysentery, epilepsy 
and tumours (28). Gold colloids were used widely for diagnosis of syphilis which 
continued until 20th century (29). Until the 1920s gold colloid, or what is now often 
referred to as gold nanoparticles, were used in medical applications to treat 
rheumatoid arthritis (30).  
 
1.4.1. Synthesis of AuNPs 
 
Study of AuNPs synthesis using various techniques has been reported and 
reviewed since 19th century (24, 28). Citrate reduction methods, introduced by 
Turkevitch in 1951, are the most common and popular techniques employed to 
synthesise spherical AuNPs (28). The citrate reduction of gold salts (HAnCl4) in 
water is a well known technique and has also been applied to other metallic atoms 
such as platinum and silver (31). In contemporary research, various synthesis 
techniques are being developed for AuNPs fabrication. Generally, synthesis of 
AuNPs can be done in either bottom up method or top down method as described 
below in tabular form in Table 2. 
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Table 2: Preparation of AuNPs (24) 
Method Description  Common 
Technique 
Advantages Disadvantages 
Bottom up  Atoms produce 
from ion reduction 
or molecular 
precursor are 
resembles to 
generate 
nanostructure  
 
Nanosphere 
lithography 
Reduction:  
Thermal, chemical, 
electrochemical, 
photochemical etc  
 
More 
control on 
morphology 
of the 
material 
Poor 
monodispersity  
Top down  Material is 
dispersed from bulk 
material leaving the 
nanostructures 
 
Photolithography 
Electron beam 
lithography  
Smaller 
nanoparticle 
can be 
produce 
Removal of large 
amount of materials  
Broad size 
distribution 
 
 
1.4.2. AuNPs properties 
 
AuNPs are such a promising avenue for research because their properties can 
be controlled by changing the size or shape of the nanoparticles and hence they are 
flexible enough to be employed in various applications, especially in medicine. Gold 
(Au) is the most inert and stable metal. Gold atoms present in nanometer sized 
particles have their basic properties of metal type materials such as melting point, 
crystal structure, conductivity, magnetic properties and optical properties completely 
altered (28). Unlike their presence in bulk materials, their properties become more 
dependent on the size than chemical composition. This size dependent behaviour is 
also known as quantum size effects (28). It occurs when the electronic structure of 
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the metal changes from a continuum electronic band to discrete electronic levels. In 
bulk materials, there is no gap between the valence band and the conduction band 
whereas in nanoparticles this gap is present (28). The effect of this transition 
between quantum physics and solid state physics is what causes the size dependent 
quantization effects to occur (28). The particles behave electronically as zero 
dimensional quantum dots or quantum boxes relevant to quantum mechanical rules. 
Freely mobile electrons are trapped in such metal boxes and show a characteristic 
collective oscillation frequency termed  plasma resonance, giving rise to the so-
called plasmon resonance band (PRB) (28).  Brilliant colours exhibited by AuNPs is 
a result of this surface plasmon resonance (24). 
Another common property of nanoparticles is high surface to volume ratio, 
which means the number of atoms at the surface almost equal to the number of the 
atoms inside the particles. The surface atoms are chemically more active compared 
to the bulk atoms because they usually have fewer adjacent coordinate atoms and 
unsaturated sites or more dangling bonds (32).  Surface characteristics of 
nanoparticles are also important factors in controlling the nanoparticles’ properties. 
Defects on the nanoparticles’ surface induce additional electronic states in the band 
gap and hence alter the physical and chemical properties of the nanoparticles. These 
two major factors contribute the difference in the properties of nanoparticles 
compared to the bulk materials. Below in Table 3 is a summary of the differences 
between some of the properties of AuNPs and the use of gold in bulk.    
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Table 3: Comparison of gold in bulk and gold in nanoparticles form 
Properties  Gold in bulk  Gold nanoparticles  
Picture 
  
Melting point 1337.33 K, 1064.18°C 
1947.52°F   
 
Lower than bulk material 
Reduction of melting 
point with the reduction 
of nanoparticles size (33)  
300-400 °C (28)  
Magnetic 
properties 
Diamagnetic  (34) Localized permanent 
Magnetism (34)  
Crystal structure Lattice face centered 
cubic 
Random orientation (32) 
Conductivity Depend on the band 
structure  and follow 
the linear ohm’s law 
Ohm’s law is no longer 
valid because the 
structure of electron band 
becomes discrete energy 
level (32) 
Optical 
properties 
Gold colour is 
determined by the 
density of loosely 
bound (valence) 
electrons. 
 
Well defined 
absorption limit (35) 
Different colours depend 
in shape and size. This is 
due to strong absorption 
band because of surface 
plasmon resonance 
caused by the coherent 
motion of the conduction 
band electrons, which 
interact with an 
electromagnetic field.  
(32) 
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Utilisation of AuNPs for radiotherapy is highly desirable because of its 
ability to absorb radiation and therefore increase the dose to the tumours if they 
were included in the tumour prior irradiation. Compared to the other common 
metallic contrast agents employed in radiotherapy for dose enhancement such as 
iodine and gadolinium, gold has a higher Z. AuNPs are also able to absorb 3 times 
more radiation than iodine at 20 to 100 KeV (36). Moreover, using a metallic 
solution compound such as an iodine contrast agent allows only one atom to be 
delivered to the target.  With nanoparticles thousands of atoms in particles can be 
delivered to the tumours and hence increase the radiation interaction probability in 
other words, nanoparticles are a very efficient method of delivering large number of 
atoms to the target (37). This is shown as illustration in Figure 17.  
 
 
Figure 17: Many gold atoms inside one nanoparticle means thousands or hundreds of gold 
atoms can be delivered to the tumour site.   
 
Better radiation absorption of AuNPs also provides good contrast for 
imaging purposes before delivery of treatment such as in image guided radiotherapy 
(38-39). Therefore, treatment aided by AuNPs has additional advantages where the 
potential of imaging tumours during and after irradiation is made possible hence it 
could be used for implementing image guided radiotherapy in future. For clinical 
applications, biocompatible material is required. Gold is known to be an inert 
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material; however, the toxicity of gold in nanoparticles form is still not well known 
and depends on the type of the AuNPs itself. Flexible properties of nanoparticles 
makes it possible to bioconjugate it with organic capping materials and reduce any 
existing low toxicity.  Nanoparticles toxicity is an area of active research at this 
stage and it is included in some parts of this research project.  
Currently available drugs and contrast agents for radiotherapy are not very 
specific to the target; they can also be taken up by the normal tissue. Nanoparticles 
can be engineered to target different tumours and cells type. They can be designed 
to penetrate and deliver drug to the tumours because they can conjugate with other 
materials such as targeting antibodies and drugs. The flexible design and 
multifunctionality of nanoparticles may therefore be highly beneficial for the 
treatment of cancer especially for radiotherapy. 
 
1.5 Thesis aims  
 
AuNPs assisted radiotherapy is a new technique that is potentially very useful in 
the treatment of cancer with minimal effects on normal tissue. This technique will 
increase the differential of the dose received between tumours and the surrounding 
normal cells tissues. This work aims to pioneer the application AuNPs as radiation 
dose enhancer for cancer therapy. AuNPs must be studied and assessed in terms of 
dosimetry, biological effects and a justification must be made of how the potential 
benefits of their use outweigh any risks before AuNPs will be considered for clinical 
trials. This thesis is just such an assessment of the applications of AuNPs in medical 
radiations. Moreover, this thesis develops a technique for measuring dose 
enhancement for specialised techniques in radiotherapy. Studies are conducted 
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either biologically or by phantom to quantify the dose enhancement factors (DEF) 
produced by AuNPs for various radiotherapy techniques. The specific aims of this 
thesis are as stated below:  
 
• To assess the dose enhancement produced by AuNPs from experimental studies 
using Bovine Aortic Endothelial Cells (BAECs) irradiated with 1-7 Gy range of 
radiation doses at different concentration of AuNPs and with different type of 
radiation sources and beam energy used. DEF is determined by analysing each cell 
survival curve; the data was tabulated and compared to determine the conditions that 
produce maximum DEF.  
 
• To understand the radiobiological effects of AuNPs on cells.  In this study, 
radiological models such as Linear Quadratic model were used to analyse the effects 
of AuNPs on radiation dose. Linear Quadratic parameter from the cell survival 
curve such as alpha (α) and beta (β) were analysed. Another radiobiological 
parameter which were calculated is the mean inactivation dose ( D ) that can be used 
to describe DEF.  
 
• To determine any viable applications of AuNPs to extended or specialise 
techniques in radiotherapy; specifically, MRT and SSR. The objective is to reduce 
the very high dose (100 – 4000 Gy) normally employed in both techniques and to 
determine the lowest dose that can be achieved with AuNPs. Dose enhancement 
study for MRT was conducted using cell culture and in the case of SSR using 
polymer gels.  
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• To examine the roles of AuNPs in cell migration so as to determine their impact 
on the normal tissue healing or repair process. This aspect is important in normal 
tissue recovery in MRT and also conventional radiotherapy. The study showed the 
importance of AuNPs as an agent that can both enhance the killing of tumour cells 
and at the same time induce recovery by promoting normal cells’ migration to the 
affected tumorous area.  
 
• To conduct studies based on polymer gel phantoms in order to verify biological 
studies results. Measurements of dose enhancement were conducted using nomorxic 
polymer gels and DEF was calculated from the dose response curves obtained for 
the gel dosimeters with and without AuNPs.   
 
• To predict the optimal energy range for maximum DEF and dependency on 
AuNPs concentration based on theoretical analysis. This theoretical analysis was 
done to guide the experimental work. Theoretical calculation of DEF for different 
elements commonly used in medical radiation such as gold, iodine and gadolinium 
were presented and discussed. 
 
• To investigate the dependence of the dose enhancement produced by AuNPs on 
the beam energy and AuNPs concentrations. Experimental DEF for different beam 
energies and types were analysed and compared to the theoretical calculations. The 
DEF of different concentrations of AuNPs will also be analysed. 
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• To assess the cytotoxicity of AuNPs by studying different AuNPs concentration, 
size and incubation time in cells. The end point of the toxicity study is cell viability 
and changes to the cell morphology.  
 
• To determine whether AuNPs are taken up inside the cells and observe any 
localisation of AuNPs inside the cells. Different techniques, such as darkfield 
microscopy using confocal microscope and cell staining techniques, were used to 
confirm the internalisation of AuNPs inside cells. 
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2. BACKGROUND, THEORY AND LITERATURE REVIEW 
 
This chapter presents a review of the radiation dose enhancement produced 
by high Z materials in general and AuNPs in particular, including an analysis of the 
attenuation and absorption physical data. This data is used for theoretical calculation 
of the dose enhancement factor (DEF) of the different elements commonly used in 
medical radiation such as gold, iodine and gadolinium, which is also presented and 
analysed in this chapter.  
 
2.1. Dose enhancement by high Z materials 
 
Early studies of radiation dose enhancement caused by the existence of high 
Z materials in the target were conducted by Spiers and reported in several 
publications since 1949 (40-42).  Later, the dose enhancement due to the increase of 
photoelectron production, as a by-product of the interaction between x-rays and the 
high Z materials, was investigated by many other scientists (43-44). In these studies, 
dose enhancements were observed in the presence of the high Z material due to the 
increased number of photoelectrons depositing their dose in the area adjacent to the 
high Z materials. Increases in dose in the vicinity of the high Z material due to the 
scattered electrons only have also been previously reported (44-47). The effects of 
the increased number of photoelectrons and scattered electrons on biological 
materials have also been the subject of the research, with experiments establishing 
that when cells monolayers are exposed to kilovoltage x-rays adjacent to high Z 
materials, this results in an increase in the numbers of cells killed (48-54).  
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The interaction of high Z material with low energy x-rays has raised 
concerns about the risks of radiographic procedures that employed high Z contrast 
agents. Concerns also arose for the possible effects on bone since bone is composed 
of a high Z element, calcium. Many studies have observed high dosage to the bone 
marrow when bone is irradiated with kilovoltage range x-rays (55-62). The increases 
of dose effects were also observed in radiographic imaging procedures that used 
high Z contrast agent such as iodine. Adams et al (1977) estimated the effects of 
radiation in combination with contrast media by measuring chromosome aberrations 
in peripheral blood lymphocytes (63). The study showed an increase in absorption 
of x-rays and breakage of chromosomes even in the absence of x-rays indicating 
iodine toxicity to the cells (63). A study by Norman et al (1978) also showed 
increasing damage to peripheral blood lymphocytes isolated from patients following 
cardiac catheterization and angiocardiography (64). Other studies on peripheral 
blood leukocytes found increase in aberrations caused by diagnostic x-ray studies 
using iodine as the contrast agent (65-66).    
These undesirable effects in diagnostic radiology were found to be useful for 
radiotherapy. It was proposed that these effects can be applied directly to tumours 
by loading the tumours with high Z materials that will subsequently increase the 
radiation dose to the tumours with much less harm done to the surrounding normal 
tissue. In vitro study showed reduction of cells survival for cells irradiated with 
kilovoltage x-ray beams from clinical x-ray tubes in the presence of contrast media 
such as iodine at various concentrations (67-72). Some studies investigated dose 
enhancement caused at high photon energies (in megavoltage range) and found it to 
be negligible compared to the kilovoltage range of energies. Matsudaira et al (1980) 
and Mello et al (1983) reported that no dose enhancement was observed with high 
 53 
energy gamma rays (7, 72). Measurements of chromosome aberration and 
micronuclei in lymphocyte irradiated with 100 kVp x-rays in the presence of iodine, 
however, showed significantly high dose enhancement. Tumours growth regression 
in animal studies were also observed when kilovoltage beams where used (72). 
Clearly, it can be concluded that maximum dose enhancement occurs at low energy.  
This energy dependence of the dose enhancement effects of high Z media 
presents difficulties with regard to application for treatment using conventional 
therapy machines, such as LINACs, since they deliver an unsuitable, megavoltage 
range of energy for maximum radiation absorption. Superficial radiotherapy sources 
produce kilovoltage x-rays but have limited application. Earlier animal testing of 
radiotherapy with iodine used simple irradiation schemes with modified computed 
tomography scanners (CTRx) that delivered kilovoltage x-rays to the tumours (73-
76). The first human clinical trials using iodinated contrast media for dose 
enhancement on human metastatic brain tumours delivered by CTRx showed the 
great potential of contrast enhanced radiotherapy (77). Monte Carlo simulations of 
different radiation sources from modified CT to LINACs confirm that better dose 
enhancement is achieved at lower energies compared to high energies (78-79). 
Energy spectra from LINAC sources without filters have been tested where more 
soft x-rays are present in the spectrum compared to the filtered spectrum. Unfiltered 
high energy x-ray beams from LINAC also provide higher penetration and low 
surface dose compare to low energy x-rays. A study by Robar et al (2002) using 
modified x-rays photon spectra from LINACs achieved dose enhancements up to 
23% for energy ranges from 6 to 24 MV (80). Measurement using an ionization 
chamber also gives reasonable dose enhancement (80). 
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It has been found that dose enhancement is obtained at particular energy for 
the specific target high Z materials. Maximum dose enhancement can be achieved if 
the x-rays’ energy can be tuned to have only the energy (monoenergetic) of interest 
rather than a spectrum of beam energies. However, clinical x-ray tubes and LINACs 
produce a spectrum of x-rays that have ranges of beam energies which makes it 
impossible to deliver optimal energy to the tumours. The developments of 
synchrotron technologies make it possible to deliver monochromatic beam energy 
that can be tuned to the specific energy required to produce maximum dose 
enhancement (80b). Third generation synchrotrons are now available that are able to 
produce monochromatic x-ray beams using devices called monochromators, which 
allow the desired energy to be precisely selected. A few research studies on dose 
enhancement by high Z material using monoenergetic beams have been conducted 
in major synchrotron research centres such as the ESRF, Grenoble, France. One of 
the  investigations is the cell survival study by Esteve et al (2002) using 
monochromatic synchrotron x-rays on human cancerous cells in presence of various 
iodine concentrations (81). Reduction in cell survival rate was obtained and 
calculations of biological dose enhancement were found to increase with increasing 
iodine concentrations (81). Another work from conducted at the same centre is an 
in-vitro study by Corde et al (2004) which experimentally determined the optimal 
energy for dose enhancement (82). The energy of 50 keV was found to be optimal 
for the irradiation of tumours in the presence of stable iodinated contrast media (82).  
Optimally increasing the radiation dose applied to tumours utilizing high Z 
materials and monochromatic energy beams has showed promising results and has 
led to more thorough animal and phantom studies which have paved the way for 
possible human trials. Different irradiation techniques such as stereotactic 
 55 
radiosurgery using synchrotron beams have also been introduced. SSR consists of 
loading the tumour with a high Z element and exposing it to monochromatic x-rays 
from synchrotron source (50-100 keV) (83). Pioneering work at ESRF on SSR 
showed significant dose enhancements were observed for most F98 glioma bearing 
rats, which experienced prolonged survival (84) . Many dosimetric studies using 
Monte Carlo simulation and polymer gel dosimeter have proven the feasibility of 
applying high Z materials such as iodine as radiosensitisers for SSR (83, 85-86) . 
Biological dose escalation in the various treatment phases and the dosimetric 
properties required for clinical trial also have been assessed and proposed (87). 
Compared to the conventional radiotherapy, it is found that dose enhancement in the 
tumours with the presence of high Z materials can be obtained in SSR with an 
increase in brain  tumour control probability while the doses received by the skull 
remain within tolerable levels (87). Encouraging dosimetric, in-vitro and animals 
results prove that this technique is capable of killing radioresistant tumours and 
planning towards the first human clinical trials is already underway in ESRF (10).  
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2.2. Dose enhancement by gold nanoparticles 
 
The effects of gold on the radiation dose enhancement were first 
demonstrated by Regulla et al (1998) using gold sheet to measure the dose 
enhancement effects on cells (53). Cells were grown on a gold sheet and were 
irradiated with x-rays of energy ranging from 40 to 120 kVp showing outstanding 
measured DEF of more than 100 (53). Later, radiosensitization by gold particles was 
measured by Herold et al (2000) using 1.5 to 3.0 µm gold microspheres injected 
directly in the tumours (88). Evidence of enhanced killing of cells was also observed 
on different types of tumour cells, where a reduction in plating efficiency was 
observed (88) . Hainfeld et al (2006) introduced gold nanoparticles (AuNPs) as 
contrast agent in radiography for the first time and later pioneered its application in 
radiotherapy (38, 89-90). The first application of AuNPs for dose enhancement was 
on mice bearing subcutaneous EMT-6 mammary carcinoma. 1.9 nm AuNPs were 
applied and the tumours irradiated with 250 kVp x-rays. Results showed tumour 
ablation and prolonged mice survival (89). The AuNPs also were found to be non 
toxic to the mice and were cleared quickly from the body through kidney (89).  
As a consequence of the success of this first work by Hainfeld et al (2004), 
many works studying the feasibilities of AuNPs for radiotherapeutical application 
have been published. Monte Carlo simulations have also been used to theoretically 
simulate effects of AuNPs for different types of treatment and beam energies (91-
95). In study by Cho (2005), DEF for several phantom test cases representing 
radiation treatment using gamma rays, kilovoltage and megavoltage photon beams 
with different levels of AuNPs concentration in the tumours were estimated using 
BEAMnrc/DOSXYZnrc code (91). Low energy x-rays and gamma rays were found 
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to be more efficient in enhancing doses (tumours dose enhancement up to 31%) 
compared to the high energy ones. Another study, also by Cho et al (2009), 
demonstrated that significant increases were observed in the spectra and fluence of 
the photoelectrons within the tumours loaded with AuNPs during low energy x-ray 
or gamma ray irradiation (95). A significant increase in the production of Auger 
electrons was also observed and macroscopic dose enhancement factors obtained 
were around 40 to 70% for different brachytherapy and x-rays sources (95).  
Another comprehensive calculation by McMahon et al (2009) investigated 
the total dose enhancement which could be derived from the introduction of AuNPs 
at reasonable concentration levels in tissue when exposed to a variety of radiation 
spectra including LINAC sources, conventional kilovoltage x-ray spectra and 
kilovoltage sources filtered to specifically target the gold nanoparticles (92). In this 
study, ‘figure of merit’ is obtained through analytical and numerical methods in 
which the value can be directly compared for different radiation source  types and 
treatment conditions; i.e. the dose deposited in the tumour to the peak dose to 
healthy tissue. Overall, the study suggested that kilovoltage radiation in combination 
with AuNPs can potentially be viable alternative to LINAC-based therapies for 
treatment of cancer (92).  
The feasibility of using kilovoltage x-rays in conjunction with AuNP as an 
alternative treatment to high energy LINAC radiotherapy was also investigated by 
Garnica-Garza (2009). Prostate cancer treatment were modeled using Monte Carlo 
code PENELOPE where the radiation dose to the tumours loaded with AuNPs were 
delivered in 360o arc delivery technique. This rotational technique was found to 
provide enough doses to the tumours while dose to the skin and organ at risk were 
observed to be within acceptable limit. However, the author strongly suggested that 
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the distribution of AuNPs inside patient must be quantified as severe degradation of 
dose distribution can occur if the AuNPs are deposited non uniformly (94). 
Macroscopic dose enhancements quantified in previous studies may 
underestimate dose enhancement produced microscopically around AuNPs as 
shown in previous study by Cho et. al. (2005, 2009). A recent study by Jones et. al. 
(2010) has taken this into account where microscopic dose around AuNPs were 
quantified. Dose enhancement with a factor of up to more than 100 was obtained 
around AuNPs and microscopic doses within tumours were enhanced over 100% 
over short distances (taking into account realistic AuNPs distribution in tissue) (96).  
This study also again confirmed the energy dependency of the effects; dose 
enhancement for low energy sources increased by a factor ranging from 10 to 1000 
over 30 µm whereas for the higher energy sources the increase is only a factor of 10 
or less for distances greater than 1 µm (96). Compared to the macroscopic DEF 
obtained by Cho et al (2009) which is around 40 to 70%, microscopic DEF more 
accurately predict the radiobiological effects of AuNPs on cells and therefore enable 
more realistic estimation on biologic consequences such as the DNA damage caused 
by the combination treatment of AuNPs and radiation (96). 
Computational study considered previously used a model which is based on 
a gold-water mixture (gold compound) to simulate gold concentration in tumours. 
Zhang et. al. (2009) have taken this study further by simulating AuNPs in a 
nanoparticle form (93). Using GEANT4 Monte Carlo dose calculation code, 
nanospheres of 100 nm diameters were embedded in a 10x10x10 mm3 region in a 
water phantom and irradiated with Ir-192 high dose rate (HDR) source. Radiation 
dose enhancement up to 60 % for 1013 gold nanospheres per cm3 (9.6% by weight) 
in water phantom were obtained selectively around the nanospheres. The study also 
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compared two different calculations based on the gold-mixture model and AuNPs 
solution model. In gold-water mixture model, 36% dose enhancement was observed, 
while in AuNPs solution model about 28% dose enhancement was obtained. 
Differences of 16% were observed between the two models and it was thereby 
established that, in order to accurately predict radiation dose enhancement by 
AuNPs, the AuNPs have to be simulated in its actual form and geometry so that 
accurate calculation can be performed (93).     
The variation of the DEF obtained from the computational simulation based 
on the Monte Carlo code depends on the models that are used. Some models may 
imposed some limitation that prevent accurate calculation be performed. Biological 
study on cells (in-vitro) and animal (in-vivo) provide a more accurate real situation 
which incorporates many of the challenges that perhaps involved in real clinical 
trials. As mentioned before, Hainfeld et. al. (2004) for the first time used AuNPs in 
animals treated with kilovoltage x-rays radiotherapy (89). Since then, several studies 
have been published on the effects of AuNPs on the cells survival. Chien et. al. 
(2007) performed a study using an electron beam with CT-26 cells. Less cells 
survivals were obtained with the presence of AuNPs (97).  Another study using 
electrons by Chang et. al. (2008) investigated the dose enhancing effects and 
apoptotic potential of AuNPs in combination with single dose clinical electron 
beams on B16F10 melanoma cells. AuNPs were found to radiosensitise the 
melanoma cells (98). Chang et. al. (2008) used B16F10 tumour bearing mice and 
found prolonged survival for mice with gold compared to radiation alone. The dose 
enhancement by AuNPs was found to be significant for treatment using kilovoltage 
x-rays and electron beams as supported by the aforementioned studies and the 
published results from this thesis (99) . 
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The use of a biocompatible surface and coating for AuNPs reduces the 
toxicity of AuNPs, as is evidenced by several studies which have used surface 
modified AuNPs for the application of dose enhancement in radiotherapy (100-102). 
Liu et. al. (2010) explored the use of polyethylene glycol (PEG) modified AuNPs 
and studied their effectiveness when exposed to different types of radiation sources. 
All of the radiation sources such as monochromatized kilovoltage synchrotron 
sources (6.5 keV), x-rays LINAC sources (6 MV) and proton sources (3 MeV) show 
2 to 45 % reduction in percentage of surviving cells after irradiation in the presence 
of PEG-AuNPs (101).  Zhang et. al. (2008) also showed that functional glucose 
bound AuNPs enhanced radiation sensitivity and toxicity in prostate cancer cells 
(100). Using the same type of functional AuNPs, Kong et. al. (2008) evaluated two 
types of cell lines: MCF-7 breast cancer cells and MCF-10A normal cells. Both 
types of cells took the same amount of AuNPs. After irradiation, the viability of the 
cancer cells decreased significantly; however, significant changes were not observed 
in normal cells (102). These results indicate that the radiation sensitisation effects 
induced by AuNPs in cancer cells are not only due to simple physical interaction 
between AuNPs and radiation but also involve complicated cellular mechanisms. 
Further study by the same group also investigated the mechanism of enhancement 
by AuNPs by investigating the effects of AuNPs on cells cycles regulation and its 
relation with radiosensitivity (103). In this study, Glu-AuNPs triggered activation of 
CDK kinases (Cyclin-dependent kinases) leading to cells cycle accumulation in the 
G2/M phase and acceleration in the G0/G1 phase (103). This biological pathway 
activation effect is followed by sensitisation to ionising radiation and may have 
clinical implications for enhancing radiation dose in radiotherapy (103).  
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Hainfeld et. al. (2010) recently reported a new study on radiation resistance 
murine squamous carcinoma cell (90) . In this study, they again proved the potential 
of AuNPs enhanced radiotherapy by identifying parameters, such as the radiation 
dose and energy, that influencing the efficiency of the treatment. Hyperthermia was 
also introduced in treatment as a combination to AuNPs (90). The combination 
treatment of hyperthermia and radiation therapy with AuNPs were found to increase 
the long term survival of mice (90). More detailed studies have also been published 
recently which report additional radiobiological analysis (104-105). Chithrani et. al. 
(2010) reported that radiosensitisation is dependent on the size of AuNPs, and that 
50 nm AuNPs were found to produce highest enhancement compared to the other 
AuNPs of sizes ranging from 14 to 75 nm (104). In the previous publication 
Chithrani et. al. (2006) also claimed that 50 nm AuNPs have the highest cellular 
uptake (106). In this study was also quantified the DNA double strand break using 
radiation induced foci of γ-H2AX and 53BP1. Increased DNA double strand break 
was observed in irradiated cells with internalised AuNPs (104), agreeing with other 
studies that have reported that a combination of radiation and AuNPs induced DNA 
breakage (107-109).  The level of DNA breakage is one indication of the impacts of 
AuNPs on the radiation dose. Butterworth et. al. (2010) also evaluated DNA 
damage together with multiple cellular responses to AuNPs, such as cell type 
specific cytotoxicity, apoptosis and oxidative stress. Exposure of cells to AuNPs 
alone induced an increase in apoptosis and oxidative stress as well as significant 
level of cytotoxicity which varied for different cell lines (105). DEF measured also 
varied for different cell lines, indicating the existence of a characteristic response of 
cells to AuNPs-radiation treatment (105). More studies are needed to highlight the 
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cells specific response to AuNPs when they are used as radiosensitisers in cancer 
therapy (105).  
 
 
2.3. Analysis of radiation attenuation and absorption in the 
presence of high Z material.  
 
As explained in chapter 1, when x-rays impinge on matter, incident x-ray 
photons lose some or all of their energy when interacting with atoms in any target. 
In the photoelectric interaction, all of the x-rays energy is converted into kinetic 
energy for the electrons and hence photoelectron is ejected. While in Compton 
scatter, part of the energy will be transferred to the electron and this electron will be 
ejected as Compton electron. The rest of the x-rays will scatter with reduced energy 
and continue imparting the energy to the atomic electrons. In soft tissue the most 
dominant x-ray interaction at energy range of 20 KeV and above is Compton scatter, 
while in gold the most dominant interaction is the photoelectric effects (110). 
Therefore, in the presence of gold, the process of energy transfer can be increased 
via the photoelectric interaction where all the photon energy can be transferred to 
the secondary electron “photoelectron”. The kinetic energy transferred from photon 
to electron is described as ‘kerma’ or kinetic energy released in matter. Hainfeld et. 
al. (2010) derived an equation to calculate kerma enhancement ratio (KER) due to 
gold (111). The calculation is showed equation ( 5 ) :  
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( 5 ) 
 
i = index of the spectral energy bin 
Pi = spectral yield for the bin i 
µen,w,i = mass energy absorption coefficient of water for the energy bin i 
µen,Au,i = mass energy absorption coefficient of gold for the energy bin i 
ρw,i = densities of water or tissue  
ρAu,i = densities of gold inside tumours  
Ei = mean photon energy in bin i. 
 
The equation above is dependent on the density and mass energy absorption 
coefficient (µen/ρ). Gold is known to be very dense element with density of 19.3 
g/cm3 and 17.31 g/cm3 in liquid state which is much higher compared to water or 
soft tissue of density which is about 1 g/cm3 (110). The values of µen/ρ can be 
obtained from Hubbell physical data references (110). From the attenuation and 
absorption data obtained from Hubbell physical data, the value for mass attenuation 
coefficient (µ/ρ) and mass energy absorption coefficient (µen/ρ) for gold is noted to 
be much higher than the value for water as shown in Figure 18 and Figure 19. For 
example, at 80 keV photon energy, the µ/ρ for water and gold is 0.184 cm2/g and 
2.19 cm2/g respectively. At the same energy, the value of µen/ρ for water and gold is 
0.026 cm2/g and 1.72 cm2/g respectively. These values indicate that more energy 
will be deposited and hence an increase in the KER will result from the presence of 
gold compared to the tissue alone.  
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In the Figure 18 and Figure 19, the values of µ/ρ and µen/ρ of the different 
elements commonly used in medical radiations; gold, iodine and gadolinium are 
also compared. From the data presented in Figure 18 and Figure 19, it is clear that 
gold shows higher differential contrast compared to iodine and gadolinium at energy 
range of 10 to 40 keV and beyond gold K-edge energy of 80.7 keV as highlighted in 
the figure. For maximum absorption, low energy range of 10 to 40 keV is the best 
for attenuation by gold and to produce significantly high radiation dose 
enhancement compared to the region beyond K-edge. While this range of energy is 
not commonly employed in radiotherapy when high energy photons are usually 
used, specialised techniques such as superficial radiotherapy, synchrotron SSR, and 
intraoperative radiotherapy (50 kV x-rays) will benefit from this window of energy 
since it falls within their beam energy range. 
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Figure 18: Mass attenuation coefficient (µ/ρ) of gold, iodine and gadolinium compare to water.  
All the 3 elements have dramatically increased in attenuation compare to water. The highlight 
area and arrow showing where the gold attenuation is higher than iodine and gadolinium.  
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Figure 19: Mass energy absorption coefficient (µen/ρ) of gold, iodine and gadolinium compared 
to water.  All the 3 elements have dramatically increased in absorption compared to water. The 
highlighted area and arrow shows where the gold absorption is higher than iodine and 
gadolinium.  
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2.4. Theoretical radiation dose enhancement calculation for gold 
nanoparticles (AuNPs) 
 
The radiation dose enhancements produced by high Z materials are 
determined by a parameter termed dose enhancement factor (DEF). DEF is defined 
as the ratio of the dose absorbed in tumours with the presence of AuNPs over the 
dose absorbed in the tumours without AuNPs as described by the equation ( 6 ): 
 
AuNPswithouttumoursindepositedDose
AuNPswithtumoursindepositedDoseDEF =
 
 
( 6 ) 
 
An estimation of DEF can be made by calculating the ratio of µen/ρ value of 
gold to water. The calculations of DEF based on analysing µen/ρ value for 
monoenergetic beams have been previously reported for elements such iodine and 
gadolinium (81-82). For monoenergetic beams, the DEF value can be derived from 
the equation ( 7 ):  
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( 7 ) 
 
NP = nanoparticles 
 µen/ρ = mass energy absorption coefficient  
wNP = fraction by weight of NP in the mixture 
E = energy of the monochromatic beam  
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Calculations of radiation dose enhancement for various high Z element and 
radiation sources by the means of analysing the µen/ρ have been made by Roeske et 
al (2007). In their study, DEF for materials with various Z numbers ranging from 25 
to 90 were calculated for different energy spectra. Different external beam sources 
from kilovoltage range of energy to megavoltage photons from linear accelerators 
and some common radionuclides are also included in the calculation.  The 
mathematical form of the DEF for a spectrum of energies or polyenergetic energy is 
shown in equation ( 8 ):  
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( 8 ) 
 
NP = nanoparticles 
µen/ρ = the mass energy absorption coefficient  
E = energy ranging from background 0 to maximum 
Ψ = energy fluence  
Ψ′ = differential photon energy fluence  
kNP = mass composition of the nanoparticles in tumour 
 
The equation ( 8 ) is derived from the ratio of mass energy absorption 
coefficients obtained with and without the AuNPs. The results of the calculation 
indicate that the low energy x-rays and brachytherapy sources produce highest 
degree “levels” of dose enhancement. High Z material also most preferable to be 
effective dose enhancer although elements with Z values of around 45 to 70 may 
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have DEF decrease or reach plateau (112). Selection of a material for optimal DEF 
must be made carefully based on several criteria (112).  
Using the monoenergetic based equation, the DEF of gold, iodine and 
gadolinium are calculated for different beam energies and concentration of AuNPs 
for comparison purposes. The variation of DEF with energy and concentration of 
gold are presented in Figure 20 where the DEF values for various concentrations of 
gold mixtures are plotted against the incident x-ray beam energy. The energy 
dependency of DEF is observed and the DEF is found to peak at about 40 keV. The 
value of DEF at that energy is about 160 for 100% concentration of gold mixture. It 
should be noted that this maximum/optimal energy of 40 keV is well below the gold 
k-edge energy which is at 80.7 keV. Refering to Figure 20, the DEF increases until 
it reaches peak at 40 keV and gradually decreases until it reaches the k-edge energy 
where there is sharp increase followed by a gradual decrease with the increasing 
energy. The trends of DEF variation with beam energies, which result in a bell 
shaped curve, are displayed in Figure 20.   
The same calculation was performed using iodine and gadolinium data and  
shown in Figure 21 and Figure 22, respectively. In Figure 21, the k-edge value of 
iodine is 33.3 keV where the DEF increases up to 138 compared to 49 at the energy 
before reaching the k-edge. The maximum dose value is found to be at energy way 
above the k-edge value which is around 50 keV. The DEF value at this energy is 
around 156 at 100 % concentration of iodine mixtures. After reaching the maximum 
DEF at 50 keV, the DEF starts to decrease with increasing energy.  
Unlike gold and iodine, the DEF for Gadolinium peaks close to the k-edge 
energy of gadolinium, which is around 60 keV, as shown in Figure 22. The 
maximum DEF calculated for gadolinium is around 148 at 100% gadolinium. 
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Comparing the graphs of all the three elements, a similar bell shape curve was 
observed in all of them. The DEF value gradually increases with increasing energy 
until it reaches peak at kilovoltage range of energy around 10 keV to 100 keV. 
When the photon energy increases to more than 100 keV, the DEF slowly decreases. 
 
 
Figure 20: DEF calculated for different percentage of gold mixtures in water. DEF is clearly 
dependent on energy and concentration of gold mixture (from 1% to 100% of gold in water).   
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Figure 21: DEF calculated for different percentage of iodine mixtures in water. DEF is clearly 
dependent on energy and concentration of iodine mixture (from 1% to 100% of iodine in 
water).   
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Figure 22: DEF calculated for different percentage of gadolinium mixtures in water. DEF is 
clearly dependent on energy and concentration of gadolinium mixture (from 1% to 100% of 
iodine in water).   
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Figure 23: DEF comparison for gold, iodine and gadolinium at 10% concentration.  
 
Figure 23 shows a DEF comparison for gold, iodine and gadolinium at 10% 
concentration (10 mg/ml). From 10 to 50 keV, gold yields a higher DEF compared 
to iodine and gadolinium. Around 50 keV to 100 keV, the DEF for iodine and 
gadolinium is found to be slightly higher than gold and DEF for gadolinium is 
slightly higher than iodine. When gold reaches its k-edge energy, it greatly increases 
to once again have the highest DEF. At approximately 100 keV and above, the DEF 
for gold is higher than both iodine and gadolinium. Conclusively, gold has a higher 
DEF compared to iodine and gadolinium at most range of energies which are most 
suitable radiation levels for dose enhancer assisted radiotherapy. This comparison 
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was also performed by simply taking the attenuation and absorption ratio at different 
energies. The absorption and attenuation ratios are plotted in Figure 24. From these 
graphs, it is obvious that gold produces 2-3 times greater absorption compared to 
iodine and gadolinium at most energy range. Iodine and gadolinium do have more 
absorption at some energies but the difference in ratio and range of energy is 
negligible compared to gold.   
 
Figure 24: A) X-ray absorption ratio of gold to iodine versus energy. B) X-ray absorption ratio 
of gold to gadolinium versus energy. C) X-ray attenuation ratio of gold to iodine versus energy 
D) X-ray attenuation ratio of gold to gadolinium versus energy. 
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SECTION A: 
MATERIALS AND METHODS  
(CELL CULTURE STUDY) 
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3. MATERIALS, METHODS AND PROCEDURES  
 
This chapter presents the materials and experimental methodology used for 
measuring the radiation dose enhancement of AuNPs using cells in culture (in vitro). 
The experimental methods are divided into several parts. The first part describes the 
preparation of the AuNPs for biological study, which is followed by a section which 
details cell culture protocols for biological sample preparation. The third part is the 
irradiation procedure, which is subdivided into the different x-ray modalities used in 
this experiment. After this, the method used to obtain cell survival curves is 
explained. Finally, this chapter also includes an additional study of the cytotoxicity 
and localisation of AuNPs inside cells.     
 
3.1. AuNPs preparation for biological study  
 
Batches of AuNPs from two different companies were used in this thesis.  
The first batch was the spherical AuNPs (1.9 nm) obtained in a powder form from 
Nanoprobes Inc. (Yaphank, NY 11980, U.S.A.). The sample of the AuNPs is shown 
in Figure 25. For the cell culture studies, the mass of the AuNPs powder was 
calculated and weighted to prepare 10 mMol/L of AuNPs solution. The weighted 
AuNP solution was then diluted with Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, U.S.A.) and then sterilised by 
filtering through a 0.22 µm hydrophilic polysulphonic membrane syringe bacterial 
filter (Sartorius, Goettingen, Germany). The filtrate was diluted with DMEM to the 
required concentration. 
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Figure 25: The sample of spherical AuNPs (1.9nm) obtained in a powder form from 
Nanoprobes Inc. (Yaphank, NY 11980, U.S.A.). 
 
The second batch of AuNPs was an aqueous solution of spherical shaped 
AuNPs (Au.H2O) of 2 nm and 15 nm sizes obtained from Meliorum Technologies, 
Inc. (Rochester, NY 14607, USA). These AuNPs were prepared by diluting in 
Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich Pty. Ltd., St Louis, 
Mo, U.S.A.) and then filtered through a 0.22 µm hydrophilic polysulphonic 
membrane syringe bacterial filter (Sartorius, Goettingen, Germany). The filtrate was 
diluted with DMEM to the required concentration. Table 4 show details of the 
AuNPs used. 
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Table 4: Details of the batch of AuNPs used for the biological experiments in this thesis. 
Specification Nanoprobe Inc. Meliorum Technologies, Inc. 
Sizes  1.9 nm 2 nm , 15 nm 
Concentration 40 mg Au per vial 1 M 
Batch no  RP 5222, 1102A, N/A 
Shape  Spherical  Spherical  
 
The concentration of the AuNPs was verified using the Hitachi-U 2000 
Spectrophotometer (Hitachi Ltd., Tokyo, Japan) in a 1.4 ml rectangular quartz 
cuvette. The absorbance recorded for different concentrations of AuNPs in DMEM 
and 10% fetal bovine serum (FBS) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA) is 
displayed in Figure 26. 
 
Figure 26: The absorbance spectra measured by UV-VIS spectrophotometer for different 
concentrations of AuNPs. The AuNPs were measured in DMEM with 10 % FBS. FBS does not 
have any significant effect on the absorbance reading.     
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3.2 Cell culture protocol  
 
The bovine aortic endothelial cells (BAECs) were isolated from bovine aorta 
tissue obtained from a local abattoir. The cells were harvested by collagenase 
dispersion and were cultured in DMEM supplemented with L-glutamine (Sigma-
Aldrich Pty. Ltd., St Louis, Mo, U.S.A), 10% fetal bovine serum (FBS) (Sigma-
Aldrich Pty. Ltd., St Louis, Mo, USA), antibiotics (100 units penicillin / mL and 
100 µg streptomycin / mL) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA). The 
primary cells were grown to confluence in a 75 cm2 flask (Nunc, Roskilde, 
Denmark) and split in a ratio of 1:3 by using trypsin ethylenediaminetetraacetic 
(EDTA) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA). The cells were incubated at 
37oC with 95% air and 5% CO2 in a humidified atmosphere. Cells in passages 3 to 
10 were used for this study. A sample of the cell culture flask used is shown in 
Figure 27. 
 
The cells were plated (1 x 104 cells per well) into 96-well tissue culture 
plates and were allowed to attach before AuNPs were added. Cells were incubated 
with AuNPs of different concentrations (0.125, 0.25, 0.5, 1.0 mMol/L) for 24 hours 
before they were exposed to radiation. A sample of cell culture in a 96-well plate 
with and without AuNPs is shown in Figure 28. 
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Figure 27: A sample of cell culture in 25 cm2 flask 
 
 
Figure 28: The cell culture samples in 96-well plate with and without AuNPs 
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3.3 Cell irradiation 
 
All the samples were irradiated with external x-rays from various sources 
and energies ranging from kilovoltage to megavoltage photon beams. The 
kilovoltage x-rays energy was obtained from a superficial therapy machine and the 
megavoltage x-rays from a LINAC. Studies also were done with electron beams 
from the same LINAC. All these treatment machines were located at the William 
Buckland Radiotherapy Center, The Alfred Hospital, Melbourne, Australia.  
 
 
3.3.1 Kilovoltage superficial x-ray radiotherapy  
 
Irradiation of BAECs was carried out using both x-ray and electron beams at 
the William Buckland Radiotherapy Centre (The Alfred Hospital, Australia). For the 
x-ray beam experiment, cells were irradiated with 80 kVp and 150 kVp x-ray 
energies from a superficial x-ray therapy (SXRT) machine (Therapax 3 Series, 
Pantak Inc., Branford, CT, U.S.A.) at various radiation doses (0,1,2,3,4 and 5 Gy). A 
single fraction irradiation with dose rate 1.008 Gy/min using a 15 cm diameter 
collimator with a 0.8 mmAl filter (1.2mmAl HVL) was used. The distance between 
the source and the cell culture was 25 cm. Figure 29 and Figure 30 show the setup 
for kilovoltage x-ray irradiation of cells. 
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Figure 29: The schematic picture of irradiation of the cells using SXRT machine. Image is not 
to scale.   
 
Figure 30: SXRT irradiation set up of the cells. The cells were placed under the collimator and 
totally covered.   
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3.3.2 Megavoltage electron beams radiotherapy 
 
The experiments were repeated with 6 MeV and 12 MeV electron beams 
from a medical LINAC (Clinac 2100C, Varian Associates Inc., Palo Alto, CA, 
U.S.A.). The cell culture plates were set up at a source to surface distance (SSD) of 
100 cm using a 20 x 20 cm2 electron applicator. Irradiations were also done in single 
fraction with constant dose rate of around 1 Gy/min. The doses delivered by 
megavoltage electron beams were verified using a parallel plate ionisation chamber. 
The irradiation setup for electron beam irradiation is shown Figure 31. 
 
 
Figure 31: The set up for cell irradiation with megavoltage electron beams from a clinical 
LINAC.  
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3.3.3 External megavoltage x-rays radiotherapy 
 
The experiments were performed with 6 MV x-ray beams from a medical 
LINAC (Clinac 2100C, Varian Associates Inc., Palo Alto, CA, U.S.A.). The cells 
were set up on a water plastic phantom at SSD at 100 cm using a 10 x 10 cm2 field 
size. Plastic water phantom was placed on top of cell culture plate as a build up so 
that the maximum dose was delivered to the cells. Irradiations were done in single 
fraction with constant dose rate of around 100 MU/min of radiation doses ranging 
from 0 to 7 Gy. The irradiation setup for external megavoltage x-rays beams from 
LINAC is shown in the Figure 32. 
 
Figure 32: The set up for cell irradiation with megavoltage x-ray from clinical LINAC. Build 
up were placed on top on the plate to ensure maximum dose to the cells. Also, the cell medium 
was filled to reduce the air gap effects. 
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3.3.4 Verification of dose uniformity using film dosimetry  
 
The uniformity of x-ray doses was verified using radiochromic film 
(GafchromicTM Film EBT, International Specialty Products, Wayne, NJ). A parallel 
plate ion chamber in conjunction with 2570/1 Farmer dosemeter (NE Tech) was also 
used to ensure the correct dose is given to the cells. EBT model GafchromicTM film 
is suitable to be used as reference dosimetry for biological work with wide range of 
different irradiation setups (113). Tomic et. al. (2007) have shown that dose 
deposited will not be underestimated by more than 2% when the film is positioned 
below the 96-well plate (113). The dose profiles from film measurements are shown 
in Figure 33 and Figure 34. All the cell culture plates in every experiment were 
placed at the centre of the beam to ensure that all the cells received uniform 
radiation dose.  
 
 
Figure 33: Dose profiles from radiochromic film irradiated with 5 Gy of 80 kVp x-ray 
(Horizontal axis of the film) 
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Figure 34: Dose profiles from radiochromic film irradiated with 5 Gy of 80 kVp x-ray (Vertical 
axis of the film) 
 
 
3.4. Cell survival measurement using a colorimetric assay 
 
The survival curves were obtained by a colorimetric method using CellTiter 
96® AQueous One Solution Cell Proliferation Assay, (Promega Corp., Madison, WI, 
U.S.A.). This is also known as MTS assay. It contains a tetrazolium compound [3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine 
ethosulphate; PES). Interaction with metabolically active cells bioreduces this 
compound into a coloured formazan product that is soluble for use in tissue culture 
medium (114). Metabolically active cells contain dehydrogenase enzymes that 
produce a cellular reducing agent, either NADPH or NADH (nicotinamide adenine 
dinucleotide phosphate) (114). These cell reducing agents convert the MTS 
tetrazolium compound to the formazan products as displayed in Figure 35. 
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Figure 35: The bioreduction process showing changes in MTS tetrazolium chemical structure 
into formazan products. 
 
 
MTS is a pale yellow compound that will turn into a dark blue formazan 
product indicating the metabolic activity of the cells. The optical density or 
absorbance of the solution of the formazan product can be detected using a 
multiwell spectrometer. The colour intensity is indicative of the quantity of 
formazan product measured by absorbance relative to the cell number is shown in 
Figure 36.  
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Figure 36: The relationship between cell number and absorbance measured for various 
numbers of BAECs measured in 96 well plates. The cells were cultured in DMEM 
supplemented with 10 % FBS and 1% antibiotic. The cells were allowed to attach for 5 hours 
before the MTS was added and continued for incubation. After 4 hours, the absorbance was 
measured at 490 nm using 96-well plate reader. The errors at each point represent the mean 
±SD of 3 replicates. 
 
Measurement of radiation cell survival based on a colorimetric technique using 
the tetrazolium compound MTT (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl 
tetrazolium bromide) has been explored before (115-118). Colorimetric assay was 
found to accurately predict the radioresponsiveness of cells with the results 
comparable to the clonogenic assay that is commonly used to obtained cell survival 
curves (118). Compared to the clonogenic assay, which is usually quite time 
consuming (taking 2-4 weeks), the colorimetric assay is rapid, requiring a shorter 
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duration (116-117). The clonogenic assay also requires reliable cell growth in 
culture media which is not suitable for cells that do not form a colony (115). The 
colorimetric assay is also easier to perform compared to the clonogenic assay, which 
is also more technically demanding, hence the probability of a successful test is 
higher (116-117). However, the colorimetric assay may be more expensive due to 
the cost of tetrazolium compound. There are also restrictions on radiation dose range 
and difficulties with data interpretation (117). The colorimetric assay measures the 
surviving fraction of a population of clonogenic and non clonogenic cells, whereas 
the colony forming assay measures the surviving fraction of clonogenic cells only 
(117). Therefore since the colorimetric assay measures only viable, proliferating or 
attached cells, it will likely underestimate cell death compared to the clonogenic 
assay which measures the capacity of surviving cells to divide and form colonies 
(115). 
 
In this thesis, a colorimetric technique based on MTS was established and 
introduced for the first time. This assay is similar in principle to the MTT assay 
which has previously been used (117). The MTS assay provides advantages over the 
MTT assay since MTS produces a soluble formazan product, whereas the MTT 
assay produces a crystalline precipitate that requires an additional step in the 
procedure to dissolve the crystal before absorbance is measured (114). The MTS 
assay method used in this thesis is shown as a flow chart in Figure 37. 
 
Referring to Figure 37, the irradiated cells in a 96-well plate were incubated 
for 72 hours after irradiation and were changed to a fresh medium before 200 µl of 
CellTiter 96® AQueous One Solution Cell Proliferation Assay reagent were added. 
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The plates were wrapped in aluminium foil because this assay is light sensitive.  The 
absorbance was recorded at 490 nm in a 96-well plate reader (Wallac Victor 
Multilabel Counter, Perkin-Elmer Life Sciences, Boston, Mass. U.S.A). Results are 
expressed as a percentage relative to control cells as shown in equation ( 9 ). Data 
are quoted as the mean ± standard deviation from three independent experiments 
(mean ± SD, n=3). 
 
BackgroundcellscontrolofAbsorbance
BackgroundcellsirradiatedofAbsorbanceFractionSurviving
−
−
=  
 
 
( 9 ) 
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Figure 37: Colorimetric assay using CellTiter 96® AQueous One Solution Cell Proliferation 
Assay, (Promega Corp., Madison, WI, U.S.A.) the MTS assay for cell survival measurement. 
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3.5. Cytotoxicity assay 
 
Experimental studies were performed to determine the cell toxicity of 
various AuNPs concentrations. The cells were not exposed to radiation during this 
study. The cell cytotoxicity was determined by measuring cell viability and 
observing cell morphology. 
 
3.5.1 Cell viability assay 
 
This experiment was performed to study the effects of AuNPs on cell 
viability and proliferation. The cells were seeded in the 96-well plate and were 
treated with different concentrations of AuNPs (0.125, 0.25, 0.5, 1.0 mMol/L). 
AuNPs of sizes 2 nm and 15 nm were used. The cytotoxicity of the AuNPs was 
assessed by CellTiter 96® AQueous One Solution Cell Proliferation (MTS assay) 
using a similar protocol to the cells survival assay except with no exposure to 
radiation. The cytotoxicity was measured at different time points of 24, 40 and 72 
hours after adding AuNPs. 
 
3.5.2 Cell morphology analysis  
 
This experiment was performed to study the effects of AuNPs on the 
morphology of cells. The BAEC were cultured in 6 well plates until they had 
reached confluence without AuNPs. Then AuNPs were added at concentrations of 
0.25. 0.5 and 1 mMol/L. The cells were observed at every hour and images were 
taken under phase contrast microscopy using Leitz DM-IC inverted microscope 
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(Leica Microsystems, Wetzlar, Germany) and spot pursuit camera with Spot 
Advanced  software version 4.6 (Diagnostic Instruments Inc., Sterling Heights, MI, 
USA). The cell morphology was then analysed using Image-Pro Plus software 
(MediaCybernetics, MD). 
 
3.6. AuNPs localisation in the cells 
 
This study was done to determine whether the AuNPs go inside the cells or 
not. There are two methods which were used to observe any uptake of AuNPs by 
cells. The first technique specifically targets the AuNPs inside the cells. The cells 
with AuNPs become identifiable due to bright particles inside the cells. The second 
technique, the cells are stained using hematoxylin-eosin cell staining procedure 
which shows any foreign material inside the cells. 
 
3.6.1 Darkfield observation 
 
The cells used were grown on 6 well plates (Nunc, Roskilde, Denmark). 
Different concentrations of AuNPs (0.25, 0.5, 1mMol/L) in complete DMEM were 
added to the cells and incubated at 37oC. After continuous exposure of the cells to 
the AuNPs for 24 hours, cells were fixed for 5 minutes in ice-cold methanol and 
stained with AuroDye™ Forte (GE Healthcare, Buckinghamshire, UK). AuroDye™ 
Forte is a stabilised colloidal gold which binds selectively to protein by hydrophobic 
and ionic interaction. In this case, AuroDye™ Forte selectively binds to the AuNPs 
and therefore they appear as bright particles under microscopes. Cellular localisation 
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of AuNPs was viewed with darkfield observation at 60 times magnification using 
confocal microscopy (Olympus BX-FLA, Tokyo, Japan).  
 
3.6.2 Light microscopy observation  
 
Cells were plated in slide flasks (Nunc, Roskilde, Denmark) and were 
incubated overnight with 1 mMol of 2 nm AuNPs. After 24 hours of incubation, 
cells were rinsed with Phosphate Buffer Saline (PBS) and were fixed with 4% 
paraformaldehyde. The fixed cells were then stained with hematoxylin-eosin and 
observed with light microscopy at 40X magnification (Leitz DM-IC inverted 
microscope, Leica Microsystems, Wetzlar, Germany). The image of the cells was 
captured with spot pursuit camera with Spot Advanced software version 4.6 
(Diagnostic Instruments Inc., Sterling Heights, MI, USA) for microscopic analysis. 
 
3.7. Statistical analysis 
 
The data were expressed as mean ± standard deviation (SD) of three 
independent experiments.   One way analysis of variance (ANOVA) was used to 
determine the significance of the difference between the control and experimental 
group followed by post-hoc analysis mean comparison using Bonferroni’s test.  A 
difference was considered to be statistically significant when p < 0.05. Statistical 
analysis was performed with the OriginPro 7.5 SR0 v7.5714 (B714) software.  
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4. RESULTS AND DISCUSSION (CELL CULTURE STUDY) 
 
This chapter presents the results obtained and accompanied with discussions. 
The focus is on the radiobiological study of dose enhancement produced by AuNPs 
using endothelial cells. The results are presented first (section 4.1) then followed by 
discussion (section 4.2); 
 
4.1. Results  
 
The basic characteristic of AuNPs, such as localisation inside the cells and 
cytotoxicity, were evaluated. AuNPs were then employed as radiation dose 
sensitisers for various types of radiotherapy treatment techniques using different 
beam energies and different AuNPs concentrations. Cell survival curve is used as an 
end point to analyse the enhancement effects by AuNPs. The dose enhancement 
factor (DEF) was calculated and radiobiology analysis was conducted on the cell 
survival curves obtained.   
 
4.1.1. AuNPs localisation in the BAECs 
 
Study of the cell uptake of AuNPs and its localisation inside the cells was 
undertaken to determine the distribution of AuNPs inside these cells. In this study, 
AuNPs were found to be internalised inside the cells after 24 hours of incubation. 
From different techniques used in this work to observe the aggregation of AuNPs 
inside the cells, it was found that they were clustered in the cytoplasm of the cells 
and do not enter the nucleus. The clusters of AuNPs are clearly seen in Figure 38, 
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which shows the AuNPs aggregating after entering the cells. Figure 39 show the 
darkfield image of cells with and without AuNPs. The cells with AuNPs were 
clearly glowing under the darkfield confocal microscope, where the AuNPs are 
distributed in the cytoplasm of the cells. Figure 40 shows cells with AuNPs stained 
using Hematoxylin and Eosin. The black dots in Figure 40 are representative of 
AuNPs. The black dots inside the cells surround the nucleus which was stained with 
a blue dye. The AuNPs were observed to enter the cells within 24 hours of 
incubation.  
 
 
 
Figure 38: A) Microscopic image of control BAECs without AuNPs  B) Microscopic image 
showing that AuNPs are internalized within the BAECs after 24 hours of incubation  
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Figure 39: Darkfield image of A) BAECs without AuNPs B) BAECs with AuNPs. The AuNPs 
were distributed in the cytoplasm of the cells. 
 
 
Figure 40: BAECs stained with haematoxylin and eosin show AuNPs as a black dot. The 
AuNPs were found surrounding the nucleus which is stained blue.  
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4.1.2. AuNPs cytotoxicity 
 
The toxicity of AuNPs to the cells was investigated by measuring the cells’ 
viability and observing the changes of cell morphology.  
 
4.1.2.1 Cell viability 
 
Initial studies were performed employing BAECs to determine the 
cytotoxicity of AuNPs. The studies were also performed to determine the highest 
concentration of AuNPs that could be reliably suspended in the culture medium and 
incubated within the cells without causing visible damage to the cells’ monolayer. 
AuNPs from two different companies were used in this study to determine the 
cytotoxicity effects of AuNPs. The average size of AuNPs investigated are 1.9 nm 
AuNPs (Nanoprobes Inc., Yaphank, NY 11980, U.S.A.), 2 nm and 15 nm diameter 
size of AuNPs (Meliorum Technologies, Inc., Rochester, NY 14607, USA). 
 
Cytotoxicity was determined by comparing the percentage of viable cells or 
absorbance reading of MTS assay which represent viable cells with varying 
concentration of AuNPs compared to a control (without AuNPs treatment). Results 
were collected after incubating the BAEC monolayer for 24, 48, and 72 hours. 
Figure 41 shows the cytotoxicity of 1.9 nm AuNPs at different concentrations 
measured after 24 hours of incubation. It was observed that the cells viability was 
reduced by up to 30 % for a AuNPs concentration of 1mMol/L.  
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The effects of AuNPs on cells’ viability are clearly displayed in Figure 41, 
where the number of live cells decreases with increasing AuNPs concentration of 
1.9 nm size. However, study of 2 nm and 15 nm AuNPs showed no significant 
effects of AuNPs on cells viability measured as displayed in Figure 42 and Figure 
43. The cell viability measured for different concentrations of AuNPs did not show 
any statistically significant difference at any time measured. The control cell without 
AuNPs shows no significant increase over time. However, the cells viability 
measured after 72 hours shows increased number of cells for samples with 0.25 
mMol/L of 2 nm AuNPs compared to the control cells without AuNPs which is 
statically have significant different. For 15 nm AuNPs, significant effects were only 
observed between 0.25 mMol/L and 1 mMol/L AuNPs concentration. 
The same results are also displayed in Figure 44 and in Figure 45, which 
clearly show no significant increase in the number of cells over the time with no 
significant different of cells growth or proliferation for the control cells. However, 
the cell samples with 0.25, 0.5 and 1 mMol/L of 2nm AuNPs showed significant 
difference after 72 hours where the number of cells with AuNPs is greater than the 
number of control cells at 24 hours. This indicates that AuNPs did not affect the 
cells’ proliferation or growth and in fact probably promoted the cells’ growth and 
proliferation. However for 15 nm AuNPs, only at 0.25 mMol/L concentration after 
72 hours significant different were observed. Comparing the cell viability for both 
samples of different AuNPs sizes measured after 24 hours, there are no significant 
different between both sizes except at 0.25 mMol/L,  2 nm AuNPs showed slightly 
higher toxicity compared to the 15 nm AuNPs as shown in Figure 46. 
 
 
 101 
 
Figure 41: The percentage of cell viability with different concentrations of AuNPs as an 
indicator of AuNPs cytotoxicity. The errors are standard deviation from three independent 
experiments (mean ± SD, n=3). 
 102 
 
Figure 42: Cell viability of BAECs incubated with 2 nm AuNPs of different concentrations 
measured at 24, 48 and 72 hours. The errors are standard deviation from three independent 
experiments (mean ± SD, n=3). The data mean comparisons for different concentration at the 
same time are not significantly different (P > 0.05, ANOVA and Bonferroni’s test).   
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Figure 43: Cell viability of BAECs incubated with 15 nm AuNPs of different concentrations 
measured at 24, 48 and 72 hours. The errors are standard deviation from three independent 
experiments (mean ± SD, n=3). The data mean comparisons for different concentration at the 
same time are not significantly different (P > 0.05, ANOVA and Bonferroni’s test). 
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Figure 44: The cell viability as a function of time for BAECs exposed to different 
concentrations of 2nm AuNPs. The errors are standard deviation from three independent 
experiments (mean ± SD, n=3).  There is no significant effect of nanoparticles on cell viability at 
any time point (P>0.05). (*) significantly greater than 24 hours within the same concentration 
of AuNPs. (P<0.05, ANOVA plus Bonferonni’s test) 
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Figure 45: The cell viability as a function of time for BAECs exposed to different 
concentrations of 15nm AuNPs. The errors are standard deviation from three independent 
experiments (mean ± SD, n=3). There is no significant effect of nanoparticles on cell viability at 
any time point. (P > 0.05,  ANOVA plus Bonferonni’s test)). 
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Figure 46: Comparison of percentage viability of the BAECs cells exposed to 2nm AuNPs and 
15nm AuNPs. The errors are standard deviation from three independent experiments (mean ± 
SD, n=3). There is no significant effect of different size of AuNPs on cell viability at any 
concentration (P>0.05). (*) indicate significant difference between 2 nm and 15 nm AuNPs at 
the 0.25 mMol/L concentration of AuNPs (P<0.05, ANOVA plus Bonferonni’s test). 
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4.1.2.2. Cell morphology 
 
Cells’ morphological changes over time were observed visually under phase 
contrast microscopy for various concentrations of 1.9 nm AuNPs. Cellular 
morphology was observed to change over time depending on the AuNPs 
concentration. Figure 47 shows the cells after 12 and 24 hours at different 
concentrations of AuNPs.  In this figure, it is clear that the number of cells 
becoming rounded or of abnormal shape increases after 24 hours and it has also 
increased with the increase of the AuNPs concentration.  The rounded form of cell is 
an indication of the cell dying and this observation is in agreement with cytotoxicity 
results displayed in Figure 41. Some of the cells are probably still alive and attached 
but not in the normal shaped were also recorded in these results. The number of 
abnormally shaped cells is quantified using computer software Image-Pro Plus 
software (MediaCybernetics, MD) and presented in Figure 48. 
 
From the Figure 48, the number of cells with abnormal shape is observed to 
be increasing with increasing AuNPs concentration and time of incubation. This is 
more obvious for 1 mMol/L AuNPs after 72 hours of incubation, where the 
abnormally shaped cells’ number is dramatically increased. Figure 49 shows the 
bright-field image of the cells taken using confocal microscope that contain AuNPs 
becoming rounded compared to the well spread shape of endothelial cells.   
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Figure 47: The BAECs morphology cell changes with the AuNPs. A) Control B) 0.25 mMol C) 
0.5 mMol D) 1mMol 
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Figure 48: The number of cells with abnormal morphology after 12, 24, 48 and 72 hours. The 
number of abnormal cells for three independent experiments was analysed using image pro-
plus software. The data are expressed as mean ± SD of three independent experiments. (*) 
indicates P < 0.05 compared to control at the same time. (#) indicates P < 0.05 compared to 12 
hours within the same concentration (ANOVA plus Bonferroni’s test). 
 
 
Figure 49: Brightfield image of cells with AuNPs that become rounded after 24 hours   
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4.1.3. Cell survival curve and DEF 
 
The enhancement of radiation effects by AuNPs was measured using 
BAECs. Survival curves displayed in Figure 51-55, show the effects of AuNPs on 
cell survival fractions at different radiation doses using different x-ray beams of 
various energies with and without AuNPs. Concentrations of AuNPs ranging from 
0.5 mMol/L to 1 mMol/L were used to observe the effects of AuNPs concentration 
on the dose enhancement. The dose enhancement factor (DEF) obtained from the 
cell survival curve, as explained in the method section, is used to determine the 
effects of AuNPs as dose modifiers.  Here the DEF is the ratio of the dose given to 
the control cell culture (i.e. without AuNPs) that produces 80% survival divided by 
the dose given to the cells treated with AuNPs that produces 80% survival is shown 
in Figure 50 .  The outcomes of such DEFs with various beams are listed in the next 
section. 
 
Figure 50: DEF extrapolated from cell survival curve  
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4.1.3.1 Kilovoltage superficial x-rays radiotherapy 
 
Figure 51, Figure 52 and Figure 53 show cell survival curves for BAECs 
cells irradiated with a SXRT machine with beam energies of 80, 100 and 150 kVp. 
Concentrations of AuNPs used for each experiment are 0.25 mMol/L, 0.5 mMol/L 
and 1.0 mMol/L. DEF extrapolated at 80 % survival for 80 kVp x-rays energy were 
1.59, 2.53 and 3.07 for 0.25 mMol/L , 0.5 mMol/L and 1.0 mMol/L concentration of 
AuNPs , respectively. For 100 kVp energy, DEF measured for the same 
concentration are 1.17, 1.47 and 1.9, respectively. The highest kilovoltage energy 
used which is 150 kVp show DEF of 1.22, 1.35 and 1.67 also for the same AuNPs 
concentration.   
 
Figure 51: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 80 kVp x-rays from SXRT machine. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3). The line are the fit of the Linear quadratic model. 
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Figure 52: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 100 kVp x-rays from SXRT machine. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3). 
 
Figure 53: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 150 kVp x-rays from SXRT machine. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3). 
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4.1.3.2 Megavoltage electron beam radiotherapy 
 
The potential increase of cellular damage induced by AuNPs with electron 
beam irradiation is depicted in the cell survival curves shown in Figure 54, Figure 
55 and Figure 56.  Figure 54 shows survival curves for 6 MeV electron beam. From 
Figure 54, the DEFs extrapolated for 0.25, 0.5 and 1 mMol/L AuNps concentration 
are 1.35, 1.75 and 2.7 at 6 MeV, respectively. The DEF measurements from Figure 
55 and Figure 56 indicated the enhancement by 1.3 (0.25mMol/L), 1.4 
(0.5mMol/L), 1.63 (1.0 mMol/L) for 9 MeV and 1.45 (0.5mMol/L), 1.71 (1 
mMol/L) for 12 MeV. The DEFs obtained for electron beams are significantly good 
but lower than those obtained from kilovoltage x-rays beams. 
 
Figure 54: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 6 MeV electron beam from LINAC. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3).  
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Figure 55: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 9 MeV electron beam from LINAC. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3). 
 
Figure 56: Survival curve of BAECs cell line with various concentrations of AuNPs irradiated 
with 12 MeV electron beams from LINAC. The errors are standard deviation from three 
independent experiments (mean ± SD, n=3). 
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4.1.3.3 External megavoltage x-rays radiotherapy 
 
The biological effects of external megavoltage x-rays beams on cells as 
enhanced by AuNPs are displayed in Figure 57. Enhancement effects are also 
observed in megavoltage x-rays beams with DEF value of 1.54 for a AuNPs 
concentration of 1mMol/L, which is much less than that expressed by low energy 
beams (kilovoltage range) and even less than the electron beam.  
 
 
Figure 57: The survival curve of BAECs cell line with 1mMol of AuNPs irradiated with 6 MV 
x-rays from LINAC. The errors are standard deviation from three independent experiments 
(mean ± SD, n=3). 
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4.1.4 Comparison of DEFs for different energies and beams  
 
The DEF of AuNPs in combination with various radiotherapy beams and 
techniques were compared to find out the highest DEF values obtained for this type 
of cells. The DEF comparison for different kilovoltage x-ray energies and AuNPs 
concentration are displayed in Figure 58, which shows an increase in DEF value 
with decreasing energy and increasing AuNPs concentration. Maximum DEF is 
observed at 80 kVp and at 1 mMol/L concentration which is around a factor of 3. At 
1 mMol/L AuNPs, DEF obtained for 100 kVp and 150 kVp is 1.9 and 1.67, 
respectively which shows greater enhancement at lower energy compared to high 
energy. An increase in DEF at lower energy and higher AuNPs concentration was 
also observed from the results of megavoltage electron beam.  Figure 59 show the 
DEF comparison of different electron beam energies and shows the decreasing DEF 
for higher electron beam energy. It should also be noted that the DEF values are 
much higher for kV beams in comparison to the MV beams.  
 
In general, the application of AuNPs in various techniques in radiotherapy 
shows enhancement of effects, with DEF values ranging from 1.17 to 3.07. 
Enhancement of effects observed shows an increase in the radiation dose received 
by the cells at kilovoltage x-rays and electron beams compared to the high energy x-
rays beams in the megavoltage range. This is good indication of the feasibility of 
AuNPs in enhancing the radiation dose delivered to tumours and thereby increasing 
the efficiency of cancer treatment in radiotherapy. This is very beneficial especially 
for radiotherapy using kilovoltage x-ray beams and electron beams, which are 
commonly used for superficial cancers such as melanoma and recently introduced 
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intraoperative kV beams will also benefit from this. The results also show that the 
enhancement effects are highly dependent on beams energy and on the 
concentration of AuNPs. The low energy range is the most suitable for maximum 
dose enhancement. Megavoltage photon and electron beams also produce significant 
dose enhancement, especially at high concentrations of AuNPs. In all cases, the 
DEF increases with increasing concentration of AuNPs.          
 
 
 
Figure 58: DEF comparison of different kilovoltage x-ray energy at different concentrations of 
AuNPs.  
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Figure 59: DEF comparison of different electron energy at different concentrations of AuNPs.  
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4.1.5. Radiobiological analysis of dose enhancement  
  
The shape of the cell survival curve in Figures 51 to 57 qualitatively 
indicates that there are lesser cells surviving irradiation with AuNPs compared to 
the control cells which are without AuNPs. It is also established that the shape of the 
cell survival curve is affected by different beam energies and AuNPs concentration. 
The cell survival curves also can be quantitatively described using a radiobiological 
model such as linear quadratic model. In the linear quadratic model, cell death by 
radiation can be described by two components; the linear part and the quadratic part. 
The linear part is termed alpha (α) while the quadratic part, beta (β). These have 
been explained in the introduction section of this thesis.    
 
The experimental data plotted in the cell survival curves in figures 50 to 56 
fits a linear quadratic equation. Tabulated α and β values as parameters fitting the 
cell survival curves are displayed in Table 5. It is observed that the linear parameter 
or α value tends to increase with the inclusion of AuNPs more significantly than β. 
The cell survival curve for 80 kVp indicates that the α value for 0 mMol/L is 
0.0113±0.028.  However, it is observed that the value of α changes with the 
inclusion of AuNPs into the cells. For 0.25 mMol/L, 0.5 mMol/L and 1.0 mMol/L 
the α value increases to 0.0605±0.016, 0.0995±0.018 and 0.1452±0.019, 
respectively. The survival curves show significant increase in α  value with the 
increasing concentration of AuNPs. The quadratic part of the curve or β value 
doesn’t show any significant changes with the inclusion of AuNPs.  
 
 120 
Another way of analysing cell survival curve is by using mean inactivation 
dose ( D ) (119-120). The D  represent in-vitro radiosensitivity of mammalians cells 
and was introduced by Kellerer and Hug in 1972 (121). This parameter  represents 
the whole population and is equal to the area under the survival curve in a linear-
linear plot (122-123). While it is ‘not commonly used’ a less well known parameter 
to assess the in vitro cell survival curve, D  is recommended by ICRU Report 30. 
Fertil et. al. (1984), calculated D  based on the analysis of the linear quadratic 
equation. As shown in equation ( 10 ), D can be calculated from the linear quadratic 
parameters (α and β) using Gaussian numerical integration. A program written using 
MATLAB was used to calculate the D values for the data obtained in this work.  
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 (10) 
 
D = Mean inactivation dose  
α = linear value for the survival curve  
β = quadratic value for the survival curve 
Wj = Coefficient of the “12 point” Gauss formula  
Xj = Coefficient of the “12 point” Gauss formula  
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The calculated D values are tabulated in Table 5 and ratio of D obtained for 
cell survival curve with and without AuNPs was used to obtain the DEF as 
displayed in the equation (11 ) :  
 
 
withAuNPs
PswithoutAuN
D
D
DEF =
 
 
( 11 ) 
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Table 5: Compilation of the radiobiological analysis of alpha, beta value and D . DEF 
calculated at 80% survival and D ratios are also tabulated; 
 
Energy 
AuNPs 
concentration 
(mMol/L) 
 
α (Gy-1) 
 
β (Gy-2) 
 
D  
DEF 
(at 80% 
survival) 
DEF 






AuNPs
control
D
D
 
80 kVp 0 mMol/L 0.0113±0.028 0.0031±0.006 14.94 - - 
 
0.25 mMol/L 0.0605±0.016 0.0046±0.004 8.36 1.59 1.79 
 
0.5 mMol/L 0.0995±0.018 0.0068±0.004 5.99 2.53 2.49 
 
1 mMol/L 0.1452±0.019 0.0084±0.004 4.73 3.07 3.16 
100kVp 0 mMol/L 0.0387±0.028 0.0004±0.006 18.35 - - 
 
0.25 mMol/L 0.0453±0.016 0.0007±0.004 15.89 1.17 1.15 
 
0.5 mMol/L 0.0497±0.018 0.0009±0.004 14.56 1.44 1.26 
 
1 mMol/L 0.0588±0.019 0.0031±0.004 9.73 1.8 1.89 
150kVp 0 mMol/L 0.0093±0.010 0.0063±0.002 10.32 - - 
 
0.25 mMol/L 0.0074±0.006 0.0099±0.002 9.91 1.22 1.04 
 
0.5 mMol/L 0.0305±0.008 0.0063±0.002 8.94 1.35 1.15 
 
1 mMol/L 0.0477±0.008 0.0064±0.002 7.99 1.67 1.29 
6 MeV 0 mMol/L 0.0211±0.024 0.0102±0.004 11.67 - - 
 
0.25 mMol/L 0.0536±0.020 0.0060±0.004 9.22 1.35 1.27 
 
0.5 mMol/L 0.0912±0.017 0.0014±0.004 9.07 1.75 1.29 
 
1 mMol/L 0.1458±0.020 0.0062±0.004 5.00 2.69 2.33 
9 MeV 0 mMol/L 0.0396±0.011 0.0068±0.002 8.18 - - 
 
0.25 mMol/L 0.0453±0.043 0.0068±0.008 7.91 1.29 1.03 
 
0.5 mMol/L 0.0275±0.025 0.0103±0.005 7.38 1.42 1.11 
 
1 mMol/L 0.1014±0.024 0.0028±0.004 7.36 1.63 1.11 
12 MeV 0 mMol/L 0.0482±0.015 0.0072±0.002 9.47 - - 
 
0.5 mMol/L 0.1001±0.009 0.0008±0.002 9.05 1.45 1.05 
 
1 mMol/L 0.1125±0.01 0.0009±0.001 8.10 1.71 1.17 
6 MV 0 mMol/L 0.0401±0.012 0.0026±0.002 12.18 - - 
 
1 mMol/L 0.0764±0.021 0.0011±0.003 10.73 1.54 1.14 
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4. 2. Discussion  
 
AuNPs were found to be localised inside the cells and found to be slightly 
toxic to cells. AuNPs were also found to produce significant dose enhancement to 
the cells. Factors and reasons behind these findings will be discussed in this section.  
 
4.2.1 Localisation of AuNPs  
 
This research have found that the incubation of BAECs with AuNps for 
about 24 hours leads to the inclusion of most of the AuNps into the cells as shown in 
Figure 38, 39 and 40. This is in agreement with the findings documented in other 
studies (124-126). A study by Connor et. al. (2005) found that AuNPs are 
internalised into the cells within one hour of exposure suggesting that AuNPs are 
rapidly taken up by the cells (127). 
 
This thesis study also found that AuNPs were clustered in subcellular 
compartments in the cells’ cytoplasm and did not enter the nucleus. This agrees with  
Zhang et al’s (2008) study of AuNPs, which showed that the particles were 
distributed in the cytoplasm of DU-145 cells (human prostate cancer cells) 
examined using TEM micrograph (100). Chang et. al. (2008) observed 
accumulation of AuNPs inside B16F10 cells ( murine melanoma cancer cells) after 
18 hours of incubation and the AuNPs were found to be colocalised within the 
endoplasmic reticulum and golgi apparatus in the cells (98). Chithrani et. al. (2006) 
and Connor et. al. (2005) found AuNPs to be internalised inside the endocytic 
vesicles of the cells with no changes in gross morphology of the AuNPs (106, 127). 
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In majority of such studies, the aggregation of AuNPs is mostly found to be in the 
lysosome and did not break into cytosol (106, 124, 128). However, Nativo et. al. 
(2008) also observed that AuNPs break the endosome and were found to freely 
disperse in cytosol. AuNPs were also found to be located in the perinuclear region, 
mitocondria and other subcellular compartments (129).  In summary, this study and 
the others listed above have found that the AuNPs do not go into the nucleus and are 
mostly found to be in the perinuclear region surrounding the nucleus (106, 124, 
130). Ryan et. al. (2007) successfully targeted the AuNPs to the nucleus using 
peptide and protein (131). 
 
AuNPs that are internalised inside the cells are found to be in cluster or 
aggregated form. A study by Wang et. al. (2008) claimed that the salts in the cells’ 
medium such as DMEM cause the aggregation of AuNPs which enter the cells in 
aggregated form (132). However a study by Kneipp et. al. 2006, showed that it is 
the intercellular environment which changes the individual AuNPs into clusters, 
which over time increase in size and undergo changes in morphology (133). The 
aggregation of AuNPs inside cells makes it difficult to study individual AuNPs but 
this aggregation enhances the effects of the radiation to which they are exposed 
since the probability of photon or electron interactions is increased in proportion to 
the high density and Z of the gold atoms inside the cells; hence, the cell nucleus is 
within the range of the lower energy secondary radiations produced by these 
interactions. Moreover, their aggregation makes it possible to picture them inside 
the cells by special microscopes.  
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In this study, the cells’ intake pathway and the intercellular fate of the 
AuNPs was not confirmed since it is outside the chief aims of this thesis. However, 
many studies have indicated that AuNPs are absorbed and aggregated into the cells 
via endocytosis (133-134). In this process, a number of AuNPs will be enclosed in a 
small pocket (vesicle) when the cell membrane is stimulated by their presence. The 
AuNPs are gradually internalised inside the cells via the endosomal pathway (125, 
134). Recent findings by Mironova et. al. (2010) also report that the major pathway 
for the penetration of AuNPs into the cells is clathrin-mediated endocytosis, while 
smaller AuNPs (13nm) enter cells mostly via phagocytosis (128). The amount of 
AuNPs taken up into the cells has been found to be dependent on particle size, 
shape, charge and functional coating (124, 128, 135). In this study, 1.9nm AuNPs 
were used, however, it has been reported that optimal uptake occurs with 50 nm 
diameter spherical AuNPs (106).  
 
4.2.2 Cytotoxicity 
 
The cytotoxicity tests conducted in this study show that the 1.9 nm AuNPs 
can reduce the cells viability by 30%, in agreement with the findings documented 
for CT-26 cell lines by Chien et. al. (2007). The cytotoxic response (viability and 
morphology) in the BAECs employed in this study was found to be dependent on 
the AuNPs concentration and the time of incubation as shown in Figure 41 and 
Figure 48 in the results section. Cytotoxicity analysis of 2 nm and 15 nm AuNPs 
conclude that no significant toxicity effects were observed to the endothelial cells. 
This is in agreement with other studies on AuNPs cytotoxicity presented in the 
review on several studies by Lewinski et al (2008) (136).   
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However, it should be noted that the cytotoxicity of AuNPs depends on 
many factors such as size, shape, charge, and cell type (106, 124, 128, 137). In this 
study, smaller AuNPs were found to be more toxic than relatively larger AuNPs. 
Pan et. al. (2007) reported that maximum toxicity occurs for particles 1.4 nm in 
diameter (138). Gold in rod form (Gold Nanorod) is also more toxic than AuNPs in 
spherical form (132). Negatively charged AuNPs (anionic) are less toxic than the 
positively charged AuNPs (cationic), which are moderately toxic to the cells (137). 
Cell viability was found to be reduced by 20 % in HeLa (human cervical epithelium 
cells), but only 5% in 3T3/NIH (murine fibroblastoma) cells (139). It was also found 
that AuNPs induced cell death in A549 (human carcinoma lung) cell line but 
BHK21 (baby hamster kidney) and HepG2 (human hepatocellular liver carcinoma) 
cell lines remained unaffected (140).  
 
 
4.2.3 Dose enhancement by AuNPs 
  
The results of this study clearly show that AuNPs effectively enhance the 
radiation effects on BAECS in conjunction with irradiation most effectively by 
kilovoltage energy range x-ray beams as depicted in Figure 51, 52 and 53 which 
show the cell survival curves with and without the inclusion of AuNPs. Comparison 
of the cell survival curves for cells incubated with AuNPs with those without was 
used to determine the level of radiation effects and dose enhancement caused by the 
AuNPs as explained in the sections above. The enhancement effects were 
determined by measuring the ratio of cells that survived irradiation when AuNPs 
were included in the culture and comparing this to the ratio of cells that survived the 
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same radiation dose without AuNPs at 80% of cell survival fraction. The ratio 
calculated is expressed as DEF and are tabulated in Table 5. The obtained DEF data 
reveals that the enhancement is concentration dependent. A maximum DEF of 3.07 
was obtained for 80 kVp x-ray beams employing 1 mMol of AuNPs. At lower 
concentration, the DEF values were reduced to 2.53 and 1.59. These results indicate 
that the presence of more absorbing AuNPs in the cells can increase the probability 
of radiation interactions inside the cells. The presence of metallic gold atoms inside 
the cell generates a larger number of secondary electrons from the radiation 
interactions in comparison to those generated in the absence of AuNPs. This 
increase in the number of secondary electrons and the resulting “free radicals” leads 
to an increase in cell death, since these free radicals can damage the DNA molecules 
inside the cells. These effects are in agreement with the previously documented in-
vitro studies using iodine compounds similar to those used as radiological contrast 
media (82). However, greater dose enhancement can be achieved by AuNPs 
compared to iodine due to the higher absorption coefficient (at 100 keV: gold: 5.16 
cm2g-1; iodine; 1.94 cm2g-1) and higher Z of gold atom (79) compare to iodine (53) 
(110). 
 
The dominant process of interaction of x-rays of energies between 80 to 150 
kV in tissue with the presence of AuNPs is photoelectric effect. The dose 
enhancement is observed when metallic gold atoms are internalised into the cells, 
indicating an increase in photoelectric interaction. The total attenuation cross section 
for gold just above the K edge threshold at 80.7 keV is estimated at 8.9 cm2/g (110). 
In comparison, the total attenuation cross section for tissue at this energy is 0.184 
cm2/g (110). From the data presented in the background chapter, the total scattering 
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cross section would be expected to be increased by a factor of 2.59 at 1% AuNPs (1 
mg/ml) in water. Experimentally, the obtained DEF in the presence of the AuNPs of 
only 1 mMol/L (0.197 mg/ml) was 3.07, indicating that not all of the dose 
enhancement is explained by the increased interaction cross section. The 
photoelectric effect also results in a subsequent cascade of Auger electrons, some of 
which can have a range in tissue that can be smaller than the cell radius. The 
effectiveness of the Auger electrons in causing cell damage is a complex 
relationship that depends on the size of the nanoparticles, the spectrum of the x rays 
and the energy of Auger electrons.  
 
Less radiation dose enhancement was observed when using high energy 
(megavoltage range) electron beams compared to the low energy (kilovoltage range) 
x-ray beams as shown in Figure 54-56. In the megavoltage energy range, electron 
beams the radiation interaction and hence cell damage can occur via one of the 
electron interaction processes; either ionisation or radiative losses (11). The 
presence of a high Z element (such as gold atoms) increases the proportion of 
electron radiative loss, which leads to the production of photons inside the cells. For 
6 MeV electrons interacting with tissue, 5% of the energy is lost through radiative 
losses, for gold at this energy it is 38%. For 12 MeV electrons interacting with 
tissue, 11% of the energy lost is due to radiative losses, for gold at this energy it is 
55%. Energy lost to ionisation is generally deposited in the immediate vicinity, but 
energy lost to radiative loses can propagate further before it is absorbed. The 
relatively small increase in stopping power, and the higher radiative yield of gold 
compared to water both make the DEF less dependant on AuNP concentration. 
Figure 58 and Figure 59 show the relationship between DEF and concentration of 
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the AuNPs. There were rapid increases of DEF values with increasing AuNPs 
concentrations for 80 kVp x-ray and 6 MeV electron beams.  
 
Radiobiological analysis of α and β values, the radiobiological parameters 
derived from the linear quadratic relationship between cell viability and the 
delivered dose from the cell survival curves show that the α value increases with 
inclusion of AuNPs, while there no significant changes in β value. This may be an 
indication of an increase in double strand break when AuNPs are included in the 
cells, since α is the probability of an interaction between two chromosome breaks as 
the consequence of single electron set in motion by the absorption of x-rays (22). 
Analysis of D and the calculation of dose enhancement from the D  shows a good 
agreement with the results obtained from extrapolation of the survival curve. D is 
not a widely used parameter for measuring radiosensitivity and reports of its use by 
other researchers has been limited (123). However D presents certain advantages as 
a parameter of this kind: it can be defined regardless of the shape of the survival 
curve and represents characteristic of the majority of surviving populations. The 
extrapolation of α and β is dependent only on the linear quadratic model and so 
along with other radiobiological parameters such as quasithreshold dose (Dq) from 
multitarget model, it is dependent on the particular radiobiological model used. The 
D  parameter is not dependent on any radiobiological model and can be calculated 
and used to study the effects of radiation on any cells of any form of radiation 
response.  Finally, the application of D  yielded results which supported the 
findings obtained using linear quadratic model and that is enhancement of double 
strand breakage with the inclusion of the AuNPs.  
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The enhancement of radiation effects by AuNPs demonstrates the potential 
application of AuNPs to radiotherapy especially for treatments that use low energy 
x-rays and electron beams. Improvement to therapeutic effects generated by AuNPs 
also could be highly useful for techniques such as kilovoltage x-ray intraoperative 
radiotherapy, which is recently increasingly used in breast cancer treatment by 
radiation. Treatment of high-grade glioma using monochromatic synchrotron 
radiation can also potentially be augmented by with AuNPs to enhance local toxicity 
by photoactivation therapy (141). MRT techniques can also benefit from the 
addition of AuNPs especially in procedures where extremely high dose rates are 
normally employed (142). 
 
Finally, the results clearly indicate that lower radiation doses destroy the 
same fraction of cells when AuNPs are present as larger dose without them. This 
means if AuNPs are added to a radiotherapy target, especially when kilovoltage x-
rays are used for treatment, an external dose reduction of an order of magnitude can 
be achieved to deliver the same local control as without the inclusion of AuNPs. 
Such a high level of radiation dose reduction may have obvious advantages to 
radiotherapy patients in reducing the dose to the healthy tissue during the treatment 
procedure. The results show that whenever kilovoltage x-ray beams are used, 
AuNPs can be employed to reduce the level of dose required thus reducing the dose 
delivered to healthy tissue, which is of primary concern in all radiotherapy 
procedures. 
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5. MICROBEAM RADIOTHERAPY (MRT) 
 
The results displayed in the previous chapter clearly indicates that the best 
condition for the application of AuNPs dose enhancers is x-ray beam of energies 
ranging in the kilovoltage scale. Beside superficial radiotherapy based on x-rays 
extracted from an x-ray tube, microbeam radiotherapy using synchrotron kilovoltage 
range of x-rays well collimated beams has realistic potential to be another 
remarkable application of such beams in radiotherapy and could benefit from the 
outcomes of this study through enhancing the delivered dose via inclusion of AuNPs 
in the targets prior irradiation. This chapter contains a brief introduction to the MRT 
and the cellular migration mechanism. The experimental set up and results of the 
application of AuNPs in MRT as radiation dose enhancers and their effects on 
cellular migration is then discussed and presented.  
 
5.1 Introduction and historical overview of MRT  
 
The first study of the biological effects of micrometer beam radiation was 
published in 1959 by a group of scientists from Brookhaven National Laboratory 
(BNL) in the USA. Initially, the purpose of the study was to investigate the 
biological effects of cosmic radiation on astronauts. However, through these studies 
it was soon discovered that the threshold dose required to cause lesions in the brain 
of a mouse is related to the size of the beam used. Zeman et. al. (1959) reported on a 
study in which a 22 MeV deuteron beam 25 µm in diameter was applied to a mouse 
brain and compared to a 1 mm diameter beam of the same type (143). A dramatic 
increase of the threshold dose required to produce radiogenic lesions was observed 
 133 
in the mouse brain from 30000 rad (300Gy) for 1 mm beam to 1.1 x 106 rad (11,000 
Gy) for 25 µm (143). A later study by Curtis et. al. (1967) using the same 25 µm 
deuteron beam of 400000 rad (4000 Gy) dose found that localized neuronal loss 
occurs in the microbeam path but it did not cause a radiogenic lesion (144). The 
reason for this unexpected tolerance of normal tissue to microbeams is believed to 
be the migration of surviving endothelial cells from the surrounding non irradiated 
area to the irradiated area causing regeneration or tissue recovery (144). 
 
MRT study using synchrotron generated x-rays was first conducted at the 
National Synchrotron Light Source (NSLS) of BNL in the late 1980s.  The study 
began with microtomography research of the mouse brain at high dose and found 
that the mouse recovered normally from the application of microbeam radiation 
(145).  Experimental work on MRT continued and was then conducted by other 
synchrotron research centres. Apart from the many studies were then carried out on 
animals many Monte Carlo simulations investigating the dosimetric aspects of MRT 
were also conducted (9, 146). 
 
The first theoretical simulation of MRT dosimetry for monochromatic 
synchrotron x -ray beams of energy between 50-150 kev showing the feasibility of 
microbeams for cancer treatment was reported by Slatkin et. al., 1992 (146). 
Following this paper, animal studies were then published based on histopathological 
evidence of unusual resistance to necrosis on rat brain tissue after treatment with 
MRT. This study showed that no brain damage was observed microscopically in or 
between microplanar head slices with 312 or 625 Gy absorbed doses (147). Even 
after one month the brains remained normal. The authors attributed this 
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phenomenon of radiation resistance to hyperplasia and the immigration of 
minimally irradiated endotheliocytes and oligodendrocytes (or of their precursors) 
between the slices (147)   
 
Tumour resistances to high doses of microbeams were then studied by 
Laissue et. al. (1998) using the National Synchrotron Light Source (NSLS), 
Brookhaven National Laboratory (BNL) (142). The first tumour study was 
performed by irradiating intracerebral 9L gliosarcomas (9LGS) in Fisher rats with 
one of either a single array (uni-directional) parallel microbeams or two 
orthogonally crossed arrays (bi-directional) of microbeam radiation (142). Half of 
the rats treated with MRT were found to have completely ablated tumour and slow 
growth of the tumours. Histological study of the brain tumour tissue showed 
visualized stripes of neuronal cells loss (142) . 
 
Preliminary results by Slatkin et. al. (1995) and Laissue et. al. (1998) 
triggered interest in MRT research because of its potential to spare normal tissue 
while suppressing the growth of tumours. These selective actions of MRT were then 
further investigated on both normal tissue and tumours. Studies on normal tissues 
focused on the ability of the normal cells to regenerate and resist the very high dose 
of MRT. Laissue et. al. (2001) performed animal studies on healthy weaning piglets 
irradiated with a 25 µm array of parallel beam of energy ranging from 50 to 600 
KeV with doses ranging between 150 Gy to 600 Gy (148). The irradiated piglets 
were behaviourally and neurologically analysed 15 months post-MRT irradiation.  
Observations of the irradiated piglets showed normal development and a 
histological section of the hind brain showed the characteristic stripe of MRT. No 
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tissue necrosis, haemorrhage or demyelination was observed (148). Another study 
was published on the cerebella of healthy suckling Sprague-Dawley rat pups, which 
also showed exceptional resistance to very high doses of x-ray microbeams (149). 
These sparing effects were also observed in duck brain in ovo, where MRT doses of 
40 Gy to 160 Gy were observed to fail to produce any radiation induced lesions 
(150). Some of the samples somehow showed ataxia but the results indicated that 
tolerance to MRT is approximately 3 times higher than the broad beam. Study on 
chick embryo chorio-allontic membrane (CAM) showed massive damage observed 
in the irradiated microvascular region and somehow new capillaries quickly 
developed post MRT (151).  
 
Dilmanian et. al. (2005) reported that an array of parallel individual 
microbeams can also be used for targeted, selective cell ablation in the central 
nervous system (CNS) and also induce demyelination on a rat’s brain (152). Their 
results showed that microbeams can selectively ablate slices of neurons, 
oligodendrocytes and astrocytes in the CNS because of the differential dose 
sensitivity of different cell types, without causing tissue necrosis (152). 
Furthermore, microbeams were also found to cause demyelination without 
introducing damage to the tissue structure (152).  The effects of MRT on tissues 
other than CNS tissue were investigated by Zhong et. al. (2003) using rats skin. Skin 
also shows extremely high tolerance to radiation doses delivered by MRT (153). 
This is attributed to the surviving clonogenic cells between the locations where the 
beam are applied. Miura et. al. (2006) reported radiosurgical palliation of a 
squamous cell carcinoma inoculated into the hind legs of mice (154).  The palliation 
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effects for MRT with doses of around 400 to 900 Gy was better than seamless 35 
Gy irradiation with minimal risk to normal tissue in the irradiation field (154).    
 
The positive outcomes of these preclinical studies on animal models show 
the potential benefit of MRT over conventional broad beam in treating cancer. 
Studies by Dilmanian et. al. (2002) suggested that unidirectional microbeams have 
an increase of therapeutic index compared to broad beams. Different sizes of 
microbeam spacing (50, 75 and 100 µm) were also investigated and the results 
demonstrated increased toxicity for smaller beam spacing with higher doses (155). 
Another three experiments were then performed on the CNS of healthy rats 
irradiated with thicker beams of sizes around 680 µm (156). The motivation behind 
using thicker beams was to attempt to overcome a practical limitation of MRT; that 
it can only be performed using synchrotron sources. Thicker beams may allow the 
use of high energy photons from a possible x-ray source in any clinical center 
without the need for synchrotron sources (156). In this experiment, the authors used 
orthogonal pair of interlaced thick microbeams on the rat brain not only the 
microplanar beam.  The authors claimed this technique may have advantages in term 
of using thicker beam, an unsegmented beam at the target and lower dose allowing 
for greater tolerance to the normal tissue. However, the effect of preferential killing 
of tumour cells is may be reduced with increasing beam thickness due to the fact 
that the essential element in the repair of vascular cells disappears in this case (156). 
Some other experiments on collimation size and beam spacing also have been 
published by Miura et al (2006) and Regnard et al (2008). According to Miura et al 
(2006) normal tissue damage occurs more quickly in mice irradiated with the 
broader microbeams imparting less energy per beam (442 Gy/ 70 µm) than in the 
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group with the narrower microbeam imparting greater energy per beam (884 Gy /35 
µm) (154). Beam spacing also affects the normal tissue recovery as reported by 
Regnard et al (2008) in their study of the effects of different thickness of beams and 
spacing between microbeams (157). Using 100 and 200 µm spacing, they assessed 
survival curves, conducted animal follow up and histological analysis. 100 µm 
spacing exhibited survival value significantly higher than 200 µm. However, 200 
µm spacing showed better healthy tissue preservation and therefore may be more 
suitable for clinical use (157).  
 
MRT of radioresistant tumours such as high grade glioma increases control 
of the tumours without compromising normal tissue, although high dose is required 
for treatment. As has been stated, thin microbeams with high dose can only be 
delivered by a synchrotron facility, which is currently unavailable within clinical 
centers. Attempts to use thicker beams reduces the dose tolerance and also affects 
the normal tissue regeneration (156). Treatments in combination with other drugs 
have been suggested to improve the outcome of MRT. Smilowitz et al (2006) 
combined MRT with gene mediated immunotherapy on advanced 9LGS tumours 
and reported that better results were obtained compared to the use of MRT alone 
(158).  
 
High Z radiation dose enhancers such as iodine and gold nanoparticles 
(AuNPs), which have already been extensively used for study in radiotherapy 
treatment, have been proposed as potential candidates for use in combination with 
MRT. Radiation dose enhancers such as iodine have been used for synchrotron 
based stereotactic radiosurgery (SSR) showing successful dose enhancement (159). 
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A review of the animal and phantom SSR study is included in the chapter 2.  In 
microbeam application, Regnard et al (2008) and Le Duc et al (2007) used 
gadolinium as a dose enhancement agent on rodent brain tumours treated with MRT. 
An increase in mouse life span was observed for mice treated with both gadolinium 
and MRT (157, 160) . Theoretical study using Monte Carlo simulation in human and 
rat phantom found superior dose enhancement by gold and gadolinium compared to 
iodine (87). The increase in dose deposition by gadolinium produces a significant 
decrease in peak to valley ratio (PVDR) as the concentration of gadolinium 
increases. Therefore, to maintain high PVDR, optimal energy must be applied (87). 
Calculations have indicated that 175 keV is the optimal energy for gadolinium to 
kill the tumours while sparing the normal tissue most efficiently. A recent study by 
Hainfeld et al (2010) on radioresistant murine squamous cell carcinoma treated with 
broad beam synchrotron x-rays and AuNPs showed dose enhancement with further 
optimization in terms of radiation dose energy and hyperthermia influence efficacy 
(111). Potential utilisation of AuNPs has been examined in the previous chapter and 
outstanding results were obtained. In this chapter, application of AuNPs as radiation 
dose enhancer is extended to MRT. As mentioned before, employing very thin beam 
in MRT produce selective tumour death with tolerance of normal tissue and also 
induced the normal cells regeneration to replace the tumours cells. Effects of AuNPs 
to this MRT mechanism are investigated in this chapter.     
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5.2. Mechanism of cellular migration 
 
Cell migration is an important physiological and pathological cellular 
process that regulates various biological phenomena such as immune response, 
wound healing, inflammatory response and angiogenesis. In angiogenesis and 
wound healing, for example, endothelial cells and fibroblast migration is crucial for 
vascular remodelling and tissue regeneration (161). Many studies have also been 
done on leukocytes migration to the area of damage such as neutrophils and 
macrophages (162-164). In tumour metastasis, tumour cells migrate to a new site 
from initial tumour mass via the circulatory system (165). As with many other 
cellular processes, cell migration responds to external stimuli such as chemical, 
shear stress and substrate compliance. These responses generate different signalling 
and chemical pathways that permit the mechanics of the cell motility (166). 
Endothelial cells have been used in most experimental work in this thesis and 
migration of this type of cells will be the focus of this discussion.   
 
The motile process of endothelial cells has been extensively studied for 
angiogenesis (166). Endothelial cell migration is directly regulated by different 
stimuli mechanisms and further involves the activation of intercellular signalling 
pathways which are then responded to by a progression of migrating cells. This is 
illustrated in Figure 60 below which shows the processes of cells migration.  
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Figure 60: Flowchart of cells migration process 
 
The three major mechanisms, as shown in the Figure 60, are described below;  
 
1. Chemotaxis: the directional migration towards a gradient of soluble 
chemoattractant such as vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (bFGF) (166) 
2. Haptotaxis: the directional migration toward a gradient of immobilized ligands 
such as integrin binding to extracellular matrix component (166).  
3. Mechanotaxis: the directional migration generated by mechanical forces such as 
endothelial cells in the inner face of a blood vessel, which experiences constant 
exposure to the shear stress of blood flow (166).    
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When the cell is exposed to one of the migratory stimuli, different signalling 
pathways will be activated. This process of signalling will promote a mechanically 
integrated molecular process. For example, when endothelial cells are exposed to 
VEGF, the Rho subfamily of small GTPases (large family of hydrolase enzymes 
that can bind and hydrolyse guanosine triphosphate ) the Cdc42 (Cell division 
control protein 42 homolog) pathway will be activated. In response to this signal, 
filopodia, the structure that acts as a sensor for migration, will be formed (166). 
Other signalling pathways cause cell migration by morphological polarization, 
cellular membrane extension, cytoskeleton reorganization, stabilization of the 
attachment, contractile force and traction of the cells and changes in cell adhesion, 
particularly at the rear of the individual cells (165). All these completely physical 
integrated cellular processes must be coordinated and regulated for the locomotion 
of the cells as illustrated in Figure 61. 
 
 
Figure 61: Illustration of the regulated process that occurs during cells migration 
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5.3. Materials and methods 
This section deals with the experimental set up for the study of influence of 
AuNPs on the cells migration to fill in gaps created by radiation and similar gaps 
formed mechanically by scratches to the cells in culture.  
 
5.3.1. AuNPs preparation for microbeam experiment  
 
Spherical AuNPs (1.9 nm), obtained in a powder form from Nanoprobes 
Inc. (Yaphank, NY 11980, U.S.A.), similar as used in the other experiment 
described in the previous chapter 3 were used in this experiment. The AuNPs 
were diluted with Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-
Aldrich Pty. Ltd., St Louis, Mo, U.S.A.) to the required concentration and then 
filtered through a 0.22 µm hydrophilic polysulphonic membrane syringe bacterial 
filter (Sartorius, Goettingen, Germany). The filtration was undertaken to ensure 
the AuNP used for cells culture were sterile.  
 
5.3.2. Cell culture protocol  
 
Bovine aortic endothelial cells (BAECs) were purchased from Cell 
Application Inc. (San Diego, CA, USA) and Rat Glioma 2 (RG2) were purchased 
from ATCC (American Type Culture Collection, VA, USA). The cells were grown 
in 75 ml flask (IWAKI, Tokyo, Japan) until confluence and then were split in the 
ratio of 1:3.  BAEC were cultured in DMEM supplemented with L-glutamine 
(Sigma-Aldrich Pty. Ltd., St Louis, Mo, U.S.A), with 10% Fetal Bovine Serum 
(FBS) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA), 100 units/ml penicillin and 
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100 µg /ml streptomycin (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA). RG2 were 
cultured in RPMI supplemented with L-glutamine (Invitrogen Corp.,CA, USA), 
with 10% Fetal Bovine Serum (FBS) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA), 
100 units/ml penicillin and 100 µg /ml streptomycin (Sigma-Aldrich Pty. Ltd., St 
Louis, Mo, USA). Both types of cells were maintained at 37oC and 5% CO2 
atmosphere. 
 
5.3.3 Cell irradiation with microplanar beam at Spring-8  
 
In this experiment, BAEC cells were cultured as confluent monolayers in 2 
well chamber slides (IWAKI, Tokyo, Japan), some of which had been embedded 
with AuNPs. Some samples were also cultured and prepared in slide flasks for the 
same experiment (Nunc, Roskilde, Denmark) as shown in Figure 62. 1 mMol/L of 
AuNP was added to the cells 24 hours before irradiation to ensure that the AuNPs 
had been absorbed by the cells. The cells were then irradiated with various doses of 
synchrotron generated x-rays beam using 125 keV (mean energy) white beam x-
rays. The multislit microbeam irradiations were carried out at beamline BL28B2 at 
Spring-8 synchrotron, Japan. The irradiation set up is displayed in Figure 63. Each 
microbeam is approximately 25 µm in width with a spacing of 200 µm between 
adjacent microbeams. Details of the beams and multislit irradiation system have 
been described by (167-169). The cells were then fixed with 4% paraformaldehyde 
in phosphate buffer saline immediately after irradiation and at 6, 12 and 24 hours 
after irradiation. The fixed cell samples were imaged under phase contrast 
microscopy using Leitz DM-IC inverted microscope (Leica Microsystems, Wetzlar, 
Germany) and spot pursuit camera with Spot Advanced  software version 4.6 
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(Diagnostic Instruments Inc., Sterling Heights, MI, USA). Cells viability assays 
were conducted also using the tryphan blue exclusion method after 24 hours of 
irradiation.  
 
Figure 62: The cell sample in slide flask. 
 
 
Figure 63: The cells irradiation set up with 80 kV with white beam x ray from BL28B4. The 
cells-plate was placed vertically to the beam direction. 
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5.3.4 Scratch assay  
 
This experiment was performed to study the effects of AuNPs on the cell’s 
migration and motility. The BAEC and RG2 were cultured in 6 well plates until they 
reach confluence with the different concentrations of AuNPs added to some of them. 
The concentrations of AuNP used in this experiment were 0.5,1,2 and 3 mMol/L 
and the AuNPs were added to the cells 24 hours before scratch assays were made. 
The medium of the cells was changed before the scratch was made. This was done 
as it was assumed that all the AuNP were taken up by the cells as shown in a 
previous study (Rahman et al, 2009) ( 99 ).  The cells in each well were scratch 
assayed using sterile 100 µm pipette tips. The scratches were observed under the 
Olympus CKX41 microscope (Olympus Co., Tokyo, Japan) immediately after the 
procedure and images of the cells were recorded using Olympus live view digital 
SLR camera E-330 (Olympus Co., Tokyo, Japan). The cells were then incubated in 
37oC and 5% CO2 and were observed every hour until the scratch or wound was 
fully closed. Images were taken exactly at the same position of the scratch.    
 
5.3.5 Image analysis 
 
Analysis of the cell images was performed using Image-Pro Plus software 
(MediaCybernetics, MD). The cell density counts were performed for the 
microbeam cells samples at the irradiation area (peak) and the separation area 
(valley). For the scratch sample images, the migration of the cells were analysed by 
taking the ratio of the area occupied or filled by the cells to the gap or scratch area.   
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5.3.6 Statistical analysis 
 
The data presented in this chapter (mean values ± standard deviation) 
resulted from 3 independent experiments. One way analysis of variance (ANOVA) 
was used to determine the significance of the difference between the control and 
experimental group followed by post-hoc analysis mean comparison using 
Bonferroni’s test.  A difference was considered to be statistically significant when p 
< 0.05. Statistical analysis was performed with the OriginPro 7.5 SR0 v7.5714 
(B714) software.  
 
5.4. Results  
 
5.4.1 Dose enhancement by AuNPs 
 
Irradiation of cells in culture by microbeams resulted in formation of gaps 
depleted of cells where all the cells in those regions are killed by radiation. 
Minimum dose required for formation of such gaps was found to be around 25 Gy in 
agreement with Dilmanian’s (2007) findings (170). How ever much less doses 
(about 10 Gy) were only needed to form such gaps in the same cells when 
impregnated with AuNPs. This difference in the minimal dose is a clear indication 
of the role of AuNPs in dos enhancement. At 10 Gy dose no clear gaps are observed 
in cells irradiated with microbeam while clear gaps are created by same beam of 10 
Gy when the cells are with AuNPs.  
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Cells with AuNPs experienced increased cell death at the peak dose 
compared to cells without AuNPs. Figure 64 shows the control BAECs and BAECs 
with 1 mMol/L of AuNPs irradiated using 80 kV of x-ray beam of 10 Gy of dose. 
The cells with AuNPs clearly have stripes or gaps which indicate cell death that are 
significantly better defined than those of the control cells, which experienced much 
less cell death and therefore have stripes or gaps which are not very clear.  
The ratio of the cells density for control cells at the irradiated area and the 
cells density for cells with AuNPs at the irradiated area (gap) were calculated and 
average of the ratio was taken as the overall DEF. The DEF obtained in this study is 
close to 1.2. The equation for calculation is shown in equation ( 12 ): 
 
 
AuNPs
control
areairradiatedatdensitycell
areairradiatedatdensitycell
DEF =
 
 
( 12 ) 
 
The cells viability assay show decreasing number of cells with increasing 
concentration of AuNPs when irradiated with 10 Gy of microbeam as shown in 
Figure 65. The dose enhancement effects are clearly observed here with only 52% 
cells surviving with same cells irradiated under same conditions but in this case with 
added 0.5 mMol/L AuNPs and only 18% surviving when 1mMol AuNPs was added. 
These results are expressed as percentage relative to the control samples and 
statically exhibit significant dose enhancement between control samples and 
samples with AuNPs (P < 0.05). The results are only indicative of the effects of the 
inclusion of the AuNPs since not the whole of the sample is irradiated as in previous 
cases of broad beam irradiation. 
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Figure 64: A) Phase contrast image of BAEC with 1 mMol/L of AuNPs irradiated with 80 kV of 
10 Gy MRT. B) Control BAECs. Average ratio of the number of cell at the non irradiated 
space to the number of cells at the irradiated area calculated is 1.2.    
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Figure 65: Percentage of cells viability with different concentration of AuNPs irradiated with 
10 Gy of microbeam radiation. The errors are standard deviation from three samples (mean ± 
SD, n=3). The data mean are significantly different from the controls (P < 0.05). 
 
These results of lower dose required for the formation of cells depleted gaps, 
and less cells surviving under same conditions, by the inclusion of the AuNPs 
indicates clearly the dose enhancement caused by such particles in delivering doses 
via MRT technique. Now let us look into migration of the cells from the 
unirradiated parts of the culture to fill in the gaps created by radiations and also 
mimic the study via generation of such gaps by non radiation means i.e. making 
manually scratches in such cell cultures.  
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5.4.2 Analysis of the cells migration for MRT: with and without AuNPs 
 
BAECs were irradiated with microbeam radiation and were fixed at different 
time points after irradiation to study the effects of cell migration towards filling of 
the gap produced by microbeam irradiation. After irradiation, it is hypothesized that 
the cells undergoing apoptosis or necrosis will detach from the plate, leaving an 
empty space. The cells depleted gaps observed at the irradiation areas therefore 
indicate cell deaths in those regions. In Figure 66 (A), fixed BAEC cells after 
irradiation clearly shows more cell death in the irradiation area for the samples with 
AuNPs compared to the control cells and this again confirms the dose enhancement 
effects produced by AuNPs. The quantitative image analysis of the cell density is 
depicted in Figure 67 and Figure 68. The samples with AuNP show less cell density 
in the irradiation regions compared to the control samples.  
After 12 hours, the cells were observed to migrate and completely fill the 
gap. Cells containing AuNPs formed a higher cell density in the gaps than the 
control ones. From Figure 66B, it is observed that the cells with AuNPs show more 
cells migration to the gap compared to the cells without AuNPs. Clearly, AuNPs 
have some effect on the cell migration, especially after microbeam irradiation. 
Quantitative analysis of the data displayed in Figure 68 shows higher cell density in 
the samples with AuNPs compared to the control cells in both irradiation area (gap) 
and non irradiated area (spacing).  
The observation of the migrating cells also shows that the cells extend their 
cytoplasm to the empty area. The cell size also increases and cells take on a more 
elongated, thin shape rather than normal rounded shape cells at the non irradiated 
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spacing area. The migrating cells are shown in Figure 69. These results support with 
other related findings by Dilmanian et al (2007) (170).  
 
 
Figure 66: Phase contrast image of the BAEC irradiated using 80 kV and 100 Gy of MRT with 
and without AuNPs.  A) Cells after irradiation  B) Cells after 12 hours of incubation after 
irradiation 
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Figure 67: Quantitative analysis of the cells images with and without AuNPs after irradiation. 
The cell density for three samples was analysed and the data are expressed as mean ± SD. 
There are lower cell densities in the irradiation area for cells with AuNPs compared to the 
control cells.  
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Figure 68: Quantitative analysis of the cells images with and without AuNPs after 12 hours 
irradiation. There are more cells in the samples with AuNPs compared to cells without AuNPs. 
It is clear that AuNPs accelerate the cells’ proliferation and hence expedite the gap filling 
process. The cell density for three samples was analysed and the data are expressed as mean ± 
SD.  
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Figure 69: Phase contrast picture under high magnification (30x). The migrating cells are 
obviously larger than non migrating cells at the non irradiated space.  
 
5.4.3 Influence of AuNPs on the normal and tumours cells migration  
 
The BAEC and RG2 cancer type cells were used to study the effects of 
AuNP on the migration of normal and tumours cells. In-vitro scratch assay were 
performed on both type of cells where an artificial ‘wounds’ were created on the 
cells monolayers. Cells migrations into the ‘artificial wound’ for the cells incubated 
with AuNPs and control cells without AuNPs for both types of cells were measured.  
It was observed that endothelial and cancer cells respond to AuNPs at different 
rates. The BAEC cells were found to fill the gap faster compared to the RG2 cells 
and the cells impregnated with AuNPs fill the gap faster compared to the cells 
without AuNPs for both types. As shown the Figure 70, the gap in the cells with 
AuNPs was completely filled after 10 hours while the same size gap in control cells 
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was not fully closed until well after this time.  This clearly indicates that there is a 
role for AuNPs in assisting cell motility and migration toward the gap. Cells with 
AuNPs clearly move faster than the normal cell motility rate without AuNPs. RG2 
cells show a similar trend when the cells containing AuNPs have faster motility rate 
compared to the control cells without AuNPs. However, the RG2 cells migrate at 
slower rate than the BAEC. This is shown in Figure 71; the RG2 gaps were filled by 
the cells 24 hours after the scratch assays were made.  Quantitative image analysis 
by measuring the cell density at the gap area at different time points is shown in 
Figure 72 and Figure 73. Here it is shown that the cells start to migrate in less than 4 
hours, with the difference in cells migration between cells with and without AuNPs 
becoming obvious after 10 hours of incubation. Different concentrations of AuNPs 
were also tested on the both type of cells. Figure 74 and Figure 75 shows the effects 
of AuNPs concentration on the cells migration. The findings show that all the cells 
incubated with AuNPs migrate faster compared to the cells without AuNPs. 
However, no clear pattern of effects was observed for higher concentration except 
they all migrate faster than the control cells. The 0.5 mMol/L showing the highest 
number of cells migrate as a function of time for both type of cells. 
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Figure 70: Phase contrast image of BAEC cells with and without AuNPs for scratch assay at 
different times A) 0 hours B) 4 hours C) 8 hours D) 10 hours   
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Figure 71: Phase contrast image of RG2 cells with and without AuNPs for scratch assay at 
different time A) 4 hours B) 8 hours C) 10 hours D) 24 hours   
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Figure 72: The quantitative image graphical analysis of the BAEC cells in the gap area for cells 
with and without AuNPs for three independent experiment (mean ± SD). The cell count is 
plotted against time. It is shown that there is no significant difference to the migration of cells 
before 8 hours for samples with and without AuNPs (P > 0.05). After 10 hours, there are more 
migrating cells in the samples with AuNPs, which closed the gap altogether, than cells without 
AuNPs.  Significant difference were observed at this time point compared to controls and is 
indicates as (*) (P < 0.05, ANOVA plus Bonferoni’s test ). 
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Figure 73: The quantitative image graphical analysis of the RG2 in the gap area for cells with 
and without AuNPs for three independent experiments (mean ± SD). The cell count was plotted 
against time. As was the case with BAEC cells, the migration of cells before 8 hours for samples 
with and without AuNPs did not show any significant difference (P > 0.05). Like BAEC, the 
difference in cell migration between control cells and cells with AuNPs only began to show after 
10 hours. There are more migrating cells in the samples with AuNPs compared to the cells 
without AuNPs, until the gap is fully closed after 24 hours. Significant difference observed 
compared to controls is indicates as (*) (P < 0.05, ANOVA plus Bonferoni’s test). 
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Figure 74 : The cell count at different concentrations of AuNPs at the gap area in function of 
time for endothelial cells. All the cells with AuNPs showed greater cell migration into the gap 
compared to the control cells. Different concentrations of AuNPs did not have any significant 
effect to the rate of cell migration.  The data are expressed as mean ± SD of three independent 
experiments. Data that exhibit statistically significant difference compared to control are 
indicates as (*) (P < 0.05, ANOVA plus Bonferoni’s test).  
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Figure 75: The cell count at different concentration of AuNPs at the gap area as a function of 
time for rat glioma 2 cells. All the cells with AuNPs show increased cell migration into gap 
compared to the control cells. Like the endothelial cells, different concentrations of AuNPs did 
not have any significant effect on the rate of the cells’ migration. The data are expressed as 
mean ± SD of three independent experiments. Data that exhibit statistically significant 
difference compared to control are indicates as (*) (P < 0.05, ANOVA plus Bonferoni’s test).  
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5.5. Discussion  
 
The MRT procedure is based on the delivery of a high dose of radiation to 
eradicate tumours. However, this is limited since high doses may approach normal 
tissue tolerance levels. Moreover, the high dose and dose rates required by MRT can 
only be delivered by synchrotron and this makes it impossible to be utilised in 
clinical centres at this stage. Although normal tissue tolerates much higher doses in 
MRT compared to the broad beam radiotherapy, it is more efficient to use lower 
doses that give the same therapeutic efficiency. To achieve this, AuNPs were used 
in this work as a radiation dose enhancer to demonstrate the feasibility of the MRT 
procedure at much lower doses than would otherwise be possible. For instance for 
endothelial cells clear gaps can be formed by just around 10 Gy dose compared to 
over 25 Gy without AuNPs this means more than half the dose is required to deliver 
same effect when nanoparticles are included in the target. Reductions in the dose 
used for MRT not only increase the treatment efficiency but it may also allow MRT 
to be performed using clinical treatment machines in future. The idea to use MRT in 
clinical centres has been explored by Dilmanian et al (2007), who used a larger 
beam size in this treatment so that lower dose rate could be used (170). Were this 
treatment to be combined with the use of AuNPs, it may prove to be possible to 
effectively use MRT in clinical centres without synchrotron facilities. 
 
Dose enhancement effects by AuNPs were clearly observed in this study. It 
has been established previously that AuNPs enhances the dose for radiotherapy (89, 
99, 111). It is well known that high atomic number material will increase the 
photoelectric probability, which will lead to more radiation absorption and hence 
 163 
leads to the killing of more cells. The enhancement of radiation absorption is 
contributed to by photoelectrons that continue to interact within the matter and 
deposited dose. Atoms ionised due to the ejection of a photoelectron will have a 
vacancy in the orbital shell and this will be filled by electron from higher orbit. This 
process of electron excitation from higher orbit to low orbit will create emission of 
characteristic x-rays. Sometimes these characteristic x-rays are absorbed locally by 
the weakly bound electron and will be ejected as Auger electron. This process of 
photoelectric interaction and its associate products contribute to the dose deposited 
in biological material and hence the presence of AuNPs inside the cells will enhance 
the absorbed dose manifold. This radiation enhancement concept has been explained 
in detail in the chapter 2 and chapter 4. To date there are no other studies that 
reported the application of AuNPs for MRT. There are also very limited studies on 
using high Z radiation enhancer for MRT and most of that has been focused on 
gadolinium (157, 160) .   
 
An important aspect of MRT is the differential repair rate between faster 
normal tissue repair and the slower, abnormal tissue. The same effect has been 
observed in the in-vitro study conducted as part of this thesis. This was observed to 
be the case for gaps created by radiation and in situations where similar sized gaps 
were created by scratches i.e. wounds. These results agree with the Dilmanian et al  
(2007) study, that normal non irradiated cells migrate to the irradiation area to 
occupy the space that have been left by dying cells. Although the exact mechanism 
for the repair of ‘artificial wound’ (scratch) and radiation generated gaps is not well 
understood, some possible hypotheses can be proposed for this acceleration of cell 
migration due to the inclusion of the AuNPs. At the cellular level, bystander effects 
 164 
may well be involved. It is highly plausible that the dying cells release some signal 
molecules that are recognized by healthy cells in the neighbouring area. In a 
situation typical to original wound healing in a tissue, these healthy cells will try to 
invest most of their energy towards filling in the wound gaps thus promoting growth 
in the scratched areas ‘empty gaps’  that are deficient or depleted of healthy cells. If 
this is the case, cells receive signals that make them respond and migrate to the 
damaged area in order to recover the whole cells’ mono-layers. At tissue levels there 
are more complex repair systems involved in the normal tissue sparing effects of 
MRT, as shown by many experimental studies (147-148, 152). In this study, it was 
observed that the addition of AuNPs promotes such ‘artificial wound’ repair; cells 
impregnated with AuNPs responded differently than normal cells. The cells with 
AuNPs were found to migrate or fill the gap faster compared to the control cells 
without AuNPs. In one previous study, Shukla et al (2005) reported an interesting 
anti-oxidant effect of AuNPs wherein the presence of AuNPs was found to reduce 
the toxic levels of reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) in macrophage cells (130). In the current study, wherein an enhanced ‘wound 
healing’ effect in the presence of AuNPs was observed, it is possible that AuNPs 
impacted positively on sub-cellular phenomena such as ROS and RNS reduction, as 
well as enhanced production of cell signalling molecules that further increased the 
rate of cell migration in their presence. Whatever the precise mechanism may be, 
these findings indicate that AuNPs can act as a dose enhancer agent and also as an 
agent for enhancing normal tissue healing purposes; making them a double enhancer 
of MRT. 
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As was explained in the introduction, external stimuli such as chemotaxis, 
haptotaxis and mechanotaxis are the main factor that induces cells migration.  
AuNPs can be considered as soluble chemoattractant that induced the chemotactic 
cells migration. Therefore, AuNPs may influence the basic regulation of cells 
migration be means of the activation of a different pathway that expedites the 
migration process. For example, in the process of angiogenesis, VEGF influences 
cell migration by activating a different pathway that leads to the formation of new 
blood vessels. The same process may occur in the presence of AuNPs, which would 
result in changes in many mechanisms such as longer membrane extension, 
disruption of cytoskeleton reorganization and increase in contractile force and 
traction of the cells as shown in Figure 76. Evidence of cytoskeleton filament 
disruption as a result of exposure to AuNPs has been studied recently by Mironava 
et. al. (2010) In this report the actin filaments were found to be broken, appearing 
disrupted and thinner due presence of vacuoles inside the cells (128).   
 
It is also possible to consider the impact of AuNPs on cells from physics 
perspective by considering the cells as objects. AuNPs can also present some 
electrical charges due to the electronic transition from bulk material to particles 
states (28). When the AuNPs are embedded inside cells, this creates some electrical 
polarization to the cell.  These charges repel the ones in the surrounding cells, an 
effect which is particularly prominent at the boundary of the gap pushing cells 
towards the gap. The number of particles in each cell varies, hence the total charges 
acquired in them will also be different. This electrostatic repulsion force could 
therefore also have a role in accelerating the motion towards the gap of the cells 
through Coulomb repulsion. This dynamical force can be considered as a 
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mechanotaxis stimulus that impacts on the directional motion of the cells. For 
example, endothelial cells that exist in the inner layer of the vascular are constantly 
exposed to the shear stress of the blood flow. Shear stress applied to the luminal 
surface of endothelial cells can be sensed by the cells’ membrane and associated 
receptors, resulting in directional motion of the cells (171). The same effects may 
happen to the force that comes from charged AuNPs. The cells may detect the force 
and hence be driven by the polarized action of signalling molecules. If this is the 
case, then the charged particle force from AuNPs, together with the cells’ own 
contractile force as a response to the AuNPs, would produce a strong net force 
leading to the directional, accelerated migration of cells faster than the cells without 
AuNPs validating the experimental findings of this research. 
 
     
 
Figure 76: The normal migration process can be affected by the presence of AuNPs. 
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5.6. Conclusion 
The results using MRT on endothelial cells have indicated that AuNPs, 
which can enhance the dose, can also help cells to recover. Scratch assay (‘artificial 
wound’) experiments were done to study the behaviour of normal and tumours cells 
with and without AuNPs. From these results we have shown that normal cells 
migrate faster than the tumour type cells. This study also showed the role of AuNPs 
in aiding the cells to migrate. Tumour cells with AuNPs also migrate faster 
compared to the control tumours cells but at much slower rate compared to the 
normal endothelial cells. This may explain the slower tumour growth or complete 
tumour ablation in some studies in which animals have been treated with MRT.      
 The results obtained give an impetus towards more detailed research on this 
aspect of MRT study. More experiments are under planning for future work. This 
includes:  
• Investigation of the dose enhancement and cell migration for tumour cell line 
and also planning towards animal study. 
• Determination of the mechanism of cells migration with AuNPs and the 
subcellular effects of AuNPs in general. 
• Evaluation of the optimal energy for increasing radiation dose by AuNPs 
using monochromatic x-rays energy.   
• Effects of different type of AuNPS. For example, different size, surface 
coating, shape and charge.  
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SECTION B: PHANTOM STUDY 
USING POLYMER GEL 
DOSIMETER 
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6.1. INTRODUCTION TO POLYMER GEL DOSIMETRY  
 
In this chapter, the technique for measuring dose enhancement by using 
normoxic polyacrylamide gel (nPAG) dosimeters doped with AuNPs is developed. 
In other words, in this section the work is based on employing polymer gels as 
phantoms with AuNPs embedded in them and at the same time using them as 
dosimeters to evaluate the dose with and without the metallic particles then 
determining the dose enhancement. The measurements aim to determine the 
feasibility of using nPAG-AuNPs as a dosimeter and also to validate the cell culture 
results conducted in this work and presented in the previous chapters. The 
measurements report dose enhancement from superficial x-ray therapy and electron 
beam therapy.  The feasibility of AuNPs as a dose enhancer for synchrotron based 
stereotactic radiosurgery (SSR) is also investigated. It should also be noted that this 
work represents the first precedent of embedding metallic nanoparticles into 
polymer gels and using the compound for dose measurements as a phantom and 
dosimeter at the same time. 
6.1.1. Historical overview 
 
Polymer gel dosimeters are radiation dosimeters that are used to quantify the 
amount of energy deposited via measuring the polymerisation of monomers by 
radiation. Polymer gels are made from radiation sensitive materials which react to 
irradiation by polymerisation. The level of polymerisation is found to be a function 
of the absorbed dose. Polymer gels have some specific advantages over other types 
of radiation dosimeters; the most significant of these is the ability of polymer gels to 
measure doses in 3 dimensions (3D) (172). Another feature of polymer gels that 
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make them ideal for the current application is that they are excellent for steep dose 
gradient dosimetry such as IMRT, SRS and MRT (172). The effects of foreign 
materials such as inhomogeneity and contrast agents can be easily quantified using 
gels (172). The gels can also be considered as soft tissue equivalents, which makes 
polymer gels the dosimeter of choice in medical radiation applications such as ion 
chamber and radiographic film (172). 
 
The idea of using gel to measure radiation dose as listed in Table 6 originated 
in the early 1950s (173-174). Significant developments in gel dosimeter were made 
in the 1980s (175) and, in early 1990, new polymer gel formulations were proposed. 
From that time, polymer gel dosimeters have been applied in a number of preclinical 
applications in radiotherapy (176-178). The development of polymer gel dosimeters 
has also been highly dependent on imaging systems in radiology, which have 
enabled gel dosimetry to be used in radiotherapy. There are different types of gels 
available but polymer gel systems are more prevalent than other types of gel such as 
the Fricke type gel. The most common type of polymer gels is the polyacrylamide 
gel (PAG) introduced by Baldock et al (1998) (179). There are also other types of 
polymer gels with different compositions (180-181). The historic chronological 
developments of gel are tabulated in Table 6. 
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Table 6: Chronological development of polymer gel dosimeter  
Author and 
date   
Type of gels  Composition Principal finding  
Day and 
Stein, 1949 
(182) 
Aqueous 
solution  
Aqueous solution + 
‘acceptor’ (e.g. benzene/ 
sodium benzoate/ 
Aqueous solution 
irradiated with ionizing 
radiation would produce 
hydrogen and hydroxyl 
radicals that will 
chemically react with 
‘acceptor’ that can be 
use as a measure of 
radiation dose  
Day and 
Stein, 1950 
(173) 
Gels 
dosimeter 
Gelatine/agar + dye (e.g. 
methylene blue/ phenol-
indo-2) 
Gels change color in the 
function of radiation 
dose   
Alexander et 
al, 1954 
(183) 
Solid 
polymer  
Polymethylmethacrylate Effects of ionizing 
radiation can be 
measured by viscosity 
measurement of 
irradiated    solid 
polymethylmethacrylate 
Andrew et al,  
1957 (174) 
Agar gels  Chloral hydrate agar gel Investigated depth doses 
for x-rays and electrons 
using spectrophotometry 
and pH probe 
measurements  
Hoecker and 
Watkins, 
1958 (184) 
Polymer 
liquid/gel 
Polymerizable liquid in 
gelatin capsules 
Investigated the degree 
to which a liquid 
monomer solution 
became solid through 
polymerisation due to 
radiation. 
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Boni et al, 
1961 (185) 
Polymer gel Polyacrylamide in 
polystyrene and glass 
vials  
 
Used polyacrylamide gel 
as gamma dosimeter  
Gore et al, 
1984 (175) 
Gels 
dosimeter   
Ferrous sulfate chemical 
(Fricke Gels) 
Chemical changes in 
gels due to irradiation 
can be measured by 
nuclear magnetic 
resonance imaging 
(MRI) 
Kennan et al, 
1992 (186) 
Aqueous 
solution  
N,N’-methylene –bis-
acrylamide and agarose 
Study the NMR 
longitudinal relaxation 
which showed that the 
relaxation rate increased 
with absorbed dose 
Maryanski et 
al, 1993 
(176) 
Polymer gel  BIS, Acrylamide, 
nitrous oxide and 
agarose (BANANA) 
Proposed new 
formulation of polymer 
gel based on 
polymerization of 
monomer (Acrylamide 
and BIS monomers 
infused in agarose 
matrix)  
Maryanski et 
al, 1994a,b 
(177-178) 
Polymer gel BIS, Acrylamide, 
nitrogen and gelatine 
(BANG) 
New formulation of 
polymer gels were 
introduced by replacing 
agarose with gelatin  
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Baldock et 
al, 1998a 
(179) 
Polymer gel Gelatine, Acrylamide,  
BIS (PAG) 
Introduce simple and 
inexpensive method to 
fabricate polyacrylamide 
gel.    
Pappas et al, 
1999 (180) 
Polymer gel N-Vinylpyrrolidone, 
BIS, Gelatine  
Developed different 
composition of polymer 
gel based on  N-
Vinylpyrrolidone 
 
Lepage et al, 
2001a (181) 
Polymer gel Acrylamide/acrylic acid/ 
methacrylic acid/ 1-
vynil-2-pyrrolidinone/ 
2-hydroxyethyl 
methacrylate/ 2-
hydroxyethyl acrylate, 
gelatin/ agarose, BIS 
Study of different 
formulations of polymer 
gel using different types 
of monomers. 
Fong et al, 
2001 (187) 
Normoxic 
polymer gel  
Methacrylic acid, 
gelatine, hydroquinone, 
copper sulphate, 
ascorbic acid 
(MAGIC)  
Developed normoxic 
type of gels  
De Deene et 
al, 2002a 
(188) 
Normoxic 
polymer gel  
Gelatin, Methacrylic 
acid/ Acrylamide 
ascorbic acid/copper (II) 
Sulphate/THP/N-acetyl-
cysteine hydroquinone, 
BIS 
Study of different 
chemical components of 
normoxic gels. THP was 
found to be the most 
reactive antioxidant. 
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Many publications on different compositions and formulations of polymer 
gels are available (189-190). Numerous studies have also been conducted on 
potential clinical applications of polymer gels especially using normoxic type gel 
dosimeter (172). 
 
 
6.1.2 Basic chemical reaction of polymer gel  
 
Given the number of different compositions of gels have been investigated 
and the length of time over which these investigations have occurred, the 
fundamental chemical reactions of gels to ionising radiations are well understood. 
For different compositions of polymer gels, water is the main constituent; 
comprising about 90% of the gels’ weight. The chemical changes which occur in 
gels due to ionising radiation are indirectly produced by radiolysis of water (191). In 
this process, water molecules are dissociated into several highly reactive radicals 
and ions(192-193). These radicals and ions subsequently react with monomers. The 
decomposition of water to the reactive intermediate (R•) can be written as shown in 
equation (13) (172) :  
 
•→ RH
Dk
202  
 
( 13 ) 
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H2O = water   
R• = reactive intermediate 
kD = dissociation rate  
  
Interaction of the radicals produced from the dissociation of water with the 
monomer leads to the polymerization of the monomers (172). The initiation process 
is represented in the equation ( 14 ) below: 
  •• →+ 1MMR  
                
( 14 )                                                                                             
M = monomer  
M1• = polymer  
This initiation process leads to growth of the polymer by chain propagation 
reaction and it continues until it reaches termination point (172). 
 
6.1.3 Applications and limitations of polymer gels 
 
Polymer gels have been used for basic dosimetry including dose 
distributions, determination of internal dosimetry and evaluation of tissue 
heterogeneity for various clinical applications (172). The ability to record doses in 
3D makes polymer gels the attractive dosimetric tool to measure and verify dose 
distribution. Polymer gels have been used to verify dose distribution in phantoms 
obtained with treatment planning in conformal radiotherapy (194). They have also 
been proven to be employed for IMRT treatment verification and regular QA (195-
196). As 3D dosimeters, polymer gels are very useful for visualisation of steep dose 
gradient and dose distribution in high and low dose brachytherapy source (197).  
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Polymer gels have also been successfully applied for measurement of 3D 
dose distributions of proton beams (198-199) and heavy ion beams (200). 
Farajollahi et al (2000) used polymer gels for boron neutron capture therapy and 
observed an increase in dose response in a PAG doped with boron as compared to 
an undoped PAG (201). This study showed that polymer gels can also be doped with 
other elements or chemicals such as boron. Experiments have also been undertaken 
to investigate the dosimetry of unsealed therapy radionuclides I-131 (202-203) and 
P-32 (204). This wide scale of applications is due to the dosimetric properties of 
polymer gels; their stability, spatial integrity, temperature insensitivity, dose rate, 
energy dependence and tissue equivalence (172) . 
  
However, there are some limitations of polymer gels which must be taken 
into account whenever they are employed. Gel experiments are time consuming 
since the whole process of fabrication, irradiation and scanning requires a minimum 
of 45 hours to complete (172). Oxygen contamination also is considered to be a 
significant issue in polymer gel dosimetry. Precautions must be taken, such as the 
use of well sealed glass or Barex vials, and experimental protocol must be observed 
in order to avoid oxygen contamination to the gels. Experimental parameters such as 
temperature, dose rate and scanning parameters must also be controlled and 
optimized to ensure less uncertainty as well as reproducible and reliable results.  
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6.2 Dose enhancement measurement using polymer gel  
 
Polymer gel dosimeters are a type of radiation dosimeter used in medical 
radiation therapy that are able to directly measure the effects of contrast agents or 
metallic radiation dose enhancers such as iodine and AuNPs inside the dosimeter. In 
gel dosimeter, contrast agents can be impregnated inside the dosimeter itself and 
therefore the effects of this material can be directly quantified. The tissue equivalent 
property of polymer gels also serves as a good phantom to simulate the application 
of medical radiation to the human body. Physical measurement of the dose 
enhancement produced by high Z materials with other types of radiation dosimeters, 
such as films and ionisation chambers, are quite complicated although there have 
been some attempts to use these dosimeters (205-206). The use of dosimeters does 
have its limits; researchers must rely on Monte Carlo simulation or biological 
measurement to obtain in vitro or in vivo results.   
  
Physical measurements of the dose enhancement produced by high Z 
materials in normoxic polymer gels have been taken using iodine (85-86, 207). 
These studies show that such a contrast agent can be added to nPAG without 
changing the dose linearity properties of the gel or producing any effects on MRI 
scanning. The linear relationship between spin-spin relaxation rates and delivered 
doses is conserved with addition of iodine. Fricke gels have been used to quantify 
the dose enhancement by gold microspheres before (88). However, Fricke gels 
failed to detect the expected increase when used to measure the dose enhancement 
of iodine, mainly due to their low sensitivity (208) . For the first time, polymer gels 
are used with AuNPs and the dose enhancement caused by such particles is 
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quantified to validate the findings of cell culture studies as discussed in the previous 
chapters.  
 
 
6.3 Materials and Methods  
 
6.3.1 AuNPs preparation for phantom study 
 
There are two types of AuNPs used in this study. In the majority of the 
experiments conducted, Spherical AuNPs (1.9 nm) obtained in a powder form from 
Nanoprobes Inc. (Yaphank, NY 11980, U.S.A.) were used. These AuNPs were 
diluted with ultra pure water to the required concentration before being mixed with 
polymer gels. In some experiments, AuNPs of 2 nm size, obtained from Meliorum 
Technologies, Inc. (Rochester, NY 14607, USA) as gold nanoparticles in aqueous 
solution (Au.H2O) with concentration of 1M were also used. The AuNPs were 
diluted with ultra pure water to the required concentration.  
 
6.3.2 Polymer gel dosimeter preparation method  
 
The nPAG polymer gels used in this study were prepared using the method 
based on work documented previously (209-210) (Wong et al 2009, McJury et al 
2000). The gel solution consists of water (89% of total mass), acrylamide (3%), 
N,N’-methylene-bisacrylamide (3%) and gelatine (5%). The gel components were 
mixed together at 40-45 °C in a 500 ml beaker. 5 mMol/L of an oxygen scavenger, 
Tetrakis (hydromethyl) phosphonium chloride (THPC), was added to the gel 
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mixture to remove oxygen from the gel solution. The gel solution was then 
separated into 2 batches. AuNPs of sizes 2 nm were added to the first batch of the 
gel. The final concentration of AuNPs when mixed with the gel solution is 1 
mMol/L (0.197 mg/ml). The AuNPs were observed to mix homogeneously in the 
gel. The second batch of the gel without AuNPs was used as a control. The gels 
were poured into separate vials. The vials were then sealed with parafilm 
surrounding the cap. Table 7 describes the type of vial used in the experiments 
conducted during this work. For the experiments using plastic vials, the samples 
were placed in a flask containing argon gas before irradiation to protect them from 
the atmospheric oxygen. The samples were only taken out for irradiation purposes. 
Most of the experiments were done using the glass vial and Pyrex® disposable 
culture tubes.  
 
Table 7: Type of vials used for the study using normoxic polymer gels. 
Type of 
container 
Dimension  Volume  Company  
Pyrex® 
disposable culture 
tubes 
13 x 100 mm 7.5 mL Sigma Aldrich Pty. 
Ltd. 
Glass vials  8 x 40 mm 1 mL Kimble Glass Inc. 
Plastic vials  15 x 50 mm  7.5 mL N/A 
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6.3.3 Polymer gels irradiation 
 
All the samples were irradiated with x-rays from various sources and of 
energies ranging from kilovoltage to megavoltage electron beam. The kilovoltage 
range of energies was derived from a synchrotron beam line and superficial x-rays 
therapy machine while the megavoltage electron beams were obtained from a 
medical type linear accelerator (LINAC).  
 
6.3.3.1. Kilovoltage superficial x-ray beam irradiation 
 
Irradiation of the gel samples was carried out at the William Buckland 
Radiotherapy Centre (The Alfred Hospital, Australia) using 80 kV from a 
superficial x-rays therapy machine (Therapax 3 Series, Pantak Inc., Branford, CT, 
U.S.A.). The gels were set at 15 cm from source under a 5 cm diameter collimator 
with a 2.0 mmAl (2.2 mmAl Half Value Layer) filter.  Irradiation was made at 
single fraction with dose rate of 1.008 Gy/min. The gels were irradiated with dose 
up to 25 Gy. The setup is displayed in Figure 77 and Figure 78. Figure 79 and 
Figure 80 show the samples of gel irradiated with kilovoltage x-rays from 
superficial machine therapy.  
 
The uniformity of x-ray doses profiles were verified using radiochromic film 
(GafChromic film EBT, International Specialty Products, Wayne, NJ) and a parallel 
plate ion chamber in conjunction with 2570/1 Farmer dosimeter (NE Tech) is used 
for calibration. The dose profiles from radiochromic film were shown in figure 33 
and 34 in section 3.3.4, chapter 3.  
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Figure 77: The gel irradiation set up using the x-rays from a superficial therapy machine. 
Polymer gel samples with and without AuNPs were irradiated simultaneously with the same 
dose. 
 
 
Figure 78: The irradiated polymer gel samples with and without AuNPs  
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Figure 79: The polymer gels without AuNPs (control samples) irradiated with different doses of 
x-rays. These samples were irradiated with 80 kVp of x-rays from superficial therapy machine. 
 
 
Figure 80: The polymer gels embedded with AuNPs irradiated with different doses of x-rays. 
These samples were irradiated with 80 kVp of x-rays from superficial therapy machine. 
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6.3.3.2. Megavoltage electron beam irradiation 
 
The experiments were performed with 6 MeV electrons from a medical LINAC 
(Clinac 2100C, Varian Associates Inc., Palo Alto, CA, U.S.A.). The gels were set up 
in water at SSD=100 cm using a 10 x 10 cm2 electron applicator as shown in Figure 
81. Irradiations were also done in single fraction with constant dose rate of around 
200 MU/min. The gel samples were exposed to radiation doses ranging from 0 to 70 
Gy in water. The electron beam doses delivered by LINAC were verified with 
parallel plate ionisation chamber. 
 
 
 
Figure 81: The schematic illustration of the gels irradiation set up with 6 MeV electron beams. 
Image not to scale.  
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6.3.3.3. Synchrotron beam irradiations 
 
Gel irradiation was performed on beamline BL28B2 at the Spring-8 
Synchrotron, Japan using x-ray beams that was filtered through 3 mm thick copper 
filter with mean energy of 125 keV produced by the standard bending magnet of the 
storage ring (168). The beam current in the storage ring was kept constant at 
approximately 100 mA with an aid of a top-up operation.  The dose of the x-rays 
was measured by a parallel plate ionisation chamber and have been reported in the 
literature (S-1194A1, OKEN, Fusa, Japan) (211). 
Both pure nPAG and nPAG-AuNPs were irradiated with doses ranging from 
5 to 300 Gy. The experimental setup and dimension of the beam was 10 mm 
horizontally and 2 mm vertically as shown in Figure 82 and Figure 83 . 
Radiochromic films were tagged to the gels during the irradiation and then used to 
validate the dose received by the gels as shown in the Figure 82. The films were 
then scanned and analysed using an Epson perfection V700 photo flatbed scanner 
(Seiko Epson Corporation, Nagano, Japan). The scanning procedure is described in 
previous work (212). 
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Figure 82: Gel sample irradiated with synchrotron beam. Gafchromic film is tagged behind the 
gel from the beams. 
 
 
 
Figure 83: The gels irradiation set up at synchrotron beamline. 
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6.3.4 MRI scanning of the gels 
 
Irradiated and non-irradiated gel samples were scanned using a 1.5 T MRI 
scanner (GE Signa, Milwaukee, USA) at the Radiology department, The Alfred 
Hospital, Melbourne, Australia, to determine the spin-spin relaxation time of the 
free protons in the gels using the head coil of the MRI. A fast-spin echo sequence 
was used with the following parameters: head coil, field of view = is set to 180 mm 
x 180 mm. This results into resolution of 1 mm, slice thickness 1 mm, TE (echo 
time) = 92.7, TR (repetition time) = 5360, matrix = 256 x 256 and total imaging 
time =11 Min 37 seconds. These MRI parameters are the optimum parameters for 
gel scanning since they give reasonable dose resolution. The gels were scanned after 
a minimum of 24 hour had elapsed since the irradiation of the gels to allow for full 
polymerisation to take place. The samples were scanned three times to reduce the 
uncertainties in T2 measurements.  Figure 84 show the scanning setup. 
 
Figure 84:  The gels samples scanning with 1.5 T MRI. The gels samples were placed in the 
middle of head coil for scanning.  
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6.3.5 Data analyses 
Analysis of the scanned gel images was performed using programs written 
using MATLAB software (version 7.4.0.287) (The Math Works Inc., Natick, 
Massachusetts, USA). The programs calculated the T2 values and formed the T2 
maps on a pixel by pixel basis as explained in the works (209, 212). The levels of 
the polymerisation of the irradiated gels with and without AuNPs were compared by 
comparing the R2 value (spin-spin relaxation rate) which is 1/T2 (T2 is spin-spin 
relaxation time). The data were also analysed by taking the difference of T2 value 
(∆T2) between irradiated area and non irradiated area. This ∆T2 shows the level of 
polymerisation which is proportional to the dose.   
 
6.3.6. Experimental uncertainties 
There are two types of errors which are part of this and any other 
experimental work: experimental error and statistical error. Experimental errors 
arise from each step of the experiment, starting from the gel preparation, irradiation 
and gel scanning. In the gel preparation, error becomes a factor when different 
batches of gel are used for different experiments. Although the same methods and 
chemicals are used, there was a variation in the weight (w/w) of each chemical of 
approximately ±2%.  During irradiation, the accuracy of the dose delivered varies 
for different modalities used. The accuracy for x-ray dose delivery by linear 
accelerator and superficial x-ray therapy was ±5%, measured using ionisation 
chambers. The dose profiles from radiochromic film show less than 2% variation.  
The dose delivered by a synchrotron x-ray beam is highly intense and previous 
measurements estimate a 5% uncertainty in delivered dose (211). In this work, we 
used EBT type gafchromic film to validate the dose given to the gel. The film 
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reading is shown in the results and discussion section. The uncertainty associated 
with film measurement can be attributed to possible errors in calibration, 
nonuniform thickness of the film and reading uncertainties of the densitometer.  
Main sources of error in this work come from the MRI scanning. The MRI 
inhomogeneities have great bearing on the T2 measurement. The T2 uncertainties 
were calculated by taking the mean standard deviation of the T2 value. The 
uncertainties in T2 were found to be around 10-20%.  
 
6.3.7. Statistical analysis 
Statistical analysis is based on the one way analisis of variance (ANOVA) 
using OriginPro 7.5 SR0 v7.5714 (B714) software. Significance level was set at a 
value of p < 0.05. The data presented in this chapter (mean values ± standard 
deviation) was the result of 3 independent experiments.  
 
6.4 Results 
 
The dose measured by the pure nPAG and the nPAG with AuNPs were 
plotted as dose response curves between the x-ray dose as the x axis against the R2 
(spin-spin relaxation rate). The R2 parameter is equal to 1/T2 (T2 is spin-spin 
relaxation time) and in function of dose. It is a generally accepted parameter used to 
evaluate the polymer gel dosimeter performance. The linear relationship of what the 
curves showed for the different energies and dose ranges used is shown in Table 8. 
Table 9 shows the correlation coefficients for the linear fitting curve between x and 
y. The experimental data is well modelled through a linear fit curve and good 
correlations are obtained for all of the experimental results as displayed in Table 9. 
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However, the linear relationship of dose and R2 is broken at high doses beyond 50 
Gy. 
The DEF is defined as the gel sensitivity or the curve slope ratio of R2 
versus x-ray dose in nPAG-AuNPs versus pure nPAG as described in Equation (15):  
withAuNPs
PswithoutAuN
ysensitivitGelPolymer
ysensitivitGelPolymer
DEF =
 
 
(15) 
 
Figure 85 shows the dose response curve for gels irradiated with 80 kV x-ray 
beams from superficial x-ray therapy machine. The nPAG-AuNPs shows a dose 
enhancement factor of 1.64 which is about 4.2% at 20 Gy compared to the gel 
without AuNps. Figure 86 is the dose response curve for gels irradiated with 6 MeV 
electron beams and the DEF calculated was 1.47 lower than that obtained with kV 
beam. The dose enhancements measured were 3% at 40 Gy electron beams. Figure 
87 and Figure 88 show the dose response curves from synchrotron beams of 125 
keV mean energy from two different experiments. The DEF calculated for the first 
experiment is 1.76 and for the second experiment is 1.72, which indicates 
approximately 6.3% and 4.5% dose enhancement respectively. The results also 
show great reproducibility which less than 2% variation for both experiments.  The 
x-ray dose delivered by synchrotron beam was validated using radiochromic film, as 
explained in the materials and methods section, and its dose linearity was confirmed 
as shown in Figure 89. Figure 90 shows the readings of the film placed behind the 
gels during irradiation to indicate the x-rays attenuation of AuNPs and nPAG. The 
film placed behind the nPAG-AuNPs samples received less x-rays than the film 
behind the nPAG. It shows some attenuation at about 1-2%. This is attributable to 
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the high Z properties of AuNPs. However, at high concentration of AuNPs, 
significant amount x-ray attenuation will be observed.  
 
Table 8: The details of gels samples and experimental details for each study 
Energy Field 
size 
Type of vials  Volume 
(dimension) 
Dose 
range 
explored 
(Gy) 
Dose 
range of 
linear fit 
(Gy) 
80 kV (SXRT) Broad 
beam  
Plastic and 
Glass vial  
(Kimble Glass 
Inc.) 
1 mL 
(8 x 40mm) 
 
0-25  0-25 
Electron  
(6 MeV) 
Broad 
beam 
Plastic and 
Glass vial 
(Kimble Glass 
Inc.) 
 
1 mL 
(8 x 40mm) 
 
0-80 0-45 
125 keV 
(1stexperiment)  
2mm x 
10mm 
Glass vial  
(Kimble Glass 
Inc.) 
 
1 mL 
(8 x 40mm) 
 
0- 80 0-50 
125 keV 
(2ndexperiment) 
2mm x 
10mm 
Glass vial  
Pyrex® 
disposable 
culture tubes  
(Sigma-Aldrich 
Pty. Ltd.) 
7.5 mL 
(13 x 
100mm) 
 
0-70 0-35 
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Table 9: The correlation coefficient for the linear fit, sensitivity and dose enhancement for 
nPAG with and without 2 nm AuNPs (0.197 mg/ml) at different energies. The standard 
deviations of the sensitivity and dose enhancement factor (DEF) are obtained from the 
uncertainties in the linear fits. 
Energy Type of 
Gels  
Correlation 
coefficient  
Sensitivity (s-1 Gy-
1)  
Mean (σ) 
DEF  
mean 
(σ) 
nPAG 0.99762 7.21 E-3 (1.15 E-3) 80 kV (SXRT) 
nPAG-
AuNPs 
0.99916 11.84 E-3 (1.2 E-3) 
1.64 
(0.44) 
nPAG 0.99802 3.03 E-3 (0.636 E-3) Electron  
(6 MeV) nPAG-
AuNPs 
0.99659 4.46 E-3 (0.635 E-3) 
1.47 
(0.54) 
nPAG 0.99092 3.25 E-3 (0.376 E-3) 125 keV  
(1stexperiment) nPAG-
AuNPs 
0.99700 5.71 E-3 (0.414 E-3) 
1.76 
(0.34) 
nPAG 0.99437 2.08 E-3 (0.125 E-3) 125 keV 
(2ndexperiment) nPAG-
AuNPs 
0.99609 3.58 E-3 (0.135 E-3) 
1.72 
(0.17) 
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Figure 85: Dose response curve for pure nPAG and nPAG-AuNPs irradiated with 80 kV x-rays 
from superficial therapy machine. The errors were mean of standard deviations of the R2 
value. 
 
Figure 86: Dose response curves for pure nPAG and nPAG-AuNPs with and without AuNPs 
irradiated with 6 MeV electrons. The errors were mean of standard deviations of the R2 value. 
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Figure 87: Dose response curves for pure nPAG and nPAG-AuNPs irradiated with 125 keV x-
rays from synchrotron source (1st experiment). The errors were mean of standard deviations of 
the R2 value. 
 
Figure 88: Dose response curves for pure nPAG and nPAG-AuNPs irradiated with 125 keV x-
rays from synchrotron source (2nd experiment). The errors were mean of standard deviations of 
the R2 value. 
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Figure 89: The dose delivered by 125 keV synchrotron x-rays beams measured by 
radiochromic films. 
 
 
Figure 90: The dose delivered by 125 keV synchrotron x-rays beams measured by 
radiochromic films. Comparison of the film tagged behind the gels with and without AuNPs. 
The errors were calculated from the films scan reading. 
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6.5 Discussion 
 
The comprehensibility of the results of these experiments is a strong 
indication of the feasibility of introducing AuNPs into polymer gel dosimeters. They 
are clearly able to be scanned with an MRI scanner just as the gels without such 
metallic particles. Doping polymer gels with metallic atoms (not in nanostructure 
format) has been documented and used to determine the effects of such metallic 
atoms on the dose deposited in the gels (213). In those works, the main types of 
atoms used were iodine and gadolinium based compounds. Generally, dose 
enhancement is calculated from the comparison of the dose measured by gels with 
and without inclusion of the metallic atoms. The measured dose is related to the 
dose indicator factor “T2 relaxation time” of the MRI parameter for the two gels 
(with and without AuNPs). Here, the gels are from the same batch and exposed to 
irradiations under same conditions. However, iodinated compounds have been 
observed to interfere with the interaction processes between the ions and monomers 
(214). It has been proven that iodinated compounds, such as sodium bromide and 
sodium iodine, consist of halide ions which can somehow prevent the 
polymerization reaction to certain extents (214). It is important to take into account 
the chemical properties of radiation dose enhancer that will affect the measured 
dose. In this work an aqueous solution of AuNPs was used to avoid competition in 
the polymerisation process in contrast to the addition of the iodine compounds.  
 
Figure 85, Figure 87 and Figure 88 show the significant dose enhancement 
caused by x-rays in the kilovoltage range of energies in gels with AuNPs in 
comparison to the same type of gels without such particles. Dose enhancement by 
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high Z materials is believed to be caused predominantly by the enhanced the 
likelihood of the photoelectric interaction which they provide. When AuNPs are 
added to the gel and the gel is subsequently bombarded with kilovoltage x-rays, the 
photoelectric interaction cross section increases; i.e. the probability of such 
interaction is enhanced. This can be clearly inferred from the interaction 
probabilities of such x-ray photons with gold atoms in comparison to their 
interaction with the tissue equivalent medium such as water. This is indicated in 
Figure 91 showing the probability of photoelectric absorption change with 1% of 
gold in water compared to pure water. Data is obtained from the XCOM: Photon 
Cross Section Database, National Institute of Standards and Technology (110).  
 
At 80.72 KeV (the K-edge value of gold), the photoelectric cross section for 
water is only 5.60 x 10-3 . It is increased to 6.12 x 10-3 with the presence of AuNPs 
(NIST). This photoelectric probability hike will lead to the production of many low 
energy photoelectrons, characteristic x-rays and Auger electrons as by-products of 
this interaction. For illustration purposes, let us take one x-ray photon of about 90 
keV and follow its interaction in the polymer gels with and without the existence of 
the AuNPs. Simple Monte Carlo simulation (EGSnrc Monte Carlo code) shows that 
the photoelectron energy will be around 9 KeV. This can easily be calculated by 
subtracting the incident photon energy from the k-shell binding energy; the 
remaining energy is that of the photoelectron. If such a photoelectron was generated 
at the centre of the nanoparticles of about 2 nm in diameter, then it needs to traverse 
about 1 nm of gold medium before becoming ready to ionise the tissue atoms. This 
means that the photoelectrons generated inside the AuNPs will exit the particle with 
less than 9 keV. Beside these photoelectrons, the many Auger type electrons of 
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much lower energy which are generated could escape the particle and be ready to 
ionise the atoms in the surrounding medium. Many of these secondary electrons will 
be of low energy and could qualify to be of high LET type.  
 
The characteristic x-rays produced by gold atoms have a maximum energy 
of around 72 KeV. X-rays at this energy will be able to ionise other atoms and lower 
energy will be absorbed to produce the Auger electrons. Auger electrons are 
generally of low energy and are normally considered to be of high LET for 
dosimetry purposes. The generation of such high LET low energy electrons (both 
via photoelectron and Auger electron) will lead to maximum dose deposition locally 
hence serve to enhance the dose.   
 
As shown in Figure 86, the dose enhancement for megavoltage electron 
beam is less than that observed for kilovoltage beams. This is due to the number of 
higher energy secondary electrons which are produced. These secondary electrons 
travel further away from the point of interaction to deposit energy at larger distances 
from the point of interaction and, in most cases; some part of it will be outside the 
target volume. For instance, a 6 MeV electron beam will produce secondary 
electrons of approximately 0.5 MeV and below. These are likely to escape the gels 
and in so doing deposit most of their energy outside the target. The presence of high 
Z AuNPs also increases the probability of radiative interaction of the electrons. 
Some x-rays will be produced, those x-rays will ionise atoms and hence produce 
some low energy electrons. This may contribute to the dose enhancement observed 
with megavoltage electron beams even though the number of low energy electrons 
is less than that produced by low energy x-rays beams.  
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The experiments which have been conducted also show that nPAG gel can 
be an excellent dosimeter for small field size dosimetry with the presence of a high 
Z contrast agent which is difficult to be measure by most other type of dosimeters 
(212). The application of such gels with the dose enhancing ability is applied to 
further, smaller fields generated by synchrotrons (of about 2 mm in size) as shown 
in Figure 82. This field size was used to mimic the synchrotron based SSR beam 
and is also the lowest resolution that can be imaged by the MRI scanner used to 
image the gel. Many studies have been done using iodine for SSR treatment (213). 
Prolonged survival was demonstrated in animal with radioresistant F98 Glioma but 
no long term survivors were observed with iodined enhanced SSR (159). 
Nevertheless, first human clinical trial is expected soon at ESRF due to the 
simplicity of the technique and availability of the widely used iodine contrast agent 
(10, 84). Better cure rate is expected with other metal elements such as platinum and 
gold especially in the particle form. It is observed here that the lower concentrations 
of AuNPs used in this study produced the same effects as iodine at higher 
concentrations. AuNPs clearly produce greater dose enhancement and have more 
desirable properties compared to iodine (91).  
 
This study provides verification of the theory that AuNPs can be embedded 
into the polymer gels and that these gels can be used for measurement of dose 
enhancement by the existence of the high Z material. Quantification of dose 
enhancement by 1.9 nm AuNPs using polymer gels was successfully conducted in 
this work. However, data from previous studies has shown that the particle size and 
shape affects on the intracellular and intratumoral uptake, which can also possibly 
affect the dose enhancement (106). Using polymer gels, the effects of AuNPs size, 
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shape and chemical structure can be investigated and used to validate the current in 
vitro and in vivo dose enhancement data. Just such a study is currently underway. 
 
 
 
 
Figure 91: Photoelectric probability for water and mixture of water and 1% of gold (data 
obtained from NIST:x-com) 
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6.6 Conclusion  
 
In this chapter, the dose enhancement produced by AuNPs was measured 
using polymer gel dosimeters. This study is further validation of dose enhancement 
measured biologically using cell culture. From these two studies, AuNPs can 
conclusively be seen to produce significant dose enhancement when irradiated with 
low energy x-ray in kilovoltage range. It has also been established that the 
techniques of using polymer gel can be applied to quantify dose enhancement by 
high Z particles. This agrees with previous studies measuring the dose enhancement 
provided by iodine contrast agent using the same type of polymer gel (85-86, 207).  
Relative comparison of R2 as a function of absorbed dose and variation in 
sensitivity for gels with and without AuNPs is a practical method to evaluate the 
effects of dose enhancement. Further investigation of different gel compositions or 
scanning techniques will be useful for more detailed study. Evaluation of the use of 
different parameters, such as dose resolution, will give additional insight into the 
usefulness of polymer gels doped with metallic particles.  
This work represents the first attempt of employing phantoms such as 
polymere to quantify the enhancement of dose caused by the AuNPs. So far the 
studies are based on biological investigations using either in vivo or in vitro based 
measurements. Also some simulations have been documented regarding calculations 
of the levels of dose enhancement by nanoparticles, but these simulations does not 
consider the geometry of these particles they only considers the density of the atoms 
in the solvent. 
AuNPs have been used in preclinical studies using a murine tumour model 
but still lack of dosimetric data, which to date has been limited to data from 
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computational simulation study and biological study. Physical measurement using 
polymer gels can be useful where dose distribution in the real patient set up is not 
possible to be used for such investigation. Polymer gels can provide integrated dose 
distribution in 3D anthropomorphic phantom and have been used in conformal 
radiotherapy for treatment verification and quality control (172). More data is 
needed before AuNPs can, like synchrotron stereotactic radiosurgery (SSR) 
treatment using iodine, progress towards its first human clinical trials. Polymer gel 
dosimetry for dose enhancement measurement by AuNPs will be a very useful tool 
for the acquisition of this data.  
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7. CONCLUSION AND FUTURE DIRECTIONS 
 
7.1 Conclusion  
 
This thesis comprises novel and original work based on innovative 
techniques and methods of implementing nanotechnology into medical radiations in 
general and radiotherapy in particular. The investigations are based mainly on 
AuNPs role as radiosensitisers to enhance radiotherapeutic ratio.   
This thesis investigates and discusses several characteristics of AuNPs which 
make them ideally suited for application in radiotherapy. The effects of AuNPs on 
radiation dose enhancement have been comprehensively analysed using biological 
and phantom studies. These studies included synchrotron based MRT and SSR. The 
major findings of this thesis are:   
 
• The dose enhancement produced by AuNPs from experimental studies using 
BAECs irradiated with 1-7 Gy range of radiation doses at different concentrations of 
AuNPs was quantified for different types of external radiation sources and beam 
energies. The data was analysed in the form of cell survival curves, where DEFs 
were deduced. Dose enhancements were found to be maximal at the kilovoltage 
range of energy, with significant dose enhancement also observed for megavoltage 
electron beam. High energy external photon beams show less dose enhancement 
compared to low energy x-rays and electron beam radiotherapy. Conclusively, dose 
enhancements are more prominent at low energy x-rays compared to the high energy 
x-rays. AuNPs concentration was found to affect the DEF values with higher DEF 
being observed at higher concentrations of AuNPs.  
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• The radiobiological effects of AuNPs on the cells were analysed and the data 
fitted to the linear quadratic model once parameters such alpha (α) and beta (β) were 
obtained. It was found that the linear parameter or α value increases with the 
inclusion of AuNPs while the quadratic part of the curve or β value undergoes very 
small changes that do not show any predictable trend. Mean inactivation dose ( D ) 
was also calculated and the ratio of D with and without AuNPs was used to 
calculate DEF. Analysis of D  showed good agreement with the results obtained 
from the DEF extrapolated from the survival curve and supports the findings 
obtained using linear quadratic model.  
 
• The application of AuNPs to specialised technique in radiotherapy; synchrotron 
based MRT and SSR was investigated. The potential AuNPs possess to facilitate the 
reduction of the very high dose (100 – 4000 Gy) employed in both techniques was 
demonstrated and an analysis was conducted to determine the lowest dose that can 
be applied in the presence of AuNPs to yield similar results as are observed in their 
absence. Dose enhancement study for MRT was conducted using cell culture and for 
SSR this was conducted using polymer gels. MRT was delivered to endothelial cells 
‘as a target’ using the microplanar beam collimator at Spring8 Synchrotron in Japan. 
For the SSR study using polymer gels, the synchrotron beams were collimated to 
very small dimension fields (about 2 mm) of the type used in SSR.  The results of 
the dose enhancement by AuNPs were found to be consistent with previously 
documented results for broad beams. It was determined that AuNPs can potentially 
be applied as radiosensitiser in both treatment techniques which are currently in the 
process of moving toward clinical trials.  
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• The roles of AuNPs in cell migration, which is an important factor in the normal 
tissue healing or repair process, were also identified. This process is important in 
normal tissue recovery in MRT and also conventional radiotherapy. The study 
showed the importance of AuNPs as double agent which can enhance the killing of 
tumour cells and simultaneously induce recovery by promoting normal cell 
migration to the affected tumorous area. It was observed in this study that inclusion 
of AuNPs accelerates cell migration. The phenomenon of cell migration is observed 
when cells fill depleted gaps that have been created by the microbeams or when 
such gaps are manually made by scratching the cell culture as a wound. The reason 
behind this acceleration is not well understood; however, it has been attributed to 
either various biological processes or the effects of the electrostatic charge of such 
particles or some combination thereof. Moreover, it was also observed that the 
abnormal “glioma” cells fill the gaps in much slower rates in comparison to the 
normal ‘endothelial’ cells. This is consistent with the notion upon which MRT 
techniques are based.   
 
• Normoxic type Polyacrylamide Gel (nPAG) dosimeters were employed for dose 
measurement to validate the biological studies. The level of dose enhancement was 
determined by using polymer gel dosimeters as a phantom. Comparison of the dose 
deposited by the same beam in nPAGs with those impregnated with AuNPs was 
used as an indicator of the level of radiation dose enhancement due to the presence 
of AuNPs. A standard nPAG formulation was used in this study for calibration 
together with the nPAG doped with AuNPs (nPAG-AuNPs). This study found 
significant dose enhancement by AuNPs in polymer gel phantom when irradiated 
with kilovoltage x-rays beams from a superficial therapy machine. Lesser dose 
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enhancement was observed for megavoltage electron beams generated by a clinical 
LINAC. It was concluded that AuNPs enhance the effects of radiation, which is in 
agreement with the in vitro biological investigations which were conducted. 
 
• Assessments of cytotoxicity of AuNPs were studied with different AuNPs 
concentrations, sizes and incubation times. The end point of the toxicity study is the 
cells’ viability and changes to the cells morphology. Cytotoxicity tests conducted 
for this thesis showed that AuNPs can slightly reduce the cells’ viability, which is in 
agreement with findings of other researchers. The cytotoxic response in BAECs 
employed in this study was found to be dependent on the concentration of AuNPs 
and time of incubation. The higher the concentrations of AuNPs, the lower the cell 
viability that was observed. As for the incubation time, AuNPs were found not 
effect the proliferation of cells, as the number of cells increased with the increasing 
time of incubation. The cells’ morphology was found to undergo a slight change; 
more cells become rounded in shape in the presence of AuNPs. The cell viability 
and morphology analysis which was conducted of 1.9 nm, 2 nm and 15 nm AuNPs 
found that AuNPs may have slight toxicity to the endothelial cells but no 
statistically significant effects were observed (P < 0.05). 
 
• The localisation of the AuNPs inside the cells was also observed to determine 
whether AuNPs are taken up inside the cells. Different techniques such as darkfield 
microscopy, using confocal microscope and immunohistochemistry cell staining 
techniques were used to confirm the internalisation of AuNPs inside cells. The 
incubation period of BAECs with AuNPs was found to be approximately 24 hours, 
since this was the time that was required for the inclusion of most of the AuNPs into 
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the cells. This study also found that AuNPs were clustered in the subcellular 
compartment in the cells cytoplasm and did not enter the nucleus. 
 
• The theoretical DEF for the different elements commonly used in medical 
radiation such as gold, iodine and gadolinium are distinct. Gold is found to have 
higher DEF at most energy ranges compared to iodine and gadolinium. Optimal 
energy for maximum DEF has been found to be different for each element and not 
necessarily the k-edge value of the element. Optimal energy for maximum DEFs 
varied significantly: optimal energy for gold was found to be around 40 keV (below 
gold k-edge, which is 80.7 keV); optimal energy for iodine was found to be around 
50 keV (above k-edge 33.3 keV) and optimal energy for gadolinium was found to be 
around 60 keV (at the k-edge value). Experimental work to validate this calculated 
optimal energy for maximum dose enhancement by high Z materials, in particular 
AuNPs, is currently under investigation. 
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7.2 Future Directions 
 
Certainly this research directional arrow is clearly pointing forward indicating 
ample experimental and theoretical investigations to be tackled in future. This is clearly 
seen on the basis of rapid developments in the area of nanotechnology in general and 
nanobiotechnology in particular. Just to mention few of such investigations here that is 
currently in progress; 
 
• Energy dependence:  Monoenergetic beams needs to be used to investigate the 
effects of x-ray energy on the dose enhancement by such particles. Especially 
since the theoretical calculations presented in this thesis indicates to an optimal 
energy further than the k-edge value as anticipated on the theoretical basis of 
using gold atoms as radiation targets. The experiments have started at SPring8, 
Japanese Synchrotron Radiation Facility. Preliminary data are already obtained. 
• It will be of great value to validate these findings described in this thesis using 
different particle sizes. Such investigation will shed light on the biological and 
radiological effects of such nanostructures.  
• Also validating these studies using different types of particles of such 
dimensions “nanostructures” will also help understand the underpinning physics 
and biology. 
• These studies were focused on low energy x-rays where optimal dose 
enhancements were observed. However, it will be of great value to radiotherapy 
field to extend such investigations into higher energy x-ray beams of 
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megavoltage ranges. This is currently in planning stages for our group where 
quantum dots (another type of nanoparticles) are under investigation. 
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APPENDIX 
 
Calculation of MID and software code written using MATLAB program  
 
% Mean inactivation dose 
  
% D=2*[w/(1+x)^2]*exp[-a*[(2/1+x)-1]-b*[(2/1+x)-1)^2] 
  
a=0.01129 
b=0.00313 
w0=0.2491470458 
x0=0.1252334085 
  
f=w0/(1+x0)^2 
g=-a*[2/(1+x0)-1] 
h=-b*[2/(1+x0)-1]^2 
   
D0 = 2*f*exp(g+h) 
  
w1=0.2334925365 
x1=0.3678314989 
  
f=w1/(1+x1)^2 
g=-a*[2/(1+x1)-1] 
h=-b*[2/(1+x1)-1]^2 
   
D1 = 2*f*exp(g+h) 
  
w2=0.2031674267 
x2=0.5873179542 
  
f=w2/(1+x2)^2 
g=-a*[2/(1+x2)-1] 
h=-b*[2/(1+x2)-1]^2 
   
D2 = 2*f*exp(g+h) 
  
w3=0.1600783285  
x3=0.7699026741 
  
f=w3/(1+x3)^2 
g=-a*[2/(1+x3)-1] 
h=-b*[2/(1+x3)-1]^2 
   
D3 = 2*f*exp(g+h) 
  
w4=0.1069393259 
x4=0.9041172563 
  
f=w4/(1+x4)^2 
g=-a*[2/(1+x4)-1] 
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h=-b*[2/(1+x4)-1]^2 
   
D4 = 2*f*exp(g+h) 
  
w5=0.0471753363 
x5=0.9815606342 
  
f=w5/(1+x5)^2 
g=-a*[2/(1+x5)-1] 
h=-b*[2/(1+x5)-1]^2 
   
D5 = 2*f*exp(g+h) 
  
w6=0.2491470458 
x6=-0.1252334085 
  
f=w6/(1+x6)^2 
g=-a*[2/(1+x6)-1] 
h=-b*[2/(1+x6)-1]^2 
   
D6 = 2*f*exp(g+h) 
  
w7=0.2334925365 
x7=-0.3678314989 
  
f=w7/(1+x7)^2 
g=-a*[2/(1+x7)-1] 
h=-b*[2/(1+x7)-1]^2 
   
D7 = 2*f*exp(g+h) 
  
w8=0.2031674267 
x8=-0.5873179542 
  
f=w8/(1+x8)^2 
g=-a*[2/(1+x8)-1] 
h=-b*[2/(1+x8)-1]^2 
   
D8 = 2*f*exp(g+h) 
  
  
w9=0.1600783285 
x9=-0.7699026741 
  
f=w9/(1+x9)^2 
g=-a*[2/(1+x9)-1] 
h=-b*[2/(1+x9)-1]^2 
   
D9 = 2*f*exp(g+h) 
  
  
w10=0.1069393259 
x10=-0.9041172563 
  
f=w10/(1+x10)^2 
g=-a*[2/(1+x10)-1] 
h=-b*[2/(1+x10)-1]^2 
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D10 = 2*f*exp(g+h) 
  
  
w11=0.0471753363 
x11=-0.9815606342 
  
f=w11/(1+x11)^2 
g=-a*[2/(1+x11)-1] 
h=-b*[2/(1+x11)-1]^2 
   
D11 = 2*f*exp(g+h) 
  
MID=D0+D1+D2+D3+D4+D5+D6+D7+D8+D9+D10+D11 
  
%Notes: 
%x0=-x6=0.1252334085 
%x1=-x7=0.3678314989 
%x2=-x8=0.5873179542 
%x3=-x9=0.7699026741 
%x4=-x10=0.9041172563 
%x5=-x11=0.9815606342 
  
%w0=w6=0.2491470458 
%w1=w7=0.2334925365 
%w2=w8=0.2031674267 
%w3=w9=0.1600783285 
%w4=w10=0.1069393259 
%w5=w11=0.0471753363 
  
%D=2*f*exp(g+h) 
     
%f=w/(1+x)^2 
%g=-a*[2/(1+x)-1] 
%h=-b*[2/(1+x)-1]^2 
  
%D = 2*f*exp(g+h) 
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